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ABSTRACT
Despite recent advances in our understanding of the possible
factors involved in the local control of testicular function,
reproductive endocrinologists have suffered from a dearth of in
vitro techniques for the study of paracrine regulation of the testis.
The aims of this study were to investigate novel ways of studying
seminiferous tubule-Leydig cell interaction, with a view to
establishing techniques which would permit the investigation of
paracrine events within the testis. Linked to this, studies on the
quantitative distribution of testosterone within the testis were
undertaken.
Three separate systems for the investigation of seminiferous tubule-
Leydig cell communication have been evaluated(Chapters 3-5) and one
system has been identified, based on co-perifusion of seminiferous
tubules with Leydig cells, which provides consistent and reproducible
results(Chapter 5). The addition of isolated seminiferous tubules to
Leydig cells in 'physiological' proportions significantly enhanced
Leydig cell testosterone production. Furthermore, it has been shown
that the degree of LH stimulation to which Leydig cells are exposed
plays a role in determining their response to seminiferous tubule
stimulation(Chapter 5). This perifusion system represents a
significant improvement upon the _in vitro systems currently
available for the investigation of seminiferous tubule-Leydig cell
interactions.
Techniques for the determination of intratesticular distribution
of testosterone have, combined with histological techniques, provided
insights into the role of testosterone in the regulation of spermato-
- iv -
genesis and have also identified chemicals which may further advance
the understanding of the role of intratubular cell associations in the
maintenance of testicular function. It has been shown that, whilst
testosterone is essential for the maintenance of spermatogenesis, many
stages of the spermatogenic cycle are relatively resistant to
complete testosterone withdrawal, following destruction of the
Leydig cells(Chapter 7). Despite the removal of all Leydig cells
from the testis, complete restoration of the Leydig cell population
occurred within 10 weeks and this was associated with restoration
of near normal testicular morphology. Furthermore, results from
studies in which the intratesticular testosterone levels were reduced
suggest that under these conditions, seminiferous tubule testosterone
concentrations were conserved preferentially, either by the action of
paracrine factors, or by the retention of testosterone within the
tubules(Chapter 6).
The techniques established here will permit a number of novel
approaches to the investigation of testicular paracrine regulation.
For example, having established a reliable in vitro system for the
investigation of seminiferous tubule-Leydig cell interaction, it
should prove possible to use this as a 'bioassay' with which to assess
both the role of putative paracrine factors and the functional







The testis has long been recognised as the organ involved in
fertility in men. The Romans refused to allow the testimony of a
man to stand unless he was able to prove that his testicles were
intact, and it is from this practice that the word testify originates.
The infertility of castrates, or eunuchs, was also recognised by early
civilisations, and such individuals were in great demand for the
guarding of harems etc.
It seems surprising then that it was not until the late
seventeenth century that the existence of spermatozoa was discovered.
Even then it was some time before it was accepted that these motile
cells were in fact the male gametes and not just parasitic infections
of the urogentital tract. However with the development of the simple
early light microscopes, histologists and anatomists had access to
an area of study not previously possible, and it was Hamen, a student
working with one of the pioneers of microscopy, Leeuwenhoek, who
first described spermatozoa in 1677. Despite the backing of
Leeuwenhoek, Hamen's discovery was not accepted and it was not until
1841 that these cells were found to originate from the testis, and
in 1865 that they were proved to be involved in fertilization.
Although the structure of the testis was described in 1668 it
was many years later before the seminiferous tubule was recognised
as the site of spermatogenesis. Microscopists described the fine
structure of the tubules in the late 19th century, with the
nomenclature of the cell types being derived from their discoverers.
For example, the Sertoli cell was named for its Italian discoverer by
the German scientist von Ebner(l888) and the Leydig cell was named
after himself by von Leydig(1850). The advent of selective staining
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techniques for the Leydig cell early in the 20th century and for the
seminiferous epithelium around 1950 led to further investigations into
the structure and function of these tissues. In 1903, on the basis of
purely morphological evidence, the Leydig cell was postulated as the
site of synthesis of many of the factors responsible for the
development of male characteristics. Between the 1950's and
1960's the complex organization of the seminiferous epithelium was
shown to be arranged in distinct and recognizable stages, for which a
simple yet detailed classification system could be devised(Leblond &
Clermont, 1952a,b).
Thus over the first 300 years of research the evidence for the
involvement of the testis in fertility was mainly morphological. It
is only over the last 25 years or so that techniques for the
quantification of testicular hormones and the culture of testicular
cells have enabled detailed investigation of the physiological and
biochemical role of the testis. Investigation of the hormonal
regulation of the testis indicated the dependence of the testis upon
pituitary gonadotrophins as early as 1927. Regression of the
seminiferous epithelium and Leydig cells followed the removal of the
pituitary and renewal of spermatogenesis could be demonstrated only if
pituitary extracts were given or if whole pituitaries were
implanted(Hooker, 1970).
The presence of androgens was established in the late 1920's
leading to the purification of androstenedione and testosterone in the
1930's. The separation of pituitary products in the 1930's into
Luteinizing Hormone and Follicle Stimulating Hormone(LH & FSH) showed
that research was still predominantly female orientated, but effects
of LH on the interstitium and later its androgen-mediated effects on
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the seminiferous tubules were also demonstrated around this time in
hypophysectomized rats, and the ability of testosterone to maintain
spermatogenesis qualitatively following hypophysectomy in rats was
also shown(Smith, 1930). The ability of the gonadal steroids to
influence the pituitary secretion of gonadotrophins was also
demonstrated and the existence of a negative feedback control
established. However the role of FSH upon the adult testis and the
ability of the testis to regulate pituitary FSH production was not
established at this time, although in 1932 an FSH regulatory hormone,
inhibin, was postulated(McCullagh, 1932).
The sensitivity of the testis to heat and the dependence of
fertility upon complete descent of the testis in animals with scrotal
testes was also demonstrated in the between 1920-1935; animals in
which the testis was either heated or prevented from remaining cool by
insulation showed loss of fertility accompanied by a reduction in the
endocrine activity of the testes(Moore, 1924).
Therefore prior to the 1960's the basis for the endocrine and
biochemical investigation of the testis was laid, and the testis had
been established as an organ of amazing structural organization and
complexity, with major endocrine functions.
1.2: Testicular structure and organization:
The mammalian testis is separated into two major compartments,
the avascular seminiferous tubules, which comprise over 80% of the
testicular mass in most mammals, and the vascularized interstitium
which comprises about 16$ of the testicular mass and contains the
Leydig cells, macrophages, and other minor cell components. Because
of the high proportion of avascular tissue within the testis, it is
perhaps not surprising that the majority of mammalian species have
large volumes of interstitial fluid or testicular lymph, which fills
the interstitial spaces between the seminiferous tubules and provides
the medium for communication and transport between the vasculature and
the seminiferous tubules and interstitial cells. In rats, the volume
of interstitial fluid and its testosterone concentration increase with
age(Sharpe, 1979), and injection of hCG increases the volume of
interstitial fluid and its testosterone concentration. hCG treatment
also increases testicular capillary permeability(Setchell &
Sharpe, 1981), and this may explain the increased interstitial fluid
volume. This may contribute to the action of hCG/LH on testosterone
production seen in these animals, since increased blood flow would
result in increased LH exposure. The volume of interstitial fluid
recovered from the rat testis has been shown to reflect the
total extratubular interstitial fluid volume of the testis(Sharpe &
Cooper, 1983) and to provide a means of assessing changes within the
interstitial environment(Sharpe & Cooper, 1983). The volume of
interstitial fluid also reflects changes in the permeability of
testicular blood vessels(Setchell & Sharpe, 1981; Sharpe & Cooper,
1983).
The existence of a well documented barrier at the level of the
basal tight junctions of the Sertoli cell(Setchell, 1980), obviously
plays a part both in the maintenance of the intratesticular environ¬
ment and in controlling the entry of peripheral hormones and the exit
of hormones produced within the testis which act elsewhere, for
example to modulate the release of gonadotrophins. However, although
this is often assumed to be the only barrier within the testis there
is evidence that, at two other levels of the testis, barriers exist
which exclude substances from the testis. The first of these is at
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the level of the testicular capiliaries, and appears during puberty
as shown by Kormano(1967). The barrier excludes certain dyes from
the interstitium after puberty, which previous to the formation of
this barrier have free access to the testis(Kormano, 1967).
Substances which cross the capillary barrier may then be excluded
from entering the seminiferous tubules by either the layer of myoid
cells which surround the seminiferous tubules(Dym & Fawcett, 1970)
or by the Sertoli cell junctions which form the last of the barriers
which separate the seminiferous epithelium from the rest of the
body. The function of these barriers is presumably to isolate the
seminiferous epithelium and to allow the formation of the unique
intratubular environment necessary for the production of fully
differentiated spermatozoa. An additional effect of these barriers
is to separate the testis into distinct compartments.
Although all three of the barriers described above play a
role in this compartmentalization, it is the barrier at the level of
the Sertoli cells which has been most widely characterized(Setchell,
1980). It is impermeable to many large molecules, and functionally
separates the tubules from the interstitium. The main function of
this barrier is not merely the exclusion of certain large molecules,
but rather the maintenance of a specific ionic and hormonal
environment which enables the complex process of spermatogenesis to be
maintained(¥aites <& Gladwell, 1982). The differences in ionic
composition of seminiferous tubule fluid, rete testis fluid and
plasma show that the barrier is also capable of maintaining ionic
differences within the testis, as the concentration of potassium in
seminiferous tubule fluid is more than ten times higher that in
plasma, while sodium and chloride concentrations are lower in
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seminiferous tubule fluid than in plasma(Setchell, 1980). These
observations have been interpreted as providing evidence for the
secretion of a potassium and bicarbonate rich fluid into the lumen of
the seminiferous tubules. In terms of larger molecules their passage
across the Sertoli cell barrier appears to relate more closely to
their lipid solubility than to their molecular size(Setchell, 1980)
although some specific uptake mechanisms do exist for certain
molecules. It is thought that the lipid soluble molecules enter
by traversing the Sertoli cells(Setchell, 1980), and that water
soluble materials enter via the spaces between the cells, and hence
are obstructed by the tight junctions between Sertoli cells(Dym &
Fawcett, 1975; Russell, 1978). Specific uptake of some molecules has
been demonstrated, but the data is limited to a very few instances.
Facilitated diffusion of both glucose and testosterone has been
shown(Setchell & Middleton, 1971; Setchell & Main, 1975; Setchell,
Laurie, Main & Goats, 1978), and it has been suggested that in
situations in which testosterone production is reduced, this mechanism
could ensure that any testosterone produced is more likely to enter
the seminiferous tubules than the circulation, thus providing a means
of conserving testicular levels of testosterone. In this respect it
is interesting that when interstitial fluid levels of testosterone are
elevated following hCG treatment, then a relatively large proportion
of the testosterone produced is secreted into the bloodstream, whilst
when testosterone levels are normal, relatively less testosterone
is secreted into the bloodstream(Sharpe & Cooper, 1983).
Some molecules enter the Sertoli cells in the form of a
permeable precursor which is then transformed into an non-permeable
product, as is the case for inositol(Middleton & Setchell, 1972) and
for some amino acids(Setchell, Hinks, Volgmayr & Scott, 1967). The
presence of the Sertoli cell barrier has several important
implications both with respect to the physiology of the testis itself
and in the study of any possible testicular hormones or toxins. The
barrier appears during pubertal development(Setchell, Laurie & Fritz,
1980) and this suggests that its functional integrity is closely
linked with the production of spermatozoa, and it is therefore
interesting to note that an early sign of testicular damage
in cryptorchid animals is the appearance of vacuoles in and around the
Sertoli cell tight junctions which may lead to the breakdown of the
Sertoli cell barrier(Kerr, Rich & de Kretser, 1979b). It has also been
suggested(Setchell, 1980) that toxins with specific actions on the
seminiferous tubules could be concentrated in a similar manner to the
natural metabolite inositol, resulting in a locally toxic effect.
However, it should be noted that no such toxins are presently known.
When functional, the Sertoli cell barrier protects the haploid germ
cells from the immune system, and this may be crucial as surface
autoantigens may be expressed for the first time after meiotic
division of germ cells(0'Rand & Romrell, 1980). Although it is known
that FSH exerts its action on the Sertoli cell, it cannot penetrate
the Sertoli cell tight junctions to reach the adluminal portion of
the Sertoli cells and it is therefore interesting that FSH receptors
appear to be exclusively located on the basal surface membrane of
Sertoli cells(Orth & Christensen, 1979).
1.2.1: Organization of Spermatogenesis:
The seminiferous tubules, which are the site of sperm
production, are a highly differentiated and organized tissue.
Within the tubules, specific cellular associations can be recognized,
and cross sections of fixed seminiferous tubules show several layers
of germ cells at different stages of development, combined in a
consistent manner, and in a fixed cycle(Perey, Clermont & Leblond,
1961 ). Thus, spermatids at a given stage of differentiation are always
linked with spermatocytes and spermatogonia at a set stage of their
respective developmental processes. These stages of development can
be classified into a number of different types, and the definition of
these types has greatly assisted the study of tubular cell
interactions. Originally the spermatogenic wave of the rat was
separated into 8 stages(Roosen-Runge & Giesel, 1950), but the most
widely accepted classification now separates the wave into 14 distinct
stages based on the nuclear morphology of spermatids(Leblond &
Clermont, 1952a,b). Further subdivision of the stages shows that a
total of 27 sub-stages can be identified(Perey _et _al, 1961), but due
to the ease of identification of the 14 main stages, it is with this
system that the majority of so-called stage-dependent investigations
have been carried out. In the rat it has been shown that each stage
of the spermatogenic cycle generally comes into contact only with the
stages numerically adjacent to it(thus stage VIII will always be found
between stages VII & IX), and because of this it is possible
to dissect out pools of tubules of a specific stage(Parvinen &
Ruokonen, 1982). Whilst the type of organization of the spermatogenic
wave seen in the rat is found widely amongst other mammals, including
the primates(Roosen-Runge, 1977; Chowdhury & Marshall, 1980), man is a
notable exception to this rule. In the human testis instead of a
sequential wave of spermatogenesis as is seen in the rat, there is a
"patchy" organisation of the spermatogenic epithelium, with
considerable variation in the stages of adjacent zones of epithelium
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(Perey _e_t al, 1961). However, the most recent analysis of the human
seminiferous epithelium suggests that, as in the rat, there is a
sequential spermatogenic wave which progresses along the length of the
seminiferous tubule, but it is organized in a highly complex helical
pattern(Schulze & Rehder, 1984).
Based on the classification of the rat seminiferous epithelium
described by Leblond and Clermont(l952b), a system of transilluminated
stage dissection of whole seminiferous tubules has been developed
(Parvinen & Ruokonen, 1982), by which it is possible to distinguish
between four broad groups of stages(stages IX-XII, XIII-I, I-VI and
VII-VIIl), and also to separate out individual stages and, in the case
of stage VII, substages as well. Using this system a number of
hormonal and enzymatic differences have been described between
different stages of the spermatogenic cycle(see Parvinen, 1982 for
review, see also section 1.4 below).
1.2.2: Interstitial tissue:
The interstitial tissue constitutes about 16$ of the total testis
volume, and contains Leydig cells, macrophages, fibroblasts,
capillaries and lymphatic vessels or spaces(Christensen, 1975).
The Leydig cells form nearly 3$ of the total volume of the rat
testis, and morphometric analysis has shown that there are
approximately 22 million Leydig cells per gram of tissue(Mori &
Christensen, 1980). Whilst little is known about the physiological
role of testicular macrophages and fibroblasts, the Leydig cell has
been more widely studied,
a) Leydig cells:
The major functional component of the interstitial tissue is the
Leydig cell, which is the source of the testosterone produced by the
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testis. Studies have shown that the major intracellular organelle of
the Leydig cell is the smooth endoplasmic reticulum, which is the site
of many of the steroidogenic enzymes and comprises 60$ of the membrane
area of the Leydig cell(Mori & Christensen, 1980). The average Leydig
cell has a surface area 3 times that of a sphere of the same volume,
suggesting that the surface of the cell is highly microvillous(Mori &
Christensen, 1980). By measuring the total testosterone output of the
testis Jni vivo(Free & Tilson, 1973) and dividing by the total Leydig
cell number per testis it has been calculated that each Leydig cell
secretes an average of 0.44pg of testosterone per day, or just under
11,000 molecules per second(Mori & Christensen, 1980). Since
testicular androgens are essential for masculinization and fertility,
the role of the Leydig cell in the induction and maintenance of
spermatogenesis and fertility is a central one. It is therefore of
interest to trace the development and function of the Leydig cell,
with particular reference to the parallel development of the
seminiferous epithelium since the function of these testicular
compartments are closely interlinked and dependent on each other.
i) Leydig cell development: In many mammals there are two
distinct generations of Leydig cells with different morphological
appearances. The first generation of Leydig cells arises in utero as
early as the fifteenth day of gestation in the rat(Picon & Gangnerau,
1980), and disappear at birth or shortly thereafter, and are known as
the 'foetal' generation of Leydig cells. The timing of the appearance
of the second generation of 'adult' Leydig cells is geared to puberty,
so that in the rat it occurs almost simultaneously with the reduction
in foetal Leydig cells. However, in man these adult Leydig cells do
not appear until between 11-13 years of age(Niemi & Ikonen, 1963;
Niemi & Korraano, 1964; Labrie e_t al, 1980; Mancini, Vilar, Lavieri,
Anderson & Heinrich, 1963). These two generations of Leydig cells have
been demonstrated in the rabbit(Gondos, Renston & Goldstein, 1976),
hamster(Gondos, Paup, Ross & Gorski, 1974), and pig(van Straaten &
Wensing, 1978) and may also be present in other species. Foetal
Leydig cells possess LH receptors and respond to gonadotrophins by
secreting testosterone(Sharpe, 1982; Huhtaniemi, Korenbrot & Jaffe,
1977).
Adult Leydig cells are thought to differentiate from interstitial
mesenchymal cells. As these cells differentiate they undergo a number
of changes, including proliferation of organelles involved in the
production and processing of secretory compounds, i.e. mitochondria,
smooth endoplasmic reticulum and Golgi bodies. The full adult
population of Leydig cells is achieved primarily by differentiation
from precursor cells, with a lesser proportion being derived directly
from dividing differentiated cells(Hooker, 1970; Christensen, 1975).
In the rat, as in man, the full adult Leydig cell population is
achieved during early to mid-puberty, that is between 32-55 days in
the rat(Clegg, 1966; Knorr, Vanha-Perttula & Lipsett, 1981; Pahnke,
Leidenberger & Kunzig, 1975; Lording & de Kretser, 1972). This
development and differentiation of Leydig cells is controlled by
pituitary hormones and can be halted, and to some extent reversed by
hypophysectomy(Hooker, 1970). Whilst LH might logically seem to be
the hormone most likely to control Leydig cell differentiation,
recent studies suggest that FSH is probably more closely involved
in the differentiation of Leydig cells than is LH. Thus, it has been
shown that high FSH levels during puberty correlate well with the
development of Leydig cells(Sharpe, 1982), and using detailed
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morphoraetric evaluation of Leydig cell numbers it has been shown
that FSH treatment can increase the number of mature Leydig cells
present in prepubertal hypophysectomized rats(Kerr & Sharpe, 1985a,b).
Since Leydig cells do not possess FSH receptors, this suggests that
FSH dependent Sertoli cell factors may play a major role in the
development and maturation of Leydig cells.
ii) Heterogenity of adult Leydig cells: Isopycnic
centrifugation of adult rat Leydig cells on Ficoll gradients
indicated that there were at least two subpopulations of Leydig cells
present in the testis(Janszen, Cooke, van Driel & van der Molen,
1976). Further studies on these Leydig cell subpopulations centred
around the possibility that cells might be damaged during isolation
causing the production of more than one population. Whilst it is now
accepted that some of the cells in the three subpopulations obtained
following Percoll density gradient separation represent cells damaged
during isolation(Cooke et_ al, 1983), it is also clear that this
observation does not completely explain the presence of multiple
Leydig cell populations. Cooke et al(l983) showed that of three Leydig
cell populations, each of differing densities, isolated, 50% of the
cells in the two less dense populations (i & II) were damaged. All 3
populations specifically bound hCG and produced LH stimulated
increases in cAMP production, although levels in band I were low or
undetectable. However, LH stimulated testosterone secretion could only
be detected in bands II & III. Studies by Payne jrt a_l(l 980a) showed
that Leydig cells isolated on metrizamide gradients form two seperate
populations and it has been shown that there is no difference in the
number or affinity of Leydig cell LH-receptors between these sub-
populations, both having about 50,000 binding sites per Leydig cell
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with a Ka of 6.4-6.7 x 10%I-'' (Payne _et_ aJL, 1980a). Nor do Leydig cells
isolated in this manner shift their positions, on the metrizamide
gradients used for isolation, following a further period of
collagenase digestion(Payne _et^ _al, 1980a) suggesting that these sub-
populations do not represent damaged Leydig cells. Further studies by
the same group suggest that pretreatment _in vivo with LH increases
testosterone production _in vitro by type I Leydig cells, to levels
comparable with the responsive type II cells(Payne, Wong & Vega,
1980b); Both cell types suffered loss of LH-receptors during this
treatment. However, following collagenase dispersion, of mouse Leydig
cells, the number of LH receptors in Leydig cells from the 'less
dense' fraction of Leydig cells was decreased(Kerr, Robertson, de
Kretser, 1985c). Since this difference was not evident in Leydig cells
obtained by mechanical dispersion, it was concluded that such effects
were the result of enzymatic dispersion(Kerr _et _al, 1985c). Whilst
this may apply to LH receptor numbers, this does not conclusively
disprove the dual population theory, especially in the light of
previous data by Payne _et^ al(l 980a,b). Furthermore the presence of two
morphologically and functionally dissimilar Leydig cell populations in
mechanically dispersed cell suspensions (Kerr _et ad., 1985c) suggests
that dissimilarities that are found in the mouse following collagenase
dispersion are not wholly attributable to enzymatic damage. Further
evidence in support of Leydig cell heterogeneity is provided by
studies on _in vivo dissimilarities in the morphology of Leydig
cells. For example, it has been shown that peritubular Leydig cells
are larger that those situated in perivascular and central positions
within the interstitium, and furthermore that those cells positioned
adjacent to stages VII-VII of the spermatogenic cycle are larger that
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those positioned elsewhere(Bergh, 1982; 1983b). Therefore, since the
possibility of damage to Leydig cells during isolation has been
considered, and since _in vitro findings have now been supported
by those _in vivo, the existence of a heterogeneous Leydig cell
population would appear to be established. However, whether
the populations seperated _in vitro truly represent those seen in
vivo, and the physiological significance of such differences seen
in vitro is not yet known. Nor is it known why different
isolation procedures should result in the isolation of two or three
Leydig cell populations(see above).
iii) Hormonal regulation of Leydig cells: LH receptors
increase dramatically in numbers from about 21 days postnatally to
full maturity in the rat(Sharpe, Hartog, Elwood & Brown, 1973)
principally due to an increase in Leydig cell numbers(Sharpe, 1982).
This rise is hormone-dependent and is rapidly reversed by both
hypophysectomy and LHRH immunization(Frowein & Engel, 1975;
Sharpe & Fraser, 1979), although short term deprivation of
gonadotrophins in the adult rat has no effect(Hauger, Chen, Kelch &
Payne, 1977) suggesting a possible role for other pituitary hormones
(e.g. prolactin). Following hypophysectoray the presence of two Leydig
cell populations with different LH receptor numbers has been reported,
with approximately 50$ of Leydig cells retaining normal LH receptor
numbers(Hsueh, Dufau, Katz & Catt, 1976; Dufau, Hsueh, Cigorraga,
Baukal & Catt, 1978). As with Leydig cell numbers the rise in LH
receptor numbers correlates well with the serum levels of both
prolactin and FSH during development in the rat, suggesting that these
hormones may be involved in Leydig cell development(de Jong & Sharpe,
1977; Negro-Vilar, Krulich & McCann, 1973; see Sharpe, 1982 for
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review). Similar rises in FSH during puberty occur in the
human(Swerdloff & Heber, 1981).
It is now widely accepted that LH down-regulates its own
receptors on the Leydig cell(See Sharpe, 1982 for review). This down-
regulation is not due merely to receptor occupancy and is maximal
about 48 hours after injection of hormone. The injected dose has
little effect on the time course of receptor loss(Sharpe & McNeilly,
1978; Tsuruhara, Dufau, Cigorraga & Catt, 1977), unless pharmacological
doses of hCG(500 I.U.)are used(Haour & Saez, 1978). Following receptor
loss, levels are gradually restored over a number of days, depending
on the dose of hormone(LH or hCG) injected(Haour & Saez, 1977).
Although these studies were carried out in the rat there is evidence
that pretreatment with hCG causes LH receptor down-regulation in man
(Sharpe, Wu & Hargreaves, 1980). The loss of LH receptors has been
shown to involve internalization of the hormone-receptor complex by
aggregation of the hormone-receptor complexes in coated pits and
subsequent microphagocytosis of the vesicles at the cell surface.
The vesicles thus formed then fuse with lysosomes and the bound
hormone is degraded. It is possible that, prior to fusion with
lysosomes, the receptors are dissociated from the hormone and that
these receptors are then recycled(Ascoli, 1984). It has been shown
that prior to down-regulation of receptors there is an initial
increase in LH receptors on the Leydig cell following LH stimulation
(Sharpe, 1982; Hsueh, Dufau & Catt, 1977). This may induce initial
hyperactivity of Leydig cells in response to LH stimulation, although
the function and relevance of this change and of the subsequent down-
regulation of LH receptors remains unclear. Moreover, not only has
the physiological significance of the down-regulation of LH-
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receptors been questioned(Payne et d, 1980b), and it is suggested
that desensitization of Leydig cell steroidogenesis does not
occur except with a single administration of a high, nonphysiological
dose of LH or hCG. Moreover, additional, 'upstream', mechanisms for
the desensitization of LH receptors have been proposed(Dix,
Habberfield & Cooke, 1984). Working with cells isolated from
rat Leydig cell tumours it has been shown that following
administration of LH an 'uncoupling' of the LH-receptor interaction
with the guanine nucleotide regulatory protein involved in
activation of adenylate cyclase occurs, without the loss of LH-
receptors from the cell surface(Dix, Schumacher & Cooke, 1982). These
changes are dependent on protein synthesis, as is the subsequent
decrease in LH-receptors, although, both are preceded by an initial
rise in LH-receptor numbers, which is probably not dependent on
protein synthesis(Dix & Cooke, 1981). It now appears that treatment
of tumour Leydig cells with LH results in a two stage
densensitization of the LH-receptor action on these cells. First,
there is a lesion between the LH-receptor and the guanine nucleotide
regulatory proteinas described by Dix _et al(l 982) , which is
independent of cAMP. Secondly via a cAMP mediated desensitization of
rat Leydig cell adenylate cyclase which occurs distal to the
regulatory protein(Dix _et_ al, 1984). The physiological role of these
and other LH-receptor regulatory systems is not yet known.
Finally it is known that prolactin increases LH-receptor numbers
in a number of species, although again the physiological significance
of this event is unclear(See Sharpe, 1982 and below).
iv) Leydig cell steroidogenesis: The enzymes involved in
Leydig cell steroidogenesis(Hall, 1970; Eik-Nes, 1975; Ewing &
Brown, 1977), show a similar developmental pattern to that of
Leydig cells and LH receptors. The majority of steroidogenic enzymes
reach their peak activity at between 30-35 days postnatally(lnano,
Hori & Tamaoki, 1967; Payne, Kelch, Murono & Kerlan, 1977). The
major exception to this rule is the final enzyme in the steroid¬
ogenic pathway for testosterone, 17^-hydroxysteroid dehydrogenase.
This enzyme starts to increase in activity at between 30-40 days
of age and this increase coincides with an increased ability of the
testis to secrete testosterone(see Sharpe, 1982 for review; Inano _et
al, 1967; Payne et al, 1977).
The relative inability of the immature rat testis to secrete
testosterone has been linked to the high activity of another
steroidogenic enzyme, 5"<--reductase(Nayfeh, Barefoot & Bagget, 1966;
Folman, Sowell & Eik-Nes, 1972), which may be stimulated by the high
levels of FSH in serum observed at this time(Folman et_ _al, 1972),
resulting in the secretion of the less androgenic steroids,
androstanediol and androsterone(Purvis, Clausen & Hansson, 1978;
Podesta & Rivarola, 1974). The maturation of the rat involves the
development of a greatly increased ability of the Leydig cells to
secrete testosterone, although the total androgen output of the
testis may actually be decreased(Purvis et al, 1978).
b) Macrophages;
Macrophages are known to be present within the testes of a
number of species, including mice(Ohata, 1979) hamsters(Wing & Lin,
1977), dogs(Connell & Christensen, 1975) rats(Christensen & Gillim,
1969) and men(see Kerr & de Kretser, 1981 for review). Their precise
function is unclear, although radiolabelling techniques have shown in
the rat that they remain within the testis and do not rapidly turn over
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(Miller, Bowman & Rowland, 1983). Testicular macrophages are closely
associated with Leydig cells in both the rat(Miller _et al, 1983;
Christensen & Gillem, 1969)and dog(Connel & Christensen, 1975) -
Miller _et ail(1983) have shown that processes extending from the
Leydig cells are closely associated with 'coated' pits within the
macrophage surface membranes, and these pits may be associated with
the transport of waste materials, steroids or other Leydig cell
metabolites. Macrophages from hypophysectomized animals have been
shown to accumulate FSH, although in untreated animals they do not
show this accumulation(Orth & Christensen, 1977).
c) Fibroblasts:
The function of testicular fibroblasts is not known,
although the deposition of connective tissue is presumably mediated
by these cells. Recently, human fibroblasts have been shown to
possess the ability both to mature into Leydig cells following hCG
stimulation, and also during this maturation, the precursors have
been shown to produce quantitatively significant amounts of
testosterone(Chemes, Gottleib, Pasqualini, Domenichini, Rivarola &
Bergada, 1985). Whether this identifies the fibroblast as the only
possible Leydig cell precursor within the human testis, and whether
these results are applicable to other species, remains to be seen.
1.3: Pituitary hormone control of the testis:
Once pituitary extracts could be separated into LH and FSH,
studies upon the relative roles of these hormones and of other
pituitary and peripheral hormones within the reproductive tissues
became a priority in the understanding of testicular function and
control(See above). The properties of these hormones are now widely
studied as are their relative mechanisms of action.
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1.3.1: Luteinizing hormone:
Luteinizing hormone, synthesized in the pituitary gland, was
first purified in the 1930's and its availability provided the
means of demonstrating that LH acted upon the Leydig cells(Greep,
Fevold, & Hisaw, 1936), as it was shown that this preparation could
maintain normal Leydig cell morphology after hypophysectomy. It was
not until the 1960's that it could be shown conclusively that LH
action was restricted to the interstitial tissue of the rat(Mancini,
Castro & Seigur, 1967). During the same period studies demonstrating
in vivo localization of iodinated LH and the jin vitro binding of LH by
rat testis homogenates were also carried out(de Kretser, Catt, Burger
& Smith, 1969; de Kretser, Catt & Paulsen, 1971). The majority of
early studies confirmed that LH had no direct effects on the
seminiferous tubule, or showed effects in circumstances likely to be
associated with Leydig cell contamination of the seminiferous tubule
preparations(Cooke, Rommerts, van der Kemp & van der Molen„ 1974). LH
has been shown to bind to a cell surface receptor on the Leydig cells
(Hsueh, Dufau, Katz & Catt, 1976) although some earlier studies had
suggested that LH was present on intracellular hormone receptor
complexes(Castro et al, 1970; de Krestser ejt _al, 1971). It is now
assumed that there is a rapid turnover of LH/hCG receptors, and that,
following binding, the receptor-hormone complex is internalized and
the receptor either recycled or degraded within the cell(Ascoli,
1984). The specificity of the LH/hCG receptors has been widely
characterized(Catt, Dufau & Tsuruhara, 1971; 1972a; Leidenberger &
Reichert, 1972; Catt & Dufau, 1973) and its affinity for hCG in the
10
male rat is reported as 3x10" M(Catt et al 1972; Leidenberger &
Reichert, 1972) which falls within the range necessary for it to be
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able to detect circulating levels of LH(10 -10 M in male rats).
Available evidence suggests that LH activates adenylate cyclase,
(Cooke, Lindh & Janszen, 1977a,b; Janszen, Cooke & van der Molen,
1977) leading to the production of cAMP which then stimulates protein
kinase(Cooke, Lindh & Janszen, 1976; Cooke & van der Kemp, 1976) and
protein synthesis and/or phosphorylation(Cooke et al 1975; Janszen,
Cooke, van Driel & van der Molen, 1976; Mendelson, Dufau & Catt,
1975). However it is not certain that cAMP has an obligatory role
since many investigations show there is a wide difference in the
amounts of LH required to produce stimulation of steroidogenesis and
cAMP production respectively(van der Molen _et afL, 1979). Thus, it has
been shown in studies using LH and cholera toxin that at low levels of
LH stimulation there is no increase in cyclic AMP levels within the
Leydig cell, while steroidogenesis can increase to half the maximum
rate before any increase in cyclic AMP can be detected. This may
indicate that cyclic AMP is involved in the action of LH but that
other factors may be present during stimulation with low levels of LH
or hCG(Cooke ert al, 1977b). However, it can be shown that over a range
of LH doses, protein kinase activation and testosterone production are
closely linked, the only discrepency being in the dose of LH required
to produce maximal stimulation of either steroidogenesis or protein
kinase activity, because when steroidogenesis is stimulated maximally
further stimulation of protein kinase by LH is possible(van der Molen
et al, 1979). The apparent discrepancy between these results can be
explained by the observations of Dufau, Tsuruhara, Horner, Podesta &
Catt(1977b), who showed a close correlation in hCG stimulated Leydig
cells between testosterone production and the number of occupied cAMP
sites upon the regulatory subunit of the Leydig cell protein kinase.
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These results suggest that although there is 110 detectable free cAMP
present in these cells, nonetheless cAMP is involved in this process
and the reason for the failure to detect its presence is that it is
closely bound to the regulatory subunit of protein kinase.
The involvement of protein synthesis has been shown in studies in
which the response of Leydig cells to LH has been blocked by cyclo-
heximide(Cooke e_t a_l, 1975). Following stimulation of Leydig cells
with LH, cycloheximide was added and testosterone production declined
to control levels, this decline following first order kinetics, with a
half-time of 15 minutes. This suggests that testosterone production is
dependent on continuous synthesis of a protein with a short half-life
(van der Molen _et^ al, 1979). Inhibitors of RNA synthesis can also
cause inhibition of testosterone production following LH stimulation,
suggesting that _d<3 novo synthesis of mRNA coding for this or other
proteins may also be involved in the action of LH on testosterone
production(van der Molen' _crt aJ, 1979). On stimulation of the Leydig
cell with LH two proteins can be detected which are newly synthesized
as a result of this stimulation(Janszen et al, 1977). The first has
a molecular weight of 21 kDaltons, a half life in excess of 50 minutes
and is not sensitive to cycloheximide. The second has a molecular
weight of 55 kDaltons and a half life of about 11 minutes and is
sensitive to cycloheximide. It has been suggested that there is a
larger precursor for the 55 kdalton protein and that a pool of this
precursor exists from which the smaller is rapidly produced upon
stimulation of the Leydig cell by LH(Janszen jrt aJ, 1977). LH has also
been shown to rapidly stimulate the phosphorylation of a number of
Leydig cell proteins(Cooke _et_ alL, 1977b), as within 5 minutes of
stimulation by LH three proteins of molecular weights 14.5, 57 & 77.6
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kDaltons were phosphorylated. This is consistent with data showing
that over the same time period protein kinase activity is increased
(Cooke & van der Kemp 1976, Cooke _ert al 1976). Whilst dibutyryl cAMP
mimics this action of LH on the Leydig cell, no effect of PSH or
testosterone was demonstrated in this system(Cooke _et sil, 1977b).
The endpoint of the action of LH appears at present to be the
regulation of mitochondrial cholesterol side chain cleavage involving
the cytochrome P450 system.(van der Vusse, Kalkman & van der Molen,
1975).
1.3.2: Follicle Stimulating Hormone:
Both FSH & LH are known to be required for the successful
initiation of spermatogenesis in immature animals or those in which
the testes have regressed following hypophysectomy(steinberger,
1971; Lostroh, 1963; Go, Vernon & Fritz, 1971). However the actions of
these hormones are rigidly separated within the testis, FSH having
direct effects only on the seminiferous tubules, whilst LH acts only
on the Leydig cells(Dorrington, Roller & Fritz, 1974). FSH binding was
first characterized using tritiated hormone preparations(Means &
Vaitukaitis, 1972; Schwartz, Bell, Rechnitz & Rabinowitz, 1973;
Miyachi & Inomata, 1974; Bhalla & Reichert, 1974), and binding to
testes from rats of all ages could be demonstrated although
significantly more FSH was bound in immature animals. This binding was
shown to be primarily associated with the plasma membrane(Means,
1973; Davies, 1981) and could only be demonstrated with membranes
prepared from the seminiferous tubules, with no binding to
interstitial cells(Means & Huckins, 1974). The FSH receptor has been
solubilized in detergent and isolated; a small water soluble
component, of either newly synthesized or internalized receptors has
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also been identified(Dufau, Ryan & Catt, 1977a). The binding of FSH to
plasma membranes has been shown to correlate closely with the
activation of a membrane bound adenylate cyclase system(Means, 1973;
Davies, 1981) and this has been shown to be specific for FSH(Braun &
Sepsenwol, 1974). Activation of adenylate cyclase then rapidly
activates protein kinase(Means, 1973; Davies, 1981; Tindall & Means,
1976). Bound FSH does not appear to be degraded on the receptors as
bioactive FSH has been recovered from receptor preparations(Means &
Huckins, 1974). The stimulation of protein kinase by FSH is age-
dependent, and there is a marked decline in FSH stimulated kinase
activity after 16 days of age, such that by 30 days of age no effect
of FSH can be demonstrated(Means & Huckins, 1974).
FSH binding has also been shown to be age dependent with the
greatest capacity for binding occurring between 10 and 16 days of age
in the rat(Salhanick & Viebe, 1980), although the number of receptor
sites per testis is reported to be greatest in mature animals(Thanki &
Steinberger, 1978). FSH binding also changes locally within the testis
according to the stage of the spermatogenic cycle of the associated
germ cells(Parvinen, Marana, Robertson, Hansson & Ritzen, 1980).
However, hypophysectomy restores the sensitivity of the testis to
FSH(see above). This decrease in activity and its return can be
associated with the appearance of a specific phosphodiesterase
isozyme(Monn, Desautel & Christiansen, 1972; Christiansen & Desautel,
1973). As with LH the levels of FSH required to increase protein
kinase activity significantly are much lower than those required to
raise cAMP levels(Means & Huckins, 1974).
To further localize within the seminiferous tubules the site of
FSH binding, studies were performed using animals in which the testes
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had been irradiated to form Sertoli-cell-only tubules, and using this
technique, it has been shown that the level of binding of FSH to the
tubules is almost identical to that seen in normal animals, proving
that the Sertoli cell is the site of action of FSH(Means & Huckins,
1974). The Kd for FSH binding has been shown to be about 10 ^M(Means
& Huckins, 1974; Dorrington ert al_, 1974).
FSH has a wide range of morphological effects on the immature
testis, including increasing the number of Sertoli cells(Courot,
1965; Davies & Lawrence, 1978), which can also explain the increase in
size of the remaining testis following early hemicastration
(Cunningham, Tindall, Huckins & Means, 1978). FSH increases the
number of spermatogonia in immature testes by reducing the number of
degenerating spermatogonia(Davies & Lawrence, 1978; Means, 1975), an
effect which may be explained by the FSH-induced increase in DNA
synthesis seen in germ cells of hypophysectomized immature rats
(Ortavant, Courot & Hochereau-de Riviers, 1972). Physiologically, the
period of development when FSH levels are highest correlates with the
period of marked increase in the number of Sertoli cells and spermato¬
gonia up to 40 days of age in the rat(Mackinnon, Puig-Duran & Laynes,
1978). FSH may also synergize with endogenous androgens to induce the
formation of primary spermatocytes and of spermatids during maturation
(Clausen, Purvis & Hansson, 1979). Yet despite this wide range of
actions in the immature animal, experiments in intact adult rats
support the theory that FSH is not absolutely essential for the
maintenance of spermatogenesis once it is successfully established
(Davies, 1981).
One of the major known effects of FSH on the testis is to
stimulate production of an androgen binding protein(ABP) by the
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Sertoli cell(Hansson, Ritzen, French & Nayfeh, 1975). Both FSH and
testosterone have been shown to stimulate the synthesis of ABP
independently(Fritz, 1978), but there are also reports that this "FSH"
effect is a result of elevated testosterone concentrations within
the testis(Tindall & Means, 1976), and that the primary regulator of
ABP synthesis within the testis is testosterone. This latter theory
is supported by results showing that only treatments which elevate
testicular testosterone levels also increase ABP levels, and that
purified FSH has no effect on ABP, whilst LH treatment causes
increased levels(Tindall & Means, 1976). Linked to this are reports
that pretreatraent of immature rats with hCG increases oestradiol
secretion following a subsequent stimulus of FSH, by increasing the
intratesticular concentration of substrate(testosterone) for the
synthesis of oestradiol within the seminiferous tubules(Pomerantz,
1984).
FSH secretion by the pituitary is partially controlled by a
testicular hormone inhibin. The existence of inhibin is now widely
accepted, although for may years there were doubts as to the
relevence of this hormone. The existence of inhibin was postulated
as early as 1923, and the compound named in 1932(See Baker, Burger, de
Kretser, Findlay, Hudson, Lee & Tsonis, 1983; Steinberger, 1983; Main,
Davies & Setchell, 1979 for historical reviews). Early experiments
were unsucessful in seeking to elucidate the structure, function and
physiological role of inhibin, and this led to speculation about its
existence. However, more recent work has shown that inhibin not only
exists but that it is probably the major feedback regulator of
pituitary FSH secretion(Baker et al, 1983; Steinberger, 1983; Main,
Davies & Setchell, 1979).
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Inhibin is a water soluble protein(Means & Huckins, 1974;
Dorrington, Holler & Fritz, 1974), but despite a decade of effort by-
different workers, its exact structure has yet to be described.
Inhibin is heat labile(Steinberger, 1983) and probably has a molecular
weight between 30-60 Kdaltons although values from 2-2,000 Kdaltons
have been reported(Baker et al, 1983 for review). A possible
explanation for this heterogeneity is the suggested ability of inhibin
to form complexes with other proteins or to polymerize with other
inhibin molecules (Baker _ert al, 1983).
The major role of inhibin is accepted as the feedback
regulation of FSH secretion, both in male and female animals and man
(Baker et al, 1983; Steinberger, 1983; Main, Davies & Setchell,
1979). In males the site of production is the Sertoli cells, and
there are many reports of inhibin production by both seminiferous
tubules and isolated Sertoli cells(Eddie, Baker, Dulmanis, Higginson
& Hudson, 1978; Steinberger, 1979; de Jong, Welschen, Hermans, Smith
& van der Molen, 1979; Steinberger & Steinberger, 1976; see also
Baker _et ad, 1983; Steinberger, 1983; Main, Davies & Setchell, 1983
for reviews). Inhibin has also been shown to be present in
follicular fluid, and is secreted from granulosa cells(de Jong &
Sharpe, 1976; Baker et al; 1983, Steinberger, 1983; Main, Davies &
Setchell, 1983). Inhibin-like activity has also been demonstrated from
other sources, including human seminal fluid(Franchimont, Demoulin,
Verstraelen-Proyard, Hazee-Hagelstein & Tunbridge, 1979), bull
spermatozoa(Lugaro, Casellato, Manera, Pasta, Bacigalupo & Lauria,
1979), rete testis fluid(Steinberger & Steinberger, 1976; Baker et al,
1983) and serum(Baker et al, 1983). However, the physiological
significance of the seminal plasma inhibin must now be open to doubt
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in view of a recent demonstration that it is prostatic in origin
(Beksac, Khan, Eliasson, Skakkebaek, Sheth & Diczfalusy, 1984).
Inhibin has been shown to act both at the hypothalamic level,
modulating the action of LHRH(Labrie et al, 1978) but also directly
on the pituitary gland to modify the synthesis and secretion of FSH
(Baker et al, 1983). Investigations aimed at characterizing the
receptors for inhibin have not yet succeeded due largely to the lack
of pure inhibin preparations(Baker jrt al, 1983).
1.3.3. Prolactin;
Prolactin binding in the rat testis has been demonstrated(Aragona
& Friesen, 1975; Bartke, Smith, Michael, Peron & Dalterio, 1977), and
these binding sites are known to be localized to the Leydig cell
(Aragona, Bohnet & Friesen, 1977; Charreau, Attramadal, Torjesen,
Purvis, Calandra & Hansson, 1977). During development in the rat
prolactin receptors increase about 3 fold between days 20 and 45(see
Sharpe, 1982), this change being more or less co-incident with
reported changes in serum prolactin over this period(Dohler & Wuttke
1974; 1975). Both LH and prolactin receptors are reduced in
prolactin deficient dwarf mice(Bohnet & Friesen, 1976) and also
following treatment of normal rats with hCG(Davies, Katikineni,
Chan, Harwood, Dufau & Catt, 1980). Treatment of rats with prolactin
causes an increase in Leydig cell LH-receptor numbers at the same time
as causing a marked decrease in the number of prolactin receptors
(Morris & Saxena, 1980). Although numerous reports of LH receptor
regulation by prolactin are present in the literature(see Sharpe, 1982
for review) the role of prolactin during maturation is still not
clear. Implantation of pituitaries, to cause hyperprolactinaemia in
immature male rats, increased serum testosterone and the development
- 28 -
of male accessory glands(de Jong & van der Schoot, 1979) and these
results were confirmed by studies using injected prolactin(Baranao _et
al, 1981). Suppression of prolactin has been shown to inhibit the
maturation of spermatocytes into spermatids in immature rats(Nag,
Sanyal, Ghosh, & Biswas, 1981), but no effect on spermatogenesis is
seen in the mature state(Alger, Pfeiffer & Bocabella, 1975). Thus
prolactin has now been established as playing a role in the
development of the testis in the immature animal, but its role in the
adult is yet to be fully explained.
1.3.4: Effects of peripheral hormones other than the gonadotrophins:
i) Growth hormone:
Growth hormone has been shown to partially maintain LH
receptor levels following hypophysectomy in both adult and immature
rats(Bambino, Schreiber & Hsueh, 1980; Zipf, Payne & Kelch, 1978), and
to increase LH receptor numbers in seasonally regressed hamsters(Bex,
& Bartke, 1978). This effect is mediated independently of a similar
prolactin effect(See Sharpe, 1982 for review). Growth hormone also
increases testicular responsiveness to LH in hypophysectomized rats
(Odell & Swerdloff, 1976). Despite this evidence for the action of
growth hormone in both adult and immature animals its role in the
regulation of Leydig cells under physiological conditions is not
clear.
ii) Insulin:
Although many studies have shown that insulin deprivation
results in impaired Leydig cell function and reduced testosterone
secretion, until recently no evidence for a direct effect of insulin
on Leydig cells could be found(Sharpe, 1982). Studies using rat
testicular cells have shown that insulin may play an important role
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in the direct augmentation of testicular androgen production, as it
was shown that treatment of cells with insulin increased their hCG
stimulated testosterone production without altering DNA or protein
content or increasing cell numbers(Adashi, Pabics & Hsueh, 1982).
Many of the changes noted in diabetic rats and men may be due either
to depletion of peripheral insulin and/or gonadotrophin supply, as
both LH levels and the pituitary response to LHRH are reduced(Cusan,
Belanger, Seguin & Labrie, 1980; see also Sharpe 1982 for review), or
to local factors released as a result of seminiferous tubule
damage(See for example, Rosenmann, Palti, Teitelbaum & Cohen, 1974; or
Sharpe, 1982 for review).
iii) Thyroid Stimulating Hormone(TSH):
High affinity receptors for thyroid stimulating hormone have
been reported in the rat testis(Amir, Sullivan & Ingbar, 1978) but
there are no reported effects of TSH on the Leydig cell,
iv) Melatonin and Serotonin:
Both these hormones have been shown to have direct
inhibitory effects on Leydig cell steroidogenesis in vitro by
inhibiting the activities of Leydig cell 17<*-hydroxylase and 17-20
desmolase(Ellis,1972). These results are supported by further in
vitro effects of melatonin on testicular steroidogenesis(Kalla,
1979) and also of serotonin in vivo(Kalla, 1979). Some effects were
also seen _in vivo but these studies are hampered by the possibility of
vasoactive effects of these hormones(See Sharpe, 1982).
1.4: Local control of the testis:
The testis is a highly complex tissue, containing numerous
different cell types. The seminiferous tubule is surrounded by a
basal lamina comprised of two acellular layers, and also by a
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layer of peritubular cells, which have been shown to be contractile
in nature(rat; Clermont, 1958; human; Ross, 1966). This myoid cell
layer has also, more recently, been shown to contain numbers of
cells which are not contractile comprising of mononuclear leukocytes
(Mori & Christensen, 1980) and also mesenchymal peritubular cells
(Mather, Gunsalus, Musto, Cheng, Parvinen, Wright, Perez-Infante,
Margioris, Liotta, Becker, Krieger & Bardin, 1983). However the
peritubular myoid layer remains the major cell component within the
basal lamina of the seminiferous tubule, and these cells contract in
response to oxytocin(see below section 1.4.4) and therefore are
presumed to play an active role in the expulsion of tubular contents
into the rete testis(Clermont, 1958; Ross, 1966). Interactions
between these cell types or between those within the seminiferous
tubules or interstitium have not been extensively studied, although
they are rapidly becoming a focal point of interest.
1.4.1: Sertoli cell-germ cell interactions:
While Sertoli cell function is obviously affected by other
testicular cell types, there should be no doubt that the most profound
and important interactions are between the developing germ cells and
the Sertoli cells. Firstly, because multiplication, meiosis and
translocation of the differentiating germ cells have to occur at
precise unvarying time intervals(Leblond & Clermont, 1952a; Parvinen,
1982). Secondly, because all of the basic metabolic requirements of
the germ cells have to be supplied by the Sertoli cells, i.e.
transferrin, lactate, etc(see below). Thirdly, metabolic requirements
of germ cells probably change according to the stage of their
development for example see plasminogen activator below).
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i) Lactate production by Sertoli cells:
In studies comparing the effects of glucose and lactate upon
the viability and function of spermatocytes and spermatids it has
been shown that these cells cannot metabolise glucose and depend
upon a supply of lactate for their energy requirements(Jutte,
Grootegoed, Rommerts & van der Molen, 1981). Although the X-
chromosome linked phosphoglycerate kinase and glucose-6-phospate
dehydrogenase enzyme genes are inactivated during meiotic
prophase(Monesi, 1965) the presence of autosomally coded iso-enzymes
could make up for this deficency and allow normal glycolysis to
continue(Vandeberg, Cooper & Close, 1973; Brock, 1977). However, the
failure of glycolysis in these cells would be an attractive
explanation for their failure to utilise glucose. Further studies
have shown that Sertoli cells secrete lactate into culture medium
and that this lactate can be utilised by spermatocyctes in culture
(Jutte, Jansen, Grootegoed, Rommerts, & van der Molen, 1983; Jutte,
Jansen, Grootegoed, Rommerts, Clausen & van der Molen, 1982) by means
of a testis-specific isozyme of lactate dehydrogenase(LHD-X) which
has an equilibrium biased towards the production of pyruvate and
preferentially catalyses the oxidation of lactate to pyruvate
(Meistrich, Trostle, Frapart & Erickson, 1977; Blanco, Burgos, Gerez
de Burgos & Montamat, 1976). It would appear therefore, that Sertoli
cells supply spermatocytes and spermatids with energy in the form of
lactate which is subsequently oxidised to pyruvate for use in the
tricarboxylic acid cycle to produce ATP.
ii) Sertoli cell regulators of mitosis and meiosis;
Cell divisions within the seminiferous tubule must be closely
controlled by the Sertoli cell as they have to occur at specific
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stages of the sperraatogenic cycle. It has been shown that seminiferous
tubules secrete a mitogenic factor in the mouse, rat, guinea pig and
calf(see review by Bellve & Feig, 1984) which may regulate the
mitotic divisions of the stem-cell type A spermatogonia, through to
the formation of primary preleptotene spermatocytes. It has been
shown that the Sertoli cell is the principal source of the
seminiferous growth factor(SGF), and it has been suggested that this
factor may act synergistically with transferrin to promote
sperraatogonial replication(Bellve & Feig, 1984). SGF has been purified
and characterized, and is a polypeptide of about 15,700 daltons
molecular weight, which is hydrophilic and anionic(Bellve & Feig,
1984).
The characterization of a meiosis regulator in females(Tsafriri,
Dekel & Bar-Ami, 1982) led to investigations in the male for similar
substances. Early studies suggested that both meiosis-inducing and
meiosis-preventing substances might interact during puberty to allow
germ cell divisions and the initiation of complete spermatogenesis
(Grinsted, Byskov & Andreasen, 1979; 0 & Baker, 1976). More
recently the presence of both meiosis-inducing(MIS) and meiosis-
preventing substances(MPS) has also been reported within the male
reproductive organs of man(Grinsted & Byskov, 1981). Previously MIS
and MPS had only been identified from foetal tissues(Grinsted,
Byskov & Andreasen, 1979; Grinsted & Byskov, 1981; 0 & Baker,
1976), but in man MIS was found in adult as well as foetal and
pubertal tissues(Grinsted & Byskov, 1981). The most exciting recent
data regarding these factors has shown differential secretion of both
MIS and MPS during the sperraatogenic cycle of the adult rat(Parvinen,
1982), with MIS secretion being maximal during the stages coinciding
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with DNA replication of preleptotene spermatocytes prior to meiosis,
i.e. stages VII to VIII.
It would appear therefore that both the maturation of oocytes,
and the meiotic events of the spermatogenic cycle in the rat are under
close control by regulators of both mitosis and meiosis.
iii) Plasminogen activator:
Linked to the control of meiosis(see above) is the transfer of
preleptotene primary spermatocytes from the basal compartment of the
seminiferous tubules, i.e. posterior to the Sertoli cell tight
junctions, to the adluminal compartment above the tight junctions
(Russell, 1980). When meiosis begins a new tight junction is formed
behind the preleptotene spermatocytes, so that for a short period
these cells are isolated from both the basal and adluminal
compartments(Russell, 1980). Next the tight junctions anterior to the
cell are dissolved and the germ cells are thus incorporated into the
adluminal compartment, and this ensures that the haploid cells are
isolated in a specialized controlled environment which appears to be
essential for their further development(Parvinen, 1982). This transfer
commences at the same stage(VIIl) as spermiation, and also coincides
with a peak in the Sertoli cell secretion of a protease, plasminogen
activator(Lacroix, Parvinen & Pritz, 1981). It is suggested that this
protease, which is known to be involved in cell migration and tissue
restructuring(Lacroix, Parvinen & Pritz, 1981), plays a role in
spermiation and/or the migration of preleptotene spermatocytes within
the tubules. This suggestion is further supported by results
suggesting that in the absence of specific germ cells, the stage VII-
VIII secretion of plasminogen activator is abolished(Vihko, Suominen
& Parvinen, 1984). The role of testosterone and other hormones in the
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control of these processes is unknown.
iv) Other Sertoli cell proteins:
A number of other proteins related to cell growth and
maintenance in culture have been reported as Sertoli cell products. It
now appears that as a consequence of the blood testis barrier, which
originates at the Sertoli cell tight junctions(see above) these cells
must provide a number of hormones which are normally provided via the
circulation to maintain the germ cell population.
Sertoli cells have been shown to secrete a somatomedin-like
peptide(Johnsonbaugh, Ritzen, Hall, Parvinen & Wright, 1982), the
levels of which may vary according to the stage of the spermatogenic
cycle, with maximal secretion at stages VII and VIII. Somatomedin is
also produced by granulosa cells and can be shown to mediate some
effects of FSH(Adashi, Resnick, Svoboda & Van Wyk, 1984). Levels of
somatomedin production by granulosa cells may be hormonally controlled
(Hammond, Barano, Skaleris, Rechler & Knight, 1984).
Ceruloplasmin, transferrin and insulin have also been
isolated from Sertoli cell cultures(Skinner & Griswold, 1982; 1983;
Perez-Infante, Parvinen, Lahdetie, Wright, Bardin & Mather, 1981;
Wright, Musto, Mather & Bardin, 1981). There is evidence that levels
of transferrin secreted in vitro may be controlled by FSH, insulin
and other hormones(Skinner & Griswold, 1982). Transferrin secretion
also varies with age(Perez-Infante _et aJL, 1981).
v) FSH effects:
During the development of the germ cells, responsiveness of
Sertoli cells to FSH falls despite increased numbers of receptors
(Parvinen, 1982). As has already been described, this fall is due to
increased phosphodiesterase activity in the mature Sertoli cell(see
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section 1.3.2). Although the adult Sertoli cell responds very poorly
to FSH there is a marked cyclicity in the binding capacity of
seminiferous tubules for FSH, such that FSH binding is lowest at
stages VII-VIII and highest at stage I of the spermatogenic cycle
(Parvinen, 1982). The ability of FSH to stimulate cAMP production in
the presence of a phosphodiesterase inhibitor also varies in a
cyclical fashion, being lowest at stages VII-VIII and rising to a
peak at stages I-V(Parvinen, 1982; Parvinen, Marana, Robertson,
Hansson & Ritzen, 1980; Gordeladze, Parvinen, Gautvik & Hansson,
1982). This pattern of FSH induced cAMP production closely parallels
the cycle of spermatid manganese-dependent adenylate cyclase activity
(Gordeladze _et ad., 1982) which is specific for haploid germ cells.
Thus there may be some transmission of the FSH stimulation of the
Sertoli cell to the adenylate cyclase of the spermatids. Another
haploid cell specific enzyme, protein carboxyl methylase has a
cyclical distribution almost identical to that of manganese-dependent
adenylate cyclase(Parvinen, 1982; Cusan, Gordeladze, Parvinen, Clausen
& Hansson, 1981), and both these enzymes are thought to have a role in
regulating subsequent sperm motility(Gagnon, Axelrod, Musto, Dym &
Bardin, 1979; Bouchard, Gagnon, Phillips & Bardin, 1980). Closely
correlated with these enzyme activities is the formation of spermatid
bundles in stages XII-I and their subsquent migration to become
closely associated with Sertoli cell nuclei in bundles at stages II-V
(Russell, 1980). These migratory processes may be regulated by
cytoskeletal components of the Sertoli cell(Parvinen, 1982), which may
be regulated by cyclic AMP levels, which are controlled in turn by FSH
(Means, Dedman, Tindall & Welsh, 1978). It is therefore of interest
that the rise in adenylate cyclase and protein carboxyl-methylase
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activity correlates well with the increased FSH sensitivity, and that
at stage VI there is a rapid fall in adenylate cyclase activity linked
with a rise in activation of a cAMP phosphodiesterase(Parvinen, 1982;
Gravis, 1978). It is thought that these activities may he linked to
normal spermatid development and spermiation, since spermiation is
inhibited by high cAMP levels(Gravis, 1978).
1.4.2: Sertoli cell-Peritubular cell interactions:
It has recently been shown that peritubular cells interact in
a number of ways with Sertoli cells. When cultured, isolated Sertoli
cell aggregates grow in monolayers, but when such cells are plated
onto a monolayer culture of peritubular myoid cells they form tubular
or ball-like structures(Cameron & Markwald, 1981; Bols, Bowen & Byrne,
1984). This effect is specific for peritubular-Sertoli cell cultures,
although some reports suggest that other cell types can partially
maintain Sertoli cell function or induce similar morphological
effects, but that only peritubular cells perform both functions
simultaneously(Tung & Fritz, 1980). Peritubular cells have also been
shown to cooperate metabolically with Sertoli cells in culture,
producing an increase in Sertoli cell ABP production, in both FSH-
stimulated and untreated Sertoli cells(Hutson & Stocco, 1981). Further
studies on the form of metabolic cooperation between Sertoli cells and
peritubular cells have shown that the latter secrete a wide range of
proteins, although studies on these proteins are hampered by the
inability to obtain pure peritubular cell cultures(Mather, Gunsalus,
Musto, Cheng, Parvinen, Wright, Perez-Infante, Margioris, Liotta,
Becker, Kreiger & Bardin, 1983). Peritubular cells can transfer RNA or
RNA precursors to Sertoli cells _in vitro only when the two cell types
are actually in contact, and the same studies have shown that the
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increase in ABP secretion is not maintained unless the two cell types
are in contact. Whether the transfer of RNA is related to ABP
production remains to be proven(Hutson, 1983).
The presence of peritubular cells in co-culture with
Sertoli cells enhances ABP production by Sertoli cells following
stimulation with testosterone. It has been further demonstrated that
the peritubular cells secrete a compound into culture medium(as shown
by incubating Sertoli cells in peritubular cell conditioned medium)
which stimulates Sertoli cell ABP production and furthermore that this
compound is modulated by testosterone(Skinner & Fritz, 1985).
1.4.3: Peritubular leukocyte changes:
Cyclic variations in the number of mononuclear leukocytes
within the peritubular membrane and also in the number of mitotic
figures in this cell population have been described(Mori &
Christensen, 1980). There is also a cyclic variation in the frequency
of degeneration of these cells, with the number of mononuclear
leukocytes peaking at stages XIV-I and IX-XII of the spermatogenic
cycle, while the number of mitotic figures peaks at stages VI and
XIV. The data suggests that these cells turnover rapidly with a
"cycle" of similar length to that of the spermatogenic wave(i.e. 12
days vs 13.3 days, Mori & Christensen, 1980). The functional
significance of these cells is still unresolved, but as their
cyclicity is so closely linked with that of the seminiferous
epithelium then it seems likely that some form of communication takes
place between these compartments.
1.4.4: Leydig cell-Peritubular cell interactions:
It has been shown that oxytocin is present in testicular
extracts from rats, bulls and men and that following mating
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behaviour in the ram, bull and pony, oxytocin is released(see Wathes,
1984 for review). This release of oxytocin could produce contractions
of the seminiferous tubules and expulsion of tubular contents from the
testes, since oxytocin has been shown to produce contractions of
seminiferous tubules(Wathes, 1984 for review). The tunica propria
and albuginea of the testis are also said to increase their
contractile activity following oxytocin treatment, as are the
epididymis & vas deferens in the rabbit(see Wathes, 1984 for review).
These effects are also linked with increased sperm and semen output
following oxytocin treatment, suggesting that the role of this
hormone is to facilitate the expulsion of spermatozoa from the
testis into the epididymus(Wathes, 1984 for review), presumably by
stimulating contraction of the myoid layer surrounding the
seminiferous tubules.
1.4.5: Sertoli-Leydig cell interactions:
A) Morphological evidence:
Most of the available evidence for Sertoli-Leydig cell
interactions is indirect and is derived from two major experimental
approaches: First, the effect that damage to the seminiferous
epithelium has on the Leydig cell, and second the effects of FSH on
Leydig cell structure or function(Sharpe & Rommerts, 1983).
Following the induction of damage to the seminiferous epithelium
by a range of techniques, and subsequent impairment of Sertoli cell
function and of fertility, it has been shown that marked alterations
in Leydig cell morphology occur, including hyperplasia, hypertrophy of
cellular organelles and enhanced steroidogenic capacity coupled with
decreased LH receptor numbers(Sharpe & Rommerts, 1983; Sharpe, 1982).
i) Cryptorchidism: Cryptorchidism involves either the failure of the
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testis to descend from its intra-abdominal position during development
or the experimental relocation of the testis into the abdomen during
surgery. Following surgical induction of cryptorchidism in adult
rats it has been shown that there is rapid degeneration of germ cells
and significant changes in the structure and function of Sertoli cells
(Kerr et al, 1979b). These changes occur within 5-7 days and include
the accumulation of lipid droplets and vacuoles within the Sertoli
cells and modifications of the Sertoli cell tight junctions with
vacuoles appearing within the region of these junctions. This
disruption of the Sertoli cell junctions may be indicative of an
alteration in the permeability of the blood-testis barrier and in
keeping with this there is evidence suggesting that such changes do
occur(Hagenas, Ploen, Ritzen & Ekwall, 1977). During longer periods of
cryptorchidism there is collapse of the seminiferous tubules due to
depletion of germ cells(Kerr ejt ad., 1979b). There is also a decrease in
ABP production during the first four weeks of cryptorchidism(Kerr _et^
al, 1979b). In bilaterally cryptorchid rats, these changes include
increases in serum LH and FSH levels(Risbridger, Kerr, Peake, Rich & de
Kretser, 1981b). Further studies have shown that changes in Sertoli
cell FSH receptors, ABP production and testicular fluid production
occur within two days following induction of cryptorchidism and that
a progressive impairment of these functions occurs thereafter(Jegou,
Risbridger & de Kretser, 1985b). Testicular inhibin content is also
markedly reduced within seven days of cryptorchidism and falls to
about 10$ of normal levels after six weeks(Au, Robertson & de Kretser,
1985).
Following this evidence of impaired Sertoli cell function in
cryptorchid rats evidence has shown that the Leydig cells are also
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affected. Leydig cells in the abdominal testis of unilaterally
cryptorchid animals have been shown to be significantly increased in
size in the presence of normal serum LH levels(Risbridger, Kerr & de
Kretser, 1981c), and ultrastructural changes in the Leydig cells during
this treatment include increases in smooth and rough endoplasmic
reticulum, mitochondria and Golgi apparatus, all changes indicative of
increased Leydig cell steroidogenic capability(Risbridger, Kerr & de
Kretser, 1981c). Some mitotic figures in Leydig cells were also seen,
suggesting that there may be an increase in Leydig cell numbers
(Risbridger, Kerr & de Kretser, 1981c). Isolated Leydig cells from
cryptorchid animals have been shown to be hyper-responsive to hCG
stimulation jln vitro(Sharpe, Cooper & Doogan, 1984; Risbridger, Kerr
& de Kretser, 1981c), yet in vivo reduced levels of testosterone
have been found in both testicular interstitial fluid and spermatic
venous blood(Sharpe et_ _al, 1984). This suggests that despite their
increased responsiveness in. vitro, the response of the Leydig cells in
vivo is impaired in some way by cryptorchidism. Since no comparable
changes occur in the scrotal testes of unilaterally cryptorchid rats,
these effects must be due to some local control mechanism. It is
interesting, therefore that in addition to the changes seen in hCG
reponsiveness, Leydig cells from the cryptorchid testis also show
increased responsiveness to LHRH agonists in vitro, as 'testicular
LHRH' has been implicated in local control processes(see below).
The paradox that remains is how can these local mechanisms
explain the differences between jln vivo and iri vitro responsiveness
of Leydig cells? It may be explained by the observation that
testicular blood flow is reduced in the cryptorchid testis(Wang,
Galil & Setchell, 1983), which would lead to a decreased exposure of
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Leydig cells to LH. The raised serum LH levels found in bilaterally
cryptorchid rats(Risbridger, Kerr & de Kretser, 1981c) may be one way
in which the animal then ensures that adequate LH levels exist within
the testis- Of interest also is the increased capability of Leydig
cells to bind oestradiol in cryptorchid testes.
Oestradiol receptors have been shown to increase dramatically
following cryptorchidism, doubling within 7 days and reaching four
times control levels 28 days post-operation(Keel & Abney, 1980).
Oestradiol concentrations within the testis are unchanged over 21
days, although there is a possible rise in oestradiol at 14 days, but
oestradiol concentrations are significantly decreased by day 28 post-
operation. Both LH and FSH receptors are reduced in the abdominal
testes of unilaterally cryptorchid animals, although it is not clear
how this occurs(Risbridger, Kerr & de Kretser, 1981c). Since loss of LH
receptors precedes any rise in serum LH it is likely that either local
damage or locally secreted factors produce these changes(Risbridger,
Kerr & de Kretser, 1981c).
Recently, evidence on the restoration of testicular function
following replacement of the cryptorchid testis within the scrotum
(orchidopexy) has suggested that germ cells may also play a major role
in intra-testicular communication(Jegou, Peake, Irby & de Kretser,
1984b). In adult rats even after only 10 days in the cryptorchid state,
recovery of spermatogenesis following orchidopexy is very poor(jegou,
Laws & de Kretser, 1983a) and Leydig and Sertoli cell function remains
impaired. Cryptorchidism induced in immature animals also impairs
Sertoli and Leydig cell function in a similar way to that seen in the
mature animal(Jegou et _al, 1984b) but even after 21 days in the
abdominal position orchidopexy can restore testicular function and
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fertility. It is suggested that the cryptorchid position of the testis
is not the major influence on Sertoli and Leydig cell function but
rather that the presence of germ cells and the ability of the immature
testis to replenish its germ cells plays a major role in regulating
testis function. This data is in agreement with the concept of
cyclical secretion of Sertoli cell products which may be dependent on
specific Sertoli germ-cell interactions(see section 1.4.1).
However, despite the usefulness of surgically induced unilateral
and bilateral cryptorchidism as an experimental model, this condition
is not identical to the failure of testicular descent seen in man. It
has been shown that whereas in the experimental replacement of testes
within the abdomen(secondary cryptorchidism) the germ cells are the
first to show signs of degeneration, in animals in which testicular
descent is prevented(primary cryptorchidism) the Sertoli cells are
those which are first damaged(Bergh, 198Ja). Also in primary
cryptorchidism there is evidence that rather than becoming
hyperplasic, the Leydig cells are actually reduced in size(Bergh &
Damber, 1978). Therefore whilst experimentally induced secondary
cryptorchidism is of great value as an experimental model, care should
be taken before extrapolating results obtained in such studies to
cryptorchidism in man.
ii) Heat damage:
The aetiology of the impairment of spermatogenesis in
cryptorchidism is unclear but it is believed to stem from damage due
to the higher temperature to whcih testes are exposed in the abdomen.
Reports of reversible impairment of testicular function following
short term(l5 minutes) heating of the testis in situ will therefore
prove of great interest in the further assesment of such interactions.
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It has been shown that heating the adult rat testis to 43 degrees
centigrade will reduce specific germ cell populations, and that this
is accompanied by reversible impairment of Sertoli and Leydig cell
functions. It is not yet clear which of these changes occurs first,
but this data provides further evidence for the close interdependence
of these cell types(Jegou, Laws & de Kretser, 1984a). The relevance
of these studies to human infertility can be seen when it is
recognised that bathing for 15 minutes at temperatures in excess of
43°C is not uncommon, and a reported 'addiction' to such hot baths
has indeed been shown to cause profound reductions in sperm numbers,
motility and morphology(Eliasson & Virji, 1985).
iii) Efferent duct ligation:
Following experimental blocking of the efferent ducts
of the rat testis by ligation, spermatogenesis becomes disrupted, with
maximal damage occurring within three weeks, by which time the
seminiferous tubules show marked signs of germ cell depletion and
spermatogenic failure(Smith, 1962). More recently, these effects have
been shown to be linked to morphological and functional changes in
Leydig cells similar to those seen in cryptorchidism(Risbridger, Kerr,
Peake & de Kretser, 1981a), suggesting that any damage of the
seminiferous epithelium results in changes in the properties of
Leydig cells. The fact that the changes in Leydig cell structure
and function occur in the absence of any change in testicular
temperature, is a further indication that while the Sertoli cell
changes in cryptorchid or 'heated' testes may be a result of
temperature damage, the changes which occur in the Leydig cells are
almost certainly mediated by the Sertoli cells rather than being
aspecific temperature effects. Vitamin A deficiency, hydroxyurea
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treatment and foetal irradiation, all of which damage the seminiferous
tubules, also produce focal hypertrophy of the Leydig cells, providing
further evidence to support the role of the Sertoli cell in the
regulation of the Leydig cell(Rich, Kerr & de Kretser, 1979).
iv) Anti-androgens;
In a study in which local damage within the testis was
induced by implanting threads impregnated with anti-androgens there
was massive hyperplasia of the interstitial tissue only in the
localities immediately surrounding the damaged areas induced by this
treatment(Aoki & Fawcett, 1978). It is argued that the most likely
explanation for this effect is altered function of the damaged Sertoli
cells. The effects on Leydig cell structure are nearly identical to
those resulting from cryptorchidism etc;(as discussed above) and it
therefore seems likely that any alteration of Sertoli cell function
results in marked stimulation of adjacent Leydig cells(Sharpe &
Rommerts, 1983).
It is thus obvious that Sertoli-Leydig cell functions are closely
linked despite the functional barrier between them at the level of the
peritubular cells(see above). Recently, evidence for a Leydig cell
cycle linked to the sperraatogenic cycle has been described(Bergh,
1982; 1984), in which Leydig cells adjacent to seminiferous tubules at
stages VII-VIII have been shown to be significantly larger than those
adjacent to either blood vessels or tubules at other stages of the
spermatogenic cycle. This effect is abolished in the abdominal testis
of unilaterally cryptorchid rats(see Bergh & Damber, 1984).
B) Effects of FSH treatment:
FSH has been shown to produce effects on the
interstitial tissue despite the evidence which shows there are no FSH
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receptors on Leydig cells(Purvis, Clausen & Hansson, 1979) - Because of
the contamination of all FSH preparations with small amounts of LH,
it has been suggested that the observed 'FSH' effects are in fact due
to contaminating LH(Purvis e_t aJ, 1979), or that FSH acts
synergistically with small amounts of LH to produce these effects
(Davies, 1981). During sexual maturation, testicular LH receptor
numbers increase in parallel with the plasma levels of FSH, whilst LH
levels remain low(Ketelslegers, Hetzel, Sherins & Catt, 1978). FSH
also increases the LH-stimulated production of testosterone by adult
Leydig cells in the rat(Aznar, Diaz, Herrera-Justiniano & Aznar,
1979), possibly by affecting 17jS-hydroxysteroid dehydrogenase
activity, an enzyme also affected by FSH in immature rats(Welsh &
Wiebe, 1978). FSH also increases the activity of both 5°*-reductase and
3jS-hydroxysteroid dehydrogenase in immature rats(Davies, 1981), whilst
effects on the conversion of progesterone to testosterone have also
been reported in hypophysectomized adult rats(Sivelle, 1979). More
recently, studies in hypophysectomized immature rats have yielded
strong morphological and biochemical evidence for the involvement of
FSH in the maturation and proliferation of Leydig cells(Kerr & Sharpe,
1985a,b), and have suggested that such effects are mediated via the
seminiferous tubules.
Although indirect, this data argues strongly for the presence of
an intricate system of communication between the Sertoli cell within
the seminiferous tubule and the Leydig cell in the interstitial space
of the testis. However, none of the studies mentioned in the above 2
sections(A & B) have identified the humoral agent(s) involved in
the changes described. A number of possible candidates have,
however, been identifed in recent functional studies.
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C) Functional Evidence;
Despite the widely documented diversity of Sertoli cell
products, up to this point in time only two locally produced
testicular hormones have been shown definitively to exert a direct
effect on the Leydig cell; testicular 'LHRH' and oestradiol.
i) Tes ticular 'LHRH':
Testicular function and development in mammals is
primarily controlled by the pituitary gonadotrophins, which in turn
are under the control of the hypothalamic decapeptide Luteinizing
Hormone Releasing Hormone(LHRH), also know as GnRH, (gonadotrophin
releasing hormone). LHRH is released in a pulsatile fashion into the
hypothalamic pituitary portal vessels and acts directly on the
anterior pituitary to stimulate release of LH and FSH(Kalra & Kalra,
1983; Clayton & Catt, 1981; Conn, Marian, McMillian, Stern, Rogers,
Penna & Grant, 1981).
The theory that LHRH might have functions in tissues other than
the pituitary conflicted with one of the central dogmas of
reproductive physiology. However LHRH-like peptides have been found to
be present in a wide range of tissues, including the adrenals, the
pancreas, the pineal gland, placenta, ovary and testis(Sharpe, 1984).
In addition chronic treatment _in vivo with LHRH analogues has a wide
range of effects on testicular function(Hsueh & Jones, 1981),
resulting in the impairment of many testicular parameters. Chronic
LHRH treatment has been shown to decrease testicular androgen
production in both adult and immature rats(Bambino, Schrieber & Hsueh,
1980; Huhtaniemi, Stewart, Channabasavaiah, Fraser & Clayton, 1984a,b;
Lacroix, Eechaute & Leusen, 1984), and to decrease testicular LH and
prolactin receptor numbers(Bambino, Schrieber & Hsueh, 1980; Catt,
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Baukal, Davies & Dufau, 1979; Auclair, Kelly, Coy, Schally & Labrie,
1977, Huhtaniemi et al, 1984a,b; Marchetti & Labrie, 1984). Testis
weights, along with seminal vesicle and prostate weights were reduced »
following LHRH treatment(Cusan, Auclair, Belanger, Ferland, Kelly,
Seguin & Labrie, 1979; Huhtaniemi _et^ _al, 1984a,b) and as might be
expected in the light of these changes spermatogenesis was greatly
impaired(Heber & Swerdloff, 1981; Pelletier, Cusan, Auclair, Kelly,
Desy & Labrie, 1978). However the potential of LHRH as a male
contraceptive is marred by its effects on testicular weight and
androgen production, as well as by reports suggesting that even
following 12 weeks of treatment in rats, and despite the above
changes, fertility is still maintained in about half of the treated
group(Vickery, McRae, Bergstrom, Briones, Worden & Seidenberg, 1983).
Although these results strongly suggest an intratesticular role for
LHRH, it is possible that they are mediated wholly or in part via the
action of this hormone on pituitary secretion of gonadotrophins.
Studies in hypophysectomized rats have shown that comparable
effects of LHRH agonists also occur in the absence of the pituitary
gland, although the down regulation of LH receptors is not as marked
(Hsueh & Jones, 1981; Lacroix, Eechaute & Leusen, 1984; Marchetti &
Labrie, 1984), suggesting that the effects seen in intact rats are at
least partly mediated via increased pituitary secretion of LH. In
experiments in which an LHRH agonist was injected intratesticularly
into one testis only, a significant increase in testosterone
levels in interstitial fluid from the treated but not from the
contralateral control testis was noted(Sharpe, Doogan & Cooper,
1983a). These effects could not be attributed to peripheral
gonadotrophins since an increase in these hormones would affect both
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testes. In animals treated with higher doses of LHRH agonist
significant increases in total testis testosterone and spermatic vein
testosterone levels were also seen in the treated when compared with
the control testes(Sharpe, Doogan & Cooper, 1983a). Interstitial fluid
formation was also modulated by LHRH agonist treatment, there being a
significant reduction in interstitial fluid levels(Sharpe, Doogan &
Cooper, 1983a). This latter result is of interest, since if it is
assumed that the interstitial fluid volume reflects the permeability
of testicular capillaries and therefore access of LH to the testis it
can be seen that LHRH agonist increased testicular testosterone
production whilst decreasing testicular capillary permeability and
hence testicular exposure to peripheral LH.
LHRH receptors within the testis are located only on the Leydig
cells(Sharpe, 1982; Clayton & Catt, 1981) and have an affinity similar
to that of both ovarian and pituitary LHRH receptors(Clayton & Catt,
1981; Dalkin, Bourne, Pieper, Regiani & Marshall, 1981). In the male
rat LHRH binding in gonadal tissues is apparent in animals of all ages
from day 1 onwards, and increases gradually with age(Huhtaniemi, Catt &
Clayton, 1985) although earlier reports failed to show binding in
animals below 40 days of age(Dalkin et al, 1981). The testicular
concentration of LHRH receptors varies biphasically, being highest
at day 1 post-partum(3.2+/-0.4 fmoles/g tissue, mean+/-se), declining
to a nadir at day 15 post partum(1.5+/-0.5 fmoles/g tissue) and
thereafter increasing with age during the period investigated(up to 60
days post partum, 2.7+/-0.3 fmoles/g tissue), this binding pattern
reflecting closely the volume density of Leydig cells at these
times(Huhtaniemi _et^ al, 1985). Administration of an LHRH agonist
increased testosterone production in testes of all ages during these
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studies(Huhtaniemi et al, 1985) showing that the LHRH receptors
demonstrated are functionally active. The Ka of the receptors
reported in this study(Huhtaniemi et al, 1985; 1.8 x lO^M-') agrees
S —I
with that reported by Dalkin _et al(1981; 6.5x10 M ) however
binding levels reported by Dalkin et_ al(l98l) are much higher than
those reported above with binding levels at 60 days of about I60fm/mg
protein from interstitial tissue(Dalkin _et _al, 1981). Although, the
dissimilarities between the tissues used(whole testis vs
interstitial tissue) makes comparison of receptor numbers between
these studies difficult.
An 'LHRH-like' peptide has been reported within the testis
(Sharpe, 1982; 1983; Sharpe & Harmar, 1983; Bhasin, Heber, Peterson
& Swerdloff, 1983) which presumably interacts with Leydig cell LHRH-
receptors(Sharpe, 1983; Sharpe & Fraser, 1980b). Its activity may be
modulated by hCG(Sharpe & Fraser, 1980a) and it appears to be
immunologically dissimilar to hypothalamic LHRH(Bhasin et al, 1983;
Sharpe & Harraar, 1983; Sharpe, 1982). The Sertoli cell has been
suggested as a likely source for this factor, since Sertoli cell
culture medium contains LHRH-like activity(see Sharpe 1984).
Testicular 'LHRH' has so far been purified to a very limited extent
and there may be more than one active component(Bhasin et al, 1983).
Although there are testicular receptors for testicular 'LHRH', its
physiological significance is unknown, and in this context the
extremely low amounts of testicular 'LHRH' detected(less than 50pg
LHRH agonist equivalents per testis) and the detection of similar
levels in liver tissue leave its' physiological significance open to
question(Sharpe & Harraar, 1983).
Studies on LHRH effects in the testis have been limited by the
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failure to purify the active testicular 'LHRH' and this has led to the
use of synthetic hypothalamic LHRH and its analogues instead. Despite
early reports that LHRH had no effect on the Leydig cell _in vitro
(Hsueh & Jones, 1981; Sharpe, 1982; Badger, Beitins, Ostrea,
Crisafulli, Little & Saidel, 1980) it is now accepted that while LHRH
has no effects on the Sertoli cell(Gore-Langton, Lacroix, Dorrington,
1981), its effects on the Leydig cell vary widely with dosage and time
of incubation. Although reports prior to 1982 suggested that the
effect of LHRH on the testis and therefore the Leydig cell was to
impair testosterone production the majority of these reports involved
chronic treatment with LHRH analogues, and more recent studies have
shown that the initial effect of LHRH on the Leydig cell both _in vitro
and Jui vivo is to stimulate testosterone production(Hunter, Sullivan,
Dix, Aldred & Cooke, 1982; Sharpe, Doogan & Cooper, 1982). This
stimulatory effect shows a 1-2 hour lag phase and studies suggest that
the Leydig cells need to be exposed continously to LHRH agonist if the
stimulatory effect is to be maintained, since preincubation with LHRH
agonists produced no subsequent stimulation of testosterone production
(Sharpe & Cooper, 1982 a,b). LHRH has been shown to stimulate phos-
phatidylinositol metabolism in rat granulosa cells and more recently
to stimulate phosphatidylinositol and prostaglandin E production in
Leydig cells(Davies, Farese & Clark, 1983; Molcho, Zakut & Naor,
1984), and these effects may indicate the intracellular mechanism of
action of LHRH after binding to its receptors. In trying to discern
why there is such a difference between acute and chronic LKRH effects
on steroidogenesis it has been shown that both the duration of
exposure of Leydig cells to LHRH and the co-incident exposure of these
cells to LH affect their responses to LHRH(Sharpe, Doogan & Cooper,
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1983b; Sharpe & Fraser, 1983). Treatment of rats with an LH-antiserum
has been shown to markedly increase Leydig cell LHRH receptors and
responsiveness to LHRH agonists suggesting that LH negatively
regulates LHRH receptor numbers and responsiveness(Sharpe & Fraser,
1983).
The ability of LHRH to modulate the testicular response to LH
stimulation, its ability to alter capillary permeability and also the
possibility that it may act over short time periods all suggest that
testicular LHRH may be an important local regulator of testosterone
production in the testis.
ii) Oestradiol;
The role of oestradiol in the regulation of testicular
steroidogenesis is still unclear. Early investigations involving this
hormone led to suggestions that it might be a major regulator of
testosterone production in the testis. The suggestions were based on
three areas of research: (1) The recognition and characterization of
Leydig cell oestradiol receptors. (2) The characterization of Leydig
cell response to oestradiol and oestrogen treatment, and (3) The
discovery that Sertoli cells produce oestradiol _in vivo and in vitro
(See Sharpe, 1982, for review).
The background to these investigations provides an illustration
of the pitfalls of applying _in vitro results too readily to the in
vivo situation. The presence of testicular oestradiol receptors and
their physical characteristics have been established in the rat(see
Mulder, van Beurdan-Lamers, de Boer, Brinkman & van der Molen, 1974,
for review). The interstitial cells of the rat testis have been shown
to contain two types of binding sites for oestradiol, a high affinity,
low capacity site and a low affinity, high capacity site. The high
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affinity receptor has been partially purified and identified as a heat
sensitive protein which is translocated to the nucleus of the Leydig
cells. No significant levels of this receptor were found in
seminiferous tubules. The association constant for this receptor
10—1 —'11+
class was 10 M , with a concentration of 2x10 moles/mg cytosol
protein(Mulder _et al, 1974).
Oestradiol treatment of hypophysectomized rats decreased the
Leydig cell response to LH _in vitro without altering hCG
binding(Damber, Bergh, Daelin, Ekholm, Selstam & Sodergard, 1983), and
whilst injected oestrogens have been shown to exert inhibitory effects
on testosterone production in rats and men, there is some dispute as
to whether these results are the consequence of a reduction in serum
LH levels, or represent a direct effect of the oestrogens on the
testis, or a combination of both effects(See Sharpe, 1982). The most
acceptable explanation for these effects is that oestrogens affect
both the testicular response to LH and serum levels of this
hormone(see Sharpe, 1982 for review).
The final set of experimental data supporting the role of oestradiol
as an intratesticular regulating factor was the detailed evidence that
the Sertoli cell produces oestradiol in response to FSH stimulation
(see Sharpe, 1982 for review). Oestradiol production by the Sertoli
cell occurs via the conversion of androgens to oestrogens, and it has
been shown that FSH can regulate the conversion of 19-hydroxylated
androgens to oestrogens(Dorrington, Fritz & Armstrong, 1976). The
above evidence, taken in isolation, strongly suggested a regulatory
role of oestrogens produced by the Sertoli cell on Leydig cell
testosterone production, and also that Leydig cell testosterone forms
the substrate for the Sertoli cell production of oestrogens, i.e. a
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two-cell theory of oestrogen synthesis as occurs in the ovary.
However, more recent evidence has shown that this is not the case. In
vivo, Sertoli cells are now known to secrete oestradiol only up to
about day 20 of life, after which their ability to produce oestrogens
rapidly disappears(Pomerantz, 1979; Rommerts, de Jong, Brinkman & van
der Molen, 1982). In addition, studies on the ontogeny of Leydig cell
oestrogen receptors show that these appear only after day 14 or as
late as day 21 of life(de Boer, Mulder & van der Molen, 1976; Abney &
Melner, 1979), and are paralleled by the appearance of adult Leydig
cells which synthesise oestradiol(see above). In adult animals PSH
produces no effect on testicular oestradiol levels or aromatase
activity, while hCG rapidly increases testicular oestradiol levels and
aromatase activity(see Sharpe, 1982 for review).
Therefore during the period when Sertoli cells are actively
converting testosterone to oestradiol, the Leydig cells contain no
receptors for this steroid, and once the adult Leydig cells appear
production of oestradiol switches from the Sertoli cell to the Leydig
cell, thus effectively ruling out any role oestradiol has as a link
between the seminiferous tubules and the interstitium.
However, the effect of oestrogens on the Leydig cell continued to
generate interest, both as to their role in the regulation of this
cell type and as to their physiological significance. It has been
suggested that oestradiol acts as an ultra-short loop feedback
regulator of testosterone production(Catt, Harwood, Clayton, Davies,
Chan, Katikineni, Nozu & Dufau, 1980), but a number of factors raise
doubts as to the physiological significance of such a feedback.
Firstly, only levels of oestrogens far in excess of those seen _in vivo
have been shown to effectively inhibit testosterone production in
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vitro. However, it can be argued that, since oestradiol is produced
within the Leydig cell, such apparently supra-physiological levels may
exist within the cell(see Sharpe, 1982 for review). Secondly, and
more recently, it has been suggested that the effect of oestradiol
on the Leydig cell is not in fact mediated via the Leydig cell
oestrogen receptors, since the effects of oestrogens were not blocked
by tamoxifen, a potent competitive inhibitor of oestrogen action
(Damber et al, 1983).
Although oestradiol was once thought of as an intratesticular
messenger with a clearly defined regulatory function, it is now
unclear what its function is in physiological states, although it is
certain that it is not as was once suggested an intratesticular
messenger between Sertoli and Leydig cells.
1.4.6: Other potential regulators of testicular function:
There is now evidence for the existence of an increasing number
of factors of intratesticular origin, each of which may play a role
in the regulation of testicular function. These factors may not, as
yet, have specifically defined actions, and often their sites of
production are unknown. The list of factors that follows is by no
means exhaustive, and there is no specific order of precedence but the
range of factors represented will no doubt give some idea of the
immensity of the task that faces those investigating cellular
communication within the testis and the degree of research required
before a clear picture will emerge.
i) Gonadotrophin receptor binding inhibitors:
Reports of factors produced within the testis which
specifically inhibit FSH and LH binding to their testicular
receptors are becoming more numerous. As yet the physiological
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significance of these factors is not known, although if they do
represent true intratesticular factors their potential for
modulating testicular function is obviously of great interest. Two
types of binding inhibitors have been reported, those which inhibit
PSH binding and those which inhibit LH binding, and this division of
function into two distinct sub-classes encourages the belief that
these factors may be of physiological significance,
a) PSH binding inhibitors:
Early experiments with testicular membrane preparations
led to the suggestion that these preparations contained an FSH binding
inhibitor(Abou-Issa & Reichert, 1976). Further studies showed the
presence of a small molecular weight inhibitor of FSH binding(Reichert
& Abou-Issa, 1977). This factor has a molecular weight of about 1500
daltons and is present in testicular extracts. The significance of
these findings is called into question however, by the presence of a
similar factor present in kidney and liver extracts(Reichert & Abou-
Issa, 1977) and its presence in serum is also unexplained(Reichert,
Sanzo & Darga, 1979). The serum factor has a molecular weight of about
700 daltons, and is heat stable over short periods, although it is
susceptible to peptidases, which suggests a peptide
structure(Reichert, Sanzo & Darga, 1979; Dias, Treble, Bennet &
Reichert, 1981). FSH binding inhibitors have also been reported in
human seminal plasma, where two different species of inhibitor are
found, a low molecular weight peptide of about 1,000 daltons, and a
high molecular weight peptide of about 19,500 daltons(Dias et al,
1981)• A factor with comparable effects has also been identified
in bovine testis and has a molecular weight of around 30,000
daltons(Dias & Reichert, 1983). Research on FSH binding inhibitors
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in bovine follicular fluid shows a correlation between the
level of inhibitor and the mean atretic rank of the follicles,
suggesting that the levels of inhibitor may be linked to the
physiological condition of the follicles from which it is isolated
(Sluss, Fletcher & Reichert, 1983). Correlation of increased
testicular levels of inhibitors with increasing age in rats further
supports a physiological function, still unknown, for these
inhibitors. However, it should be noted that levels of binding
inhibitor in liver and kidney also show an age related
increase(0'Shaughnessy, 1979).
Despite evidence for the existence of FSH binding inhibitors in
a number of species, there is as yet no clear evidence that these
factors are either tissue specific or modulated by physiological
endocrine events. It has been suggested that since the gonads are
the only site of FSH binding then demonstration of extragonadal
production of FSH binding inhibitors is not necessarily relevant to
their physiological role. Notwithstanding this, there is as yet no
clearly defined role for such an inhibitor in vivo,
b) LH binding inhibitors:
The evidence for LH binding inhibitors presents a
similar story to that for FSH, stemming from initial reports of anti-
LH activity in the gonads of various species(Yang, Samaan & Ward,
1976b). A heat resistant peptide with a molecular weight of about
3,800 daltons was isolated from ovaries of pregnant or pseudopregnant
rats and this peptide inhibited LH binding to ovarian LH receptors,
and evidence suggested that two forms of this peptide existed within
the ovary (Yang, Samaan & Ward, 1976b). No activity was detected in
testis or liver extracts nor in ovaries of non-pregnant or immature
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rats(Yang, Samaan & Ward, 1976b). Further studies showed that after
freezing ovaries from normal rats for up to 10 weeks, LH binding
inhibitors could be detected. This inhibitor appeared to be specific
for the ovarian LH receptor, having little or no effect on LH
binding to testicular LH receptors(Yang, Samaan & Ward, 1979). The
inhibition of LH binding in ovarian tissue resulted in decreased
progesterone synthesis, although basal synthesis of progesterone was
unaffected(Yang, Samaan & Ward, 1976a). The fact that other tissues,
including testes, heart and liver, plus ovaries from immature rats,
did not show any activity suggests that this factor may well have a
physiological role(Yang, Samaan & Ward, 1976a). The peptide actually
stimulated testicular testosterone production, but since the ovarian
extract used was crude it is possible that other factors may have
interfered in the test system, although a direct stimulatory effect of
the ovarian LH binding inhibitor on testicular steroidogenesis
cannot be ruled out(Yang, Samaan & Ward, 1976a).
More recently the presence of an LH binding inhibitor in rat
testicular tissue has been reported(Rojas, Moretti-Rojas, de
Bellabarba & Bishop, 1981). This factor, which has a molecular
weight below 12,000 daltons and is partially heat labile, inhibits
hCG binding to both ovarian and testicular LH receptors(Rojas jrt
al, 1981), by competing for binding sites. Like the FSH binding
inhibitor, this factor is not tissue specific and is present in other,
non-gonadal, tissues, including kidney, liver, and brain(Rojas _et_ al,
1981) and such findings cast doubt on its physiological significance,
ii) Pro-opiomelanocortin derived hormones:
Evidence for the involvement of peptides derived from the
pro-opiomelanocortin(POMC) molecule in the control of testicular
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function is growing rapidly, following the discovery of several of
these peptides in the testis. However, as yet, data is sparse and
little is known of the ways in which these peptides might influence
testicular function.
Early evidence for opiate effects on steroidogenesis In vivo
appeared to be mediated via depression of circulating LH levels,
suggesting that the effects of these compounds were manifested at the
hypothalamic or pituitary levels(Cicero, Meyer, Bell & Koch, 1976).
More recently the production of jS-endorphin, c4-MSH and ACTH by Leydig
cells of the rat, and its presence in other sites in the reproductive
tract have centred attention on possible paracrine functions of the
POMC-derived peptides(Tsong, Phillips, Halmi, Liotta, Margioris,
Bardin & Krieger, 1982). While ^-endorphin seems to be the major
endorphin component present, <=*- and Y-endorphins are also present,
along with oi-MSH(Margioris, Liotta, Vaudry, Bardin & Krieger, 1983).
Reports demonstrate that the major site of synthesis of these peptides
is the Leydig cell(Margioris et_ _al, 1983; Shaha, Liotta, Krieger &
Bardin, 1984; Chen, Mather, Morris & Bardin, 1984). Recent reports
suggest that spermatagonia and spermatocytes contain a form of
^-N-acetyl-endorphin, an inactive metabolite of /^-endorphin, but that
^-endorphin activity is confined to Leydig cells(Cheng, Clements,
Lolait & Funder, 1984).
The pro-opiomelanocortin gene is not found in Sertoli cell lines,
but is evident in two different Leydig cell lines(Chen, Mather, Morris
& Bardin, 1984). Whilst there is evidence for synthesis of
endorphins of different classes in the Leydig cells, there is no
evidence for Sertoli cell production of endorphins or related
compounds (Shaha _et_ ad., 1984; Margioris _et al, 1983; Chen ejt al,
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1984; Cheng _et al_ 1984). Testicular interstitial fluid, an essential
link in the communication between the seminiferous tubules and the
interstitium, has been shown to contain ^-endorphin and ACTH when
collected from adult rats and levels of these hormones are altered
following treatment with an analogue of LHRH(Valenca & Negro-Vilar,
1984). Opiate receptors have been identified in the testis(Boitani,
Shaha, Bardin & Hahn, 1984) although as yet their location is not
known. There is some evidence that testicular production of endorphins
can be modulated by hormones. hCG stimulation increases the number of
mouse interstitial cells staining positively for ^-endorphin, and also
increases /3-endorphin levels in ovarian interstitial cells(Shaha _et
al, 1984; Rothrock, Sarkar & Erickson, 1984). Expression of the POMC-
gene in granulosa cells is increased by concomitant stimulation with
LH and FSH when compared to FSH stimulation alone(Melner, Luo, Roos,
Clark, Roberts & Puett, 1984).
Preliminary evidence for a role of endorphins in the testis comes
from a report showing increased Sertoli cell division in foetal rats
following administration of naloxone, an antagonist of /S-endorphin,
suggesting that ^-endorphin might inhibit Sertoli cell division
(Orth, 1984).
Overall the evidence for a paracrine function of endorphins is
growing rapidly, although there is as yet no conclusive evidence that
the endorphins are involved in the physiological control of testicular
function. Whilst endorphins are produced by the Leydig cells no
receptors have been found in the Sertoli cells as yet, and although an
effect of an endorphin antagonist has been demonstrated in foetal
rats, there is currently no evidence for effects in the adult.
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iii) Epidermal growth factor:
Epidermal growth factor(EGF) is a known mitogenic peptide
found in serum(Hsueh, Welsh & Jones, 1981), and it has been shown to
stimulate mitosis in cell lines which are thought to be derived
from Sertoli and Leydig cells(Mather, 1980). However, more recent
evidence suggests that EGF has a direct effect on Leydig cell
steroidogenesis(Hsueh, Welsh & Jones, 1981; Welsh & Hsueh, 1982; St-
Arnaud, Walker, Kelly & Labrie, 1983), having no effect on basal
testosterone production In vitro but markedly inhibiting hCG
stimulated testosterone production(Hsueh, Welsh & Jones, 1981).
Comparable effects of EGF have been demonstrated on ovarian oestrogen
production(Hsueh, Welsh & Jones, 1981). EGF has been shown to act via
specific, high affinity, low capacity receptors on the Leydig cells
(Welsh & Hsueh, 1982) and to act only after a 12 hour lag period.
Decreased testosterone production under these conditions is linked
with increased cellular protein concentrations, but no change in
cellular DNA content is seen(Welsh & Hsueh, 1982). Since the presence
of receptors for EGF and a specific effect of this peptide have been
shown within the gonads it is possible that this peptide exerts a
paracrine role. It may be that EGF is produced locally within the
testis to modulate steroidogenesis, although the time taken for an
effect to be manifested is lengthy which leaves the physiological
significance of such effects open to question,
iv) Oxytocin, Vasopressin and Neurophysin:
Testicular material from both rats and man has been shown to
contain oxytocin, vasopressin and the carrier proteins for these two
compounds, neurophysin(See Wathes, 1984 for review). Oxytocin has been
recently demonstrated to modulate rat seminiferous tubule
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contractility(Wathes, 1984), and both arginine vasopressin and
oxytocin have been shown to be potent inhibitors of hCG stimulated
testosterone production by isolated Leydig cells(Wathes, 1984; Adashi
& Hsueh, 1981 a,b). Of nine compounds tested three(arginine-
vasopressin, arginine-vasotocin and lysine-vasopressin) were highly
active in inhibiting hCG-stimulated testosterone production, the
minimum effective dosage for all of these compounds being around
-10
10 M, while mesotocin, valitocin and oxytocin were of intermediate
efficacy with minimum effective doses of around 10" M. Three compounds
(isotocin, glumitocin and aspartocin) were almost ineffective at doses
of 10" %!(Adashi & Hsueh, 1981a).
Further studies have shown that the effects of argine-vasopressin
and oxytocin are mediated by specific testicular recognition sites,
which are susceptible to agonism and antagonism by compounds related
to vasopressin and oxytocin(Adashi & Hsueh, 1981b).
The fact that vasopressin and oxytocin can completely reverse the
hCG stimulated increase in Leydig cell testosterone production(Adashi
& Hsueh, 1981a,b) and that these hormones are present in
testicular tissue suggests a local role for these compounds in the
regulation of steroidogenesis. However since levels of oxytocin and
vasopressin are low in testicular tissues, and other roles of these
hormones are more convincing physiologically, e.g. in modulating
contractitily of seminiferous tubules, then it may be premature to
assume that they regulate steroidogenic function in the physiological
state.
v) Prostaglandins:
The role of prostaglandins in the regulation of testicular
function is unclear, as conflicting reports of stimulatory and
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inhibitory effects of prostaglandins on Leydig cell function _in vitro
are found in the literature(see Sharpe, 1982 for review). However the
presence on the Leydig cell of specific high affinity receptors for
PGE, and demonstrable increases in cAMP production following
prostaglandin binding to such receptors makes it possible that such
molecules are involved in the regulation of steroidogenesis(Sebokova &
Kolena, 1978). Macrophages from a number of tissue sources and
species have been shown to produce prostaglandins(Hume & Gorden,
1982), and recent reports suggest that macrophages may interact with
Leydig cells within the testis(Bergh, 1985; see also Chapter 8).
However, as yet the evidence is incomplete and further investigations
are required before such possibilities can be confirmed or refuted,
vi) Inhibin:
Although the major role of inhibin is the selective
regulation of pituitary FSH secretion, recent evidence suggests
that it may have local effects within the testis. Inhibin
preparations have been shown to inhibit the incorporation of
labelled thymidine into testicular, but not liver, DNA _in vivo and
also in vitro(Franchimont, Croze, Demoulin, Bologne & Hustin, 1981).
These results are similar to effects obtained with testicular
chalones and it has been postulated that inhibin may be identical to
these compounds(Franchimont et al, 1981). Another postulated local
effect of inhibin is the modification of basal and FSH stimulated
cAMP-phosphodiesterase activity(Sheth, Vijayalakshmi, Sheth,
Bandivdekar & Moodbridi, 1982), with inhibin increasing cAMP-
phosphodiesterase activity basally and in the presence of FSH in
both immature and adult rats(Sheth et al, 1982). It has also been
suggested that inhibin could interfere with FSH binding to its
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receptors within the testis(Vijayalakshmi, Moodbidri, Bandivdekar &
Sheth, 1980). However, these and other inhibin studies have been
challenged since the investigators do not as yet have access to
purified inhibin, and therefore, while these results are of
interest, the elucidation of the true physiological effects, if any,
of inhibin within the testis must await the synthesis or
purification of the active peptide.
vii) Thyroid releasing hormone(TRH):
Since TRH was first identified in the rat prostate(Pekary,
Sharp, Briggs, Carlson & Hershman, 1983), investigations as to its
origin have been in progress. The presence of TRH in human and rat
prostates, and human semen and testis has been shown, along with high
levels of TRH degrading enzymes in Sertoli cells(Pekary, Ross,
deKernion & Hershman, 1983; Pekary & Rosen, 1982). Interstitial cells
have been shown to be the source of this peptide(Pekary & Rosen, 1982),
and it has also been suggested that testosterone regulates the
testicular production of TRH(see Pekary, Ross, deKernion & Hershman,
1983) Therefore, the function of this peptide within the reproductive
tract is not clear.
viii) Testicular-anti-mullerian hormone;
Anti-mullerian hormone controls the regression of the
Mullerian ducts in male foetuses, and has been characterized
as a polymer of two or three 72,000 dalton monomers(Picard & Josso,
1984). This hormone has recently been isolated from rete testis
fluid from adult bulls(Josso, Picard, Dacheux & Courot, 1979), and,
as it is known to derive from the Sertoli cells(Vigier, Picard,
Tran, Legeai & Josso, 1984), it represents yet another potential
regulator of the testis, although its function is not yet known.
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ix) Renin-angiotensin:
It has recently been demonstrated that angiotensin and its
precursor renin are present in Leydig cells(Pandey, Melner, Misono &
Inagami, 1984). Rat Leydig cells from two distinct populations
separated on metrizamide gradients had different levels of *
angiotensin I and also of the inactive precursor renin(Pandey, Melner
Misono & Inagami, 1984). Angiotensins II and III were also present.
When compared with kidney renin, rat testicular renin had a similar
molecular weight and immunoreactivity(Parmentier, Inagami & Pochet,
1984). The significance of these findings is still unclear,
x) Corticotrophin releasing factor:
Specific high affinity binding sites for corticotrophin
releasing factor have been reported in a range of rat tissues
including spleen, liver, and testis(Dave, Bisserbe & Eskay, 1984).
Their significance is not known,
xi) Clusterin:
Recently a polypeptide capable of inducing clustering in
cultures of various cell types has been identified in testes and
ovaries, but not in a range of other tissues(Fritz, Blaschuk & Burdzy
1984). Clusterin is a heat-stable, trypsin-sensitive peptide and is
effective in aggregating Sertoli and other cell types _in vitro. Its





2.1: Animals and treatments:
2.1.1: Animals:
All the animals used for these studies were Sprague Dawley male
rats, either from our own colony or obtained from Charles River
Ltd(U.K.). Rats from our own colony were housed under conventional
conditions(Light:dark cycle comprising 14h light:10h dark, food and
water ad libitum, temperature 21°C). All rats obtained from Charles
River were subsequently housed under these conditions. All animals
were killed using dry ice generated carbon dioxide and cervical
dislocation. In the course of these studies the following treatments
were used:
2.1.2: Cryptorchidism:
During the course of these studies a number of rats were
subjected to either unilateral or bilateral cryptorchidism. Operations
were carried out under ether anaesthesia. The testes were exposed and
either one(unilaterally cryptochid) or both(bilaterally cryptorchid)
were translocated into the abdominal cavity. Subsequently the inguinal
canal was closed by sutures to prevent the redescent of the testes.
I am grateful to Mr Denis Doogan for performing all such operations
required for these studies.
2.1.J: Hypophysectomy:
Male Sprague-Dawley rats, which had had their pituitaries removed
via the parapharyngeal route, were obtained from Charles River. In
addition to the normal diet given to our own colony, hypophysectomized
rats received 5$ dextrose in their drinking water.
2.1.4: Injections:
i) LH: Groups of rats were injected with either 0.7mls 0.9$
(w/v) sodium chloride(controls) or 10 ;ig ovine LH(NIH-LH-S24),
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subcutaneously.
ii) LH antiserum: Groups of adult rats 80-85 days of age were
injected subcutaneously with an LH antiserum as a single dose of 0.7
mis and animals were killed at intervals between 2-40 h later. The LH
antiserum was raised in rabbits and was a gift from Dr. H.M. Fraser;
its properties have been described by Sharpe & Fraser(1983). Control
rats were injected with an equivalent volume of 0.9$ sodium
chloride.
iii) Ethane dimethanesulphonate(EDS); Groups of adult rats were
injected intraperitoneally with either 75mg EDS/kg body weight in
dimethyl-sulphoxide-water(1:3 v/v) or with an equivalent volume of
vehicle.
2.2: Preparation of Leydig cells:
2.2.1: Interstitial cell preparation:
Testes from adult(70-90 day old) rats were removed immediately
following death, decapsulated and placed in 50 ml conical flasks in
groups of 4-5 testes per flask. Collagenase(0.25 mg/ml; Sigma, U.K.
Type I) and bovine serum albumin(2.5 mg/ml; BSA, Fraction V, Sigma
U.K.) were added to M199 containing Hank's salts and 20mM Hepes buffer
(M199H, Flow Laboratories, U.K.). 1.5 mis/testis of this solution were
added to the flasks and the testes dispersed for 6-7 minutes in a
shaking water bath(l70 cycles/minute, 32°C). After dispersion groups
of 8-10 testes were decanted into 50 ml measuring cylinders, diluted
with 50 mis of M199H and mixed by 2-3 gentle inversions of the
cylinder. The tubular mass was then allowed to settle under gravity
and the supernatant, containing the interstitial cells, decanted into
5 ml plastic centrifuge tubes. The tissue mass was then discarded. The










Fig 2.1; Apparatus for formation of continuous Percoll gradients: By
placing 90% Percoll in the left hand chamber and M199H in the right
hand chamber continuous gradients are formed by the mixing of these
two chambers throughout the pumping procedure.
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at 250 x g, on a Mistral 2L centrifuge(Beckman Ltd). The supernatant
was decanted and the tubes blotted dry prior to resuspension of the
precipitated cells in 6 mis of M199H. Cells were then stored at 4°C
prior to further purification(see below) or for use as a "crude"
Leydig cell preparation. Cells isolated in this manner usually
contained 15-25$ Leydig cells as identified by 3/3Hydroxysteroid
dehydrogenase staining of air-dried smears(Sharpe & Fraser, 1983).
2.2.2: Percoll purification of Leydig cells:
a) Formation of Percoll Gradients:
i) Preparation of stock solutions:
Percoll(Pharmacia Ltd. U.K.) is a medium composed of
colloidal silica coated with polyvinylpyrrolidone to reduce toxicity.
It has a low osmolality(20 mOsmoles/kg H^O) and must therefore be
adjusted to form an isotonic solution, i.e. a solution which is normo-
osmotic. Stock Percoll was mixed with 10 times normal strength M199H
(9:1 v/v, Flow Laboratories) producing a solution containing 90$
Percoll and normal concentrations of M199H. This solution, hereafter
termed '90$ Percoll', has a density of 1.12 g/ml, and it was then
diluted further with normal strength M199H to form continuous or
discontinuous gradients.
ii) Formation of continuous Percoll gradients:
For each 50 ml continuous gradient 25 mis of M199H and
25 mis of 90$ Percoll were prepared. The 90$ Percoll was placed in the
left-hand chamber of a gradient former(Fig 2.1) and the M199H in the
right hand chamber. Using a magnetic stirrer to mix these solutions
0-90$ Percoll gradients were prepared using a Densi-Flow combined pump





Volume of 90$ Percoll
per 10 ml fraction
(mis)
Volume of M199H :
per 10 ml fraction :
(mis) :
: 1.00 0.00 10.0 :
: 1 .03 2.56 7.44 :
: 1.05 4.27 5.73 :
: 1.07 5.98 4.02 :
: 1.09 7.69 2.31 :
Table 2.1: Formation of discontinous Percoll gradients: Volume of
90$ Percoll and of M199H required for preparation of the fractions of





Fig 2.2: Comparison of continous and discontinuous Percoll gradients
using Density Marker Beads(DMB, Pharmacia U.K.). It can he seen that
whilst in the continous gradient a wider distribution of the DMB are
seen, the bands in which they appear are also more diffuse than those
seen on the discontinous gradient. On the discontinous gradient the









iii) Formation of discontinous Percoll gradients:
Discontinous Percoll gradients consisting of 5
distinct bands with densities of 1.0, 1.03, 1•05» 1.07 and 1.09 g/ml
respectively were prepared by mixing 90$ Percoll and M199H in
differing proportions as described in Table 2.1. Gradients were formed
by layering the bands, either by hand or using the meniscus follower
(Fig 2.1), in which case only the left hand chamber of the gradient
former was used. Bands were layered, commencing with the 1.09 g/nil
layer. Gradients were stored, usually overnight, at 4°C until used.
b) Calibration of preformed gradients:
Discontinous and continuous Percoll gradients were
calibrated using cross-linked dextran beads with accurately
predetermined densities(Density Marker Beads, Pharmacia, U.K.),
covering a range from 1.017 to 1.142 grams/ml. Gradients were
centrifuged under the same conditions as for cell purification and the
positions of the bands noted. The results(Fig 2.2) showed that whilst
the continuous gradients gave a wider range of separation, with the
bands usually clearly separated from each other, the discontinous
gradients gave much clearer and sharper bands. The discontinous
gradients also provided much sharper definition of the different bands
of cells found during purification of Leydig cells, and therefore
these gradients were chosen for the majority of cell preparations.
c) Leydig cell purification with Percoll gradients;
Unpurified or "crude" interstitial cells were prepared(see
section 2.2.1 above) and approximately 120 x 10^ cells layered onto
each Percoll gradient. Gradients were then centrifuged at 4°C for 20
min at 800 x g in a Mistral 2L centrifuge and the Leydig cells, which
focus in the lower of the three cell bands, were recovered by
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Fig 2.3: Apparatus for the dissection of seminiferous tubules: The
insulated water bath on the left, was filled with a mixture of ice and
water which was continously pumped through the perspex stage
throughout the dissection procedures. The microscope was adjusted for
trans-illumination of the sample being dissected.
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aspiration. Recovered cells were washed in M199H and harvested by
centrifugation at 4°C for 5 minutes at 250 x g. The cell pellets,
containing 70-90% Leydig cells, were then resuspended in M199H and
o
counted using a Neuberg Haemocytometer. Cells were then stored at 4 C
until used in the procedures described below.
2.3: Preparation of seminiferous tubules:
2.3-1: Collagenase dispersion of testes:
Groups of 4 testes were decapsulated and dispersed for 3-4 min
using 1.5mls/testis of medium 199(Plow Laboratories) containing Hank's
salts and 20mM Hepes buffer(M199H pH 7.4), 0.25mg/ml collagenase(Sigma
type I) and 2.5mg/ml bovine serum albumin(BSA, Sigma, Fraction V) in a
shaking water bath(l70 cycles/minute) at 32°C. After dispersion the
tissue was diluted with 50 mis M199H and the tubular mass allowed to
settle under gravity. The supernatant was decanted and either
discarded or used for Leydig cell preparation(see above). The
seminiferous tubules were washed with a further 50 mis of M199H and
stored on ice to provide a pool of material for dissection.
2.3-2: Dissection of seminiferous tubules:
All stages of the dissection procedure described below were
performed on a trans-illuminated 1/2 inch deep perspex stage, mounted
on a Leitz dissecting microscope, and through which ice cold water was
pumped continuously(Fig 2.3)- Seminiferous tubules were either
collagenase dispersed before dissection(see above) for use in static
cultures or perifusions, or in the case of tubules dissected for
testosterone or protein determination, lengths were teased out from
decapsulated undispersed testes.
In the latter case whole decapsulated testes were placed in
plastic Petri dishes with about 5-10 mis M199H, manually teased
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apart using watchmakers forceps, and 2-10 cm lengths of tubules
isolated. Collagenase dispersed testes were processed similarly.
Tubules with adherent interstitial/connective tissue were not used.
The 2-10 cm lengths of seminiferous tubules were pooled in a Petri
dish containing 2-5 mis ice cold M199H. When a sufficient pool of
tubules had been obtained, all but a thin film of the medium was
aspirated and the dish placed above a transparent 1 mm squared grid,
on the microscope stage. Tubules were aligned above this grid in
parallel using watchmakers forceps and cut into 0.5 cm lengths using a
scalpel. These 0.5 cm sections were then used for either co-
incubation with Leydig cells, preparation of conditioned medium,
co-perifusion with Leydig cells or for determination of their protein
and testosterone content(see below).
2.3*3: Stage dissection of seminiferous tubules;
Using transillumination microscopy the spermatogenic cycle as
described by Leblond & Clermont(1952b) can be readily dissected into
four major pools according to the appearance of the tubule(Parvinen
& Vanha-Pertulla, 1972). The stages of the spermatogenic cycle were
thus separated into four groups:- VII-VIII, which appear dark in the
centre of the tubule, stages IX-XII, which appear pale, stages XIII-I
which appear weakly spotted and stages II-VI which appear strongly
spotted under transillumination microscopy. Using identical techniques
to those described above(section 2.3*2), seminiferous tubules were
dissected according to the stage of the spermatogenic cycle(stage
dissected tubules), and used for the procedures described below. Due
to the varying lengths of these stages it was not possible to
consistently dissect out 0.5 cm lengths of each stage but the total
lengths of tubule used were kept constant in any particular
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experiment.
2.3.4: hCG binding to dissected seminiferous tubules:
a) hCG binding assay:
To either 10 cms of seminiferous tubules(20 x 0.5 cm
lengths) or 50,000 Percoll-purified Leydig cells in 200 pi M199H was
added either 50 pi of unlabelled hCG(lOO IU/ml; Chorulon) in M199H to
determine non-specific binding or 50 pi of M199H alone, and to all
tubes 50 pi of 1-125-hCG(—100,000 c.p.m; iodinated-hCG CR119; NIAMDDK,
U.S.A., gifted by Dr. T.A. Bramley) was added. Tubes were incubated at
room temperature for 18 h, then diluted with 3 mis 0.9$(w/v) saline
and centrifuged at 4°C for 5 min at 800 x g. Supernatants were
decanted and precipitates counted in an NE1600(New England Nuclear,
U.S.A) gamma-counter. Specific binding of hCG was expressed as a
percentage of total counts.
2.3*5: Diffusion of testosterone from isolated seminiferous tubules:
10 cm aliquots(20 x 0.5 cm) of seminiferous tubules were placed
in 2 mis of M199H at 20°C. At various times thereafter the tubules
were removed from the medium and both tubules and medium were
extracted and assayed for testosterone content.
2.4: Co-incubation of seminiferous tubules and Leydig cells:
For tissue co-incubation, varying lengths(1,2,4,8 & 10 cm) of
dissected seminiferous tubules(see section 2.3 above) were transferred
in 0.5 cm segments to 24-well plastic culture dishes(Nunc, Denmark) to
each well of which was added 200 pi medium 199 containing Earles'
salts(Flow Laboratories, U.K.) 2 mM L-glutamine(Flow Laboratories,
U.K.), transferrin (5 pg/ml; Sigma), insulin(10 pg/ml; Sigma),
ceruloplasmin(1 I.U./ml; Sigma), penicillin( 100 I.U./ml, Flow
Laboratories U.K.), streptomycin(100 pg/ml; Flow Laboratories U.K.),
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fungizone(2.5yg/ml; Flow Laboratories U.K.) and BSA(=M199E).
Concentrated suspensions of either unpurified interstitial cells or
Percoll-purified Leydig cells(see section 2.2 above) were diluted and
aliquots of 0.05-0.5 x 10^cells/well were added in 250 jil M199E.
Human chorionic gonadotrophin(hCG, Chorulon, Intervet) was added to a
final concentration of 0, 0.2 or 2,000 ml.U./ml and the plates
incubated in a total volume of 0.5 mis for various periods of time at
32°C under a humidified atmosphere of 5%CO-^:95% air. In some
experiments muscle tissue was also incubated with cells and in all
experiments cells, incubated with medium alone were used as a control.
For some experiments, parallel incubations were prepared and incubated
for 24 h in the absence of hCG and the medium then aspirated and
replaced with fresh M199E containing hCG prior to a further 5 h
incubation. At the end of the incubations all media were aspirated,
centrifuged at 1,000 x g for 5 min at 4°C to remove cellular debris,
and then stored at -20°C prior to measurement of testosterone by
radioimmunoassay.
2.5s Seminiferous tubule-conditioned medium:
2.5*1: Preparation of seminiferous tubule-conditioned medium:
Tubules were dissected as described above and 20 x 0.5 cm
lengths/ml(i.e. 10 cm/ml) were transferred into M199E in 5 ml aliquots
and incubated for 16-24 h at 32°C under a humidified atmosphere of
5$C0-^:95$ air. In some experiments seminiferous tubules were prepared
as described above and transferred into medium to give final levels of
either 5 cm/ml(lO x 0.5 cm lengths), 10 cm/ml(20 x 0.5 cm lengths),
20 cra/ml(40 x 0.5 cm lengths) or 40 cm/ml(80 x 0.5 cm lengths). After
incubation the medium was decanted and centrifuged(1,000 x g for 5
min at 4°C) to remove the seminiferous tubules. The supernatant was
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then mixed with 2 mg/ml activated charcoal(Norit A, Sigma) for 30-60
min at 4°C to remove steroids, and then centrifuged at 4°C for 30 min
at 1,000 x g. The supernatant was decanted and stored at -20°C until
used for the procedures described below. Aliquots of medium alone
were incubated and processed as described above and were used as a
control. As an additional control, strips of thigh muscle were also
incubated and this muscle-conditioned medium used in the experiments
described below.
2.5*2: Effect of tubule-conditioned medium on Leydig cells:
Seminiferous tubule-conditioned medium, muscle-conditioned medium
and control medium were tested for their ability to alter basal and
hCG-stimulated testosterone production by Percoll-purified Leydig
cells _in vitro. Conditions were identical to those described
above for tissue co-incubations except that instead of tubules being
added directly, a final volume of 50% of the test medium was added to
each well. Cells were incubated in the presence of this test medium,
as described above, for either 5 h in the presence of hCG or for 24 h
without hCG, following which the medium was changed and replaced with
medium containing hCG and incubation continued for a further 5 h. At
the end of each experiment samples were stored at -20°C prior to
measurement of testosterone by radioimmunoassay.
2.6: Concentration of seminiferous tubule-conditioned medium:
In an attempt to concentrate any factor(s) present in
seminiferous tubule-conditioned medium two experiments were performed
in which medium was concentrated by stepwise ammonium sulphate
precipitation. All medium was charcoal-extracted prior to treatment.
An equal volume of medium alone was also precipitated as a control.
In the first experiment, a volume of 20 mis of control and
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seminiferous tubule-conditioned medium were precipitated stepwise with
increasing concentrations of ammonium sulphate(pH6.5, BDH).
Step 1: To each 20 ml aliquot of medium were added 13-4 mis of
saturated ammonium sulphate, bringing the solution to a final
concentration of 40$ ammonium sulphate. These solutions were stirred
for 2 h at 4°C prior to centrifugation at 45,000 x g for 30 min at
4°C in an ultracentrifuge(Sorval, U.K. Ltd). The pellet was
resuspended in 2 mis M199H and the supernatant taken on to step 2.
Step 2: To each 33*4 ml supernatant from step 1 were added
16.6 mis of saturated ammonium sulphate, raising the concentration of
ammonium sulphate to 60$ . These solutions were stirred for 2 h at 4°C
prior to centrifugation as for step 1. The pellets were resuspended in
2 mis M199H and the supernatant taken on to step 3-
Step 3? To each 50 ml supernatant from step 2 a further 50 mis of
saturated ammonium sulphate was added, bringing the final ammonium
sulphate concentration to 80$. These solutions were stirred overnight
at 4°C prior to centrifugation as for steps 1 and 2. The supernatant
was then discarded and the pellets resuspended in 2 mis M199H.
All precipitated fractions and control media were then desalted
using Sephadex PD-10 columns(Pharmacia, U.K. Ltd), and dialyzed
for 12 h at 4°C against M199H prior to storage at -20°C until used in
the incubation system described above(see section 2.5-2).
In a second experiment a volume of 100 mis of control and
seminiferous tubule conditioned medium were precipitated stepwise
with increasing concentrations of ammonium sulphate adjusted to
pH 7*4. Essentially, the precipitation was as described for
the first experiment, except that after the pellets were resuspended
in 2 mis M199H they were dialysed against M199E for 40 h at 4°C,
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then made up to 5 nils in M199E and frozen prior to use in the
incubation system described above.
2.7: Co-perifusion of seminiferous tubules and Leydig cells:
2.7.1: Preparation of Leydig cells and seminiferous tubules:
Seminiferous tubules were prepared as described above, between
50-400cm of tubules being required for each column. The optimum
number of seminiferous tubules was found to be 200 cm per column and
the methods described therefore make use of this observation. For each
column, between 1.5 and 3 million Percoll-purified Leydig cells were
used, and these were prepared as described above.
2.7.2: Preparation of materials for perifusion:
For each column 0-5 g of Bio-Gel P-2(200-400 mesh, Bio-Rad
(Lowry & McMartin, 1974)
Laboratories, U.S.A.) was preswollen for 18 h in physiological saline
(0.9$ w/v sodium chloride, Steripak Ltd, U.K.). Medium 199 containing
Earles' salts(Pharraacia Ltd U.K.) was gassed for 20-30 min with
95% 0^:5$ CO^(British Oxygen Ltd) prior to the addition of 1 mg/ml
BSA, 2 mg/ral glucose(D-glucose, BDH Chemicals Ltd, U.K.), 0.1 mg/ml
L-glutamine(BDH Chemicals Ltd, U.K.) and 20 jig/ml Garamycin(gentamicin
sulphate, Schering Corporation, U.S.A). The pH of the medium was
adjusted to pH 7-4 using 0.1M sodium hydroxide. oLH(NIH-LH 23; 2.3 SI
units/mg) was diluted in medium to give doses ranging from 0.01-10
ng/ml as required. Columns were prepared by inserting a 0.8 x 40 mm
needle(Becton Dickinson Ltd, U.K.) through the plunger of a 2 ml
plastic syringe(Gillette Surgical, U.K.) and sealing the syringe
with nylon guaze.
2.7*3: Perifusion:
For each column 1.5-3 million Leydig cells were mixed with the
preswollen Bio-Gel. To some columns at this stage 50-400 cm of 0.5 cm
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Fig 2.4: Apparatus for Perifusion experiments: Medium 199 containing
oLH(oLH) or medium alone(M199) were stored in the incubator along
with columns containing either Leydig cells or Leydig cells with
seminiferous tubules, or seminferous tubules alone. The multi-channel
pump perifused the medium thorough the columns and thence into the
fraction collector shown at the right. The flow of either M199 or LH
into the columns was controlled by a three-way tap.
- 82 -
lengths of seminiferous tubules were added. The Bio-gel >
suspensions were loaded into the syringes by suction and the contents
of the columns allowed to settle while medium prepared as described
above was perifused through the system by a multichannel pump(lsmatec
mp-25, Ismatec SA, Switzerland; Fig 2.4)• After loading, columns were
allowed to settle for 30min before perifusate samples were collected
every 10 min using a multichannel fraction collector(LKB UltroRac II,
LKB, Sweden). By varying the setting on the pump the perifusion speed
was varied between experiments from 0.25-0.5 mls/min. In most
experiments columns were perifused for 2 h without LH stimulation and
then 'pulsed' with LH for 10 min at 2 and 4 h after commencement of
the perifusion. Experiments were terminated after 6 h as previous
experiments have shown that crude interstitial cell preparations begin
to deteriorate after this time(Wu, Zhang, Williams & deKretser, 1985)-
Samples were stored at -20°C prior to measurement of testosterone by
radioimmunoassay.
2.8: Collection of body fluids and samples for testosterone
determination:
2.8.1: Interstitial fluid:
Collection of interstitial fluid from the testis was performed
using techniques described by Sharpe & Cooper(1985)• The testes were
isolated after death and a small incision was made in the testicular
capsule at the caudal end of the testis(the point furthest from the
rete testis). The testis was then placed in a plastic centrifuge tube
at 4°C and interstitial fluid allowed to drain from the testis over
16 h under gravity. After collection of fluid the testis was removed
and used for determination of testis testosterone content, whilst the
interstitial fluid was centrifuged at 1,000 x g, 4°C for 15 min to
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remove any contaminating red blood cells. Interstitial fluid volume
was determined by aspiration of the interstitial fluid in 10 pi
aliquots.
2.8.2: Serum:
Serum was obtained at death by collecting trunk blood in non-
heparinised collection tubes. After storing at 4°C for 12-16 h and
centrifugation at 1,000 x g for 10 min at 4°C in a Mistral 2L
centrifuge, serum was frozen at -20°C prior to measurement of LH,
FSH, and testosterone.
2.8.J: Whole testes:
Whole testes were either decapsulated immediately after death or
after collection of interstitial fluid and tissue was stored at
-20°C until extracted for testosterone determination. Testicular
weight was determined by preweighing the tubes in which the testes
were collected, then re-weighing them after collection of the testes.
2.8.4: Seminiferous tubules:
Seminiferous tubules were dissected as described above(see
sections 2.3*3-4 above) and 10 or 20 cm aliquots placed in 0.3 mis
distilled water to cause lysis of the tissue. Samples were then
stored at -20°C, and were subsequently thawed and sonicated for 60
sec using an MSE Soniprep 150(MSE Instruments Ltd, U.K.), prior to
protein estimation or extraction for testosterone assay.
2.9: Testosterone radioimmunoassays:
For the purposes of these studies a novel iodine-based radio¬
immunoassay was validated. The assay previously in use in these
laboratories was a tritium-based radioimmunoassay previously validated
by Corker and Davidson(1978). This assay was used for comparison with
the new radioimmunoassay. Antiserum for the latter assay was kindly
- 84 -
donated by Dr. Brian Morris(ABRO) and the testosterone J-carboxy-
methyl oxime for iodination was donated by Gerry Norblom(U.S.A).
2-9-1: Tritium radioimmunoassay:
The assay was performed using 0.075M phosphate-buffered saline
with 5$ gelatin added(Type I, Sigma U.K., pH 7»4, PBGS). The antiserum
for this assay was a gift from Dr. S. Tilson and was raised in the
goat against testosterone J-carboxy-methyl oxime-BSA. Assays were
performed in a final volume of O.J mis PBGS buffer, comprising 100 yl
of sample, 100 yl of a 1:6,000 dilution of the antiserum, and 100 yul
O
of 1,2,6,7- H testosterone(Amersham International Ltd, U.K.)
containing approximately 8,000 counts per minute. Samples were
incubated either at room temperature for 1 h or overnight at 4°C.
After incubation samples were separated on ice using dextran-coated
charcoal(DCC) in PBGS(2.5 mg dextran sulphate, Pharmacia, U.K., 250 mg
activated charcoal, Norit A, Sigma Ltd. U.K./100 mis PGBS). 1 ml of
DCC was added to each tube, the tubes vortexed and allowed to stand
on ice for 15 min. Bound and free hormone were then separated by
centrifugation at 1,500 x g for 10 min at 4°C. The supernatant was
decanted into plastic scintillation vials containing 10 mis Triton:
toluene scintillant(10 g PPO, 0.75 g POPOP in 2.5 1 toluene and 1.25 1
Triton X100), prior to counting in a y#-counter. Results were then
calculated using a computer programme written for a desk top Hewlett-
Packard computer. The programme was provided by Dr. Sharpe.
2.9*2: Iodination of tracer for the iodine-testosterone assay:
2 jig testosterone-J-carboxymethyl oxime-histamine was resuspended
in 40 jil 0.5 H phosphate-buffered saline(PBS, pH 7*5) prior to
addition of 2 millicuries Na-I-125(Amersham International Ltd, U.K.).







Fig 2.5: Thin Layer Chromatography of iodinated testosterone-3-CM0
conjugate for the iodine testosterone radioimmunoassay. The peak
containing the most active product is shaded(Peak 1).
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(1 mg/ml BDH Chemicals Ltd, U.K.) in 0.05M PBS, and the reaction
allowed to proceed for 2 min before the addition of 10 ^il sodium meta-
bisulphite(l mg/ml, BDH Chemicals Ltd, U.K.) in 0.05M PBS. Subsequent
to this reaction a further 0.5 mis of 0.05M PBS were added to 'bulk
up' the solution. The solution was then extracted twice with 0.5 mis
ethyl acetate(BDH Chemicals Ltd, U.K.), by vortexing for 60 sec.
The ethyl acetate layer was allowed to separate and was then
pipetted into another vessel. The organic phase was then dried down to
about 50-100 jil and spotted onto a TLC plate(Kieselgel 60F254, Merck,
West Germany). Products were then separated by thin layer
chromatography using a mixture of Chloroform:Methanol:glacial acetic
acid(90:10:1). The plate was run until the solvent front was within
2 cm of the top of the plate. The required material was detected using
a handheld Geiger-counter with a 1 mm window, and was eluted from the
TLC plate overnight in ethanol and stored at 4°C until used. The
average yield from 10 iodinations was 33+/~12$. After TLC, 2 bands of
iodinated material were detectable(Fig 2.5) and the lower of these
bands contained the more active material which was used for the radio¬
immunoassay.
2.9-3: Assay method for the iodine-testosterone assay:
For assay, 0.1 ml sample was added to 0.5 ml PBGS followed by
0.1 ml of a 1:350,000 dilution of the testosterone antiserum and
approximately 10,000 c.p.m. of 1-125 labelled testosterone-3-CM0.
In each assay testosterone standards were included ranging from 5-640
pg/tube, and high and low quality controls were included to assess the
reproducibility of the assay. Tubes were incubated at room temperature
for 2 h before the addition of 0.1 ml of a 1:1,000 dilution of normal
sheep serum and 0.1 ml of a 1:25 dilution of goat anti-sheep
- 87 -
precipitating serum to precipitate immunoglobulins. Both the normal
sheep serum and the second antibody were provided by the Scottish
Antibody Production Unit. Following addition of the second antibody
tubes were incubated overnight at 4°C and then centrifuged for 30 min
at 1,500 x g, the supernatant decanted and the precipitate counted in
a gamma counter(NE 1600, Nuclear Enterprises Ltd, U.K.), linked to a
Commodore 4032 micro-computer(CBM computers Ltd, U.K.). Results were
calculated using this system.
2.9-4: Validation of the iodine-testosterone assay;
i) Double dilution of antiserum;
The recommended dilution of the antiserum for the assay was
1:350,000, but to test the optimal dilution the antiserum was double-
diluted throughout the range 1:22,000 - 1:2,867,200,000. The results
(not shown) suggested that the antiserum dilution recommended was far
from optimal, and also that if necessary the sensitivity of the assay
could be markedly improved. However, for the purpose of the present
studies, the sensitivity of the assay, covering a range of 5-640 pg/
tube was judged to be satisfactory and therefore the recommended
antiserum dilution was adopted for routine assay procedures,
ii) Parallel dilution curves:
Double dilution of testosterone standards and rat testicular
interstitial fluid and whole testis extracts produced curves
parallel to each other, as judged by 2-factor analysis of variance
with replication(Data not shown).
iii) Extraction and chromatography of assay quality controls:
To provide a constant measure of the reliability of the
assay a quality control was included in each assay. The quality
control for this assay was prepared from a whole testis incubate
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containing >1,000 ng/ral testosterone. To assess both the purity of
this quality control and to compare the iodine assay with the tritium
assay which was then in use these quality controls were extracted and
separated using the following procedures.
a) Hexane:Ether extraction;
0.5 mis of the quality control was mixed with 6.5 mis
hexane:diethyl ether(4:1 v/v) and the aqueous phase frozen in a dry
ice:ethanol bath. The organic phase was decanted and both the organic
and aqueous phases dried down and resuspended in 1 ml PGBS. Samples
from the unextracted, aqueous and organic phases were then assayed in
both the tritium and iodine radioimmunoassays.
b) Column separation;
0.2 mis of the quality control was mixed with 2.5 mis
hexane:diethyl ether(4:1 v/v) and the aqueous phase frozen, decanted
and dried down as described above. The organic phase was resuspended
in 0.5 mis iso-octane and left overnight. Celite 545(Johns Manville
Co. U.S.A) was activated overnight at 600°C and packed into glass
columns. The sample was loaded onto the column in 0.5 mis iso-octane
and then fractions eluted as follows:
Fraction 1) Eluted with 5-5 mis iso-octane:
Androstenedione fraction.
2) Eluted with 5*5 mis 5$ benzene in iso-octane:
Dihydrotestosterone fraction.
3) Eluted with 3-5 mis 10$ benzene in iso-octane: Waste
4) Eluted with 3«5 mis 20$ benzene in iso-octane:
Testosterone fraction.
5) Columns washed with 5 mis ethanol: Waste.
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Fig 2.6: The effect on the standard curve of adding 0.2# Triton(Top
panel), 10$ M199H(Centre panel) or EDTA(Bottom panel) to the assay
buffer for the iodine testosterone radioimmunoassay. None of the



























20 40 80 160
pg TESTOSTERONE/tube
320 640
Fig 2.7: Effects of changing the batch of antiserum(Top panel) or
tracer(Centre panel), on the standard curve for the iodine
testosterone radioimmunoassay. The reproducibility of the standard
curve is indicated in the bottom panel, which shows the composite
curve(mean+/-s.d.) from 7 successive assays.
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and assayed in both tritium and iodine radioimmunoassays along with
unextracted controls. Results from both assays agreed closely, both as
to the total content and also as to the extracted content of
testosterone in the quality controls(data not shown).
iv) Effects of medium, EDTA, and Triton on standard curves;
To reduce the background non-specific binding in the
iodine assay, 0.2$ Triton was added to the saline wash. The effects of
this addition as well as the effect of 100 ^il of M199H or EDTA were
also assessed. Results(Fig 2.6) showed no alteration of binding with
any of these treatments, although the addition of 0.2$ Triton X-100
to the assay saline wash significantly reduced the amount of non¬
specific binding in the assay.
v) Consistency of the assay;
a) Comparison of 7 different standard curves;
To assess the reproducibility of the assay during
a number of successive centrifugations, which would allow large
numbers of samples to be assayed in one assay, seven different
standard curves were averaged to determine the variation between
centrifugations. Comparing seven standard curves over a 5 h period
less than 6$ variation between curves was seen overall(Fig 2.7).
b) Assessment of assay drift:
Comparing both high and low quality controls, along
with zero binding tubes placed at the beginning and the end of seven
different centrifugations, no difference was seen between zero binding
at the beginning or end of the centrifugations(59-44$ vs 59-41$)•
Neither was any difference seen in the percentage binding for the
high(20.32$ vs 20.40$) or low(50.64$ vs 50.16$) quality controls.
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STEROID % CROSS-REACTION SOURCE :
Adrenosterone <0.001 Sigma Ltd, U.K. :
Aldosterone <0.005 Sigma Ltd, U.K. :
Androstenedione 1.6 Calbiochem :
Cholesterol <0.001 Steraloids, U.K. :
Cortisol <0.001 Steraloids, U.K. :
Corticosterone <0.005 Steraloids, U.K. :
Deoxycortisol <0.001 Steraloids, U.K.
Dehydroepiandrosterone <0.001 Sigma Ltd, U.K. :
5"Dihydrotestosterone 23.0 Sigma Ltd, U.K. :
5 jSDihydro testosterone <0.002 Sigma Ltd, U.K. :
17°^ Hydroxyprogesterone <0.001 Sigma Ltd, U.K. :
Oestradiol 17"^ <0.01 Sigma Ltd, U.K. :
Oestradiol 17/S <0.01 Koch-Light & Co Ltd, U.K.:
Estriol <0.001 Calbiochem :
Oestrone 3.1 Sigma Ltd, U.K. :
Pregnenolone <0.001 Sigma Ltd, U.K. :
Progesterone <0.001 Sigma Ltd, U.K. :
17ot testosterone <0.02 Steraloids, U.K. :
19 Hydroxytestosterone 0.17 MRC Steroid Collection. :
7olHydroxytestosterone 0.30 MRC Steroid Collection. :
16«< Hydroxytestosterone 0.48 MRC Steroid Collection. :
Bovine Serum Albumin 0.000001 Sigma Ltd, U.K. :
Cyproterone Acetate 0.002 Keymer Pharmaceuticals. :
Table 2.2: Crossreaction of various steroids in the iodine-
testosterone radioimmunoassay. The percentage crossreaction of each
of 19 steroids and BSA with reference to testosterone(100$) are shown.
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c) Comparison of different preparations of tracer:
Using two different preparations of 1-125 testosterone
the reproducibility of results between batches of tracer was tested.
No difference between batches of tracer was evident(Fig 2.7)•
d) Comparison of antiserum batches;
Using two different batches of #505 antiserum at the
same dilution the variation in batches of antiserum was assessed. No
difference in antiserum batches was seen(Fig 2.1).
vi) Cross-reactivities:
The antiserum used for the assay cross-reacted
significantly with dihydrotestosterone (23.0^)1 oestrone(3-1%) and
androstenedione(1.6%) but showed minimal(<0.1$) cross-reactivity with
19 other steroids & BSA, as shown in Table 2.2.
vii) Coefficent of variation and the limit of detection of
the assay:
The inter- and intra- assay coefficients of variation
were 10.4 and 6.5$, respectively, and the limit of detection(90$ B/BO)
was 11.0+/-2.9 pg(mean +/- standard deviation, n = 173).
viii) Comparison of iodine and tritium assays;
Comparison of testosterone values obtained for 342 medium
samples run simultaneously in this assay and in a conventional
3-H-testosterone based assay(Corker and Davidson, 1978; Sharpe and
Fraser, 1983) showed close overall correlation(r = +0.96) with no
significant difference(p>0.1) between results obtained in the two
assays.
2.9-5: Preparation of samples for iodine assay:
i) Culture medium:
Culture media from both static incubations and from
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perifusion experiments were assayed directly as extracted and
unextracted samples gave identical results(see above Section
2.9.4.ii) •
ii) Interstitial fluid:
Interstitial fluid was diluted 1:20 in M199H and then
assayed directly as extracted and unextracted samples gave identical
results(see above Section 2.9»4«ii)«
iii) Serum:
Serum testosterone was assayed after extraction with hexane-
diethyl ether. Essentially 0.3 mis serum was mixed with 0.1 mis
tritiated testosterone(approx 1,000 c.p.m, 1,2,6,7-3H-testosterone,
Amersham U.K. Ltd)to monitor for recovery. The resulting mixture was
extracted with 2x3 mis of hexane-diethyl ether(4:1 V:V), mixed, and
the aqueous phase frozen in a dry ice-ethanol water bath prior to
decanting the organic phase. The organic phase was then dried down and
resuspended in PGBS.
iv) Seminiferous tubules:
Seminiferous tubules were prepared as described above
(Section 2.8.4) and thereafter extracted using an identical procedure
to that described for serum samples,
v) Whole testes:
Whole testes were extracted using the method described by
de Jong, Hey and van der Molen(l974)« Essentially, to a whole
decapsulated testis 2 mis distilled water were added together with
approximately 1,000 c.p.m. 3-H testosterone to assess recovery. Testes
were then sonicated for 2 min and 5 mis of acetone added, mixed and
the testes centrifuged at 1,500 x g for 5 min at 4°C. The liquid phase
was decanted and a further 2 mis of acetone added to the tissue
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deposit, mixed and recentrifuged. The supernatant was added to the
previous organic phase and the acetone evaporated under nitrogen. The
remaining aqueous phase was extracted twice with 3 mis ether, the
aqueous phase frozen in a dry ice:ethanol bath and the organic phase
decanted. The ether extract was dried down and resuspended in 2 mis
70:30 v/v Methanol:water mixture. This solution was then partitioned
twice with 2 mis of redistilled hexane. The methanolic layer was
then dried down and resuspended in 0.4 mis PGBS buffer, prior to
taking aliquots for assay and recovery.
2.10: Protein assay:
Protein assays were carried out as described by Lowry _et_ al
(1951)- Essentially, 0.1 mis sonicated seminiferous tubules were made
up to 0.6 mis with distilled water. Standards were prepared at 0, 20,
40, 80, 100, 150 and 200 ^ig/0.6 mis distilled water using BSA. To
each sample 3 mis Folin's solution A(2$ Na-^CO^, 0.01$ CuSO^, 0.02$
Sodium Potassium tartrate in 0.1 N NaOH) were added and the samples
incubated at room temperature for 45 minutes. Subsequently, 0.3 mis
freshly diluted Folin-Ciocalteu's Phenol reagent(l:2 v/v with
distilled water) were added and samples mixed immediately on a vortex
mixer. After a further 15 min at room temperature samples were read at
750 nm in a spectrophotometer and results calculated from the standard
curve.
2.11: LH and FSH radioimmunoassay:
Serum levels of LH and FSH were measured by radioimmunoassay as
described by Fraser & Sandow(1977), using radioimmunoassay kits
supplied by the National Institute of Arthritis, Metabolism and
Digestive Diseases(NIAMDD, U.S.A.). I am grateful' to Miss Irene
Cooper for carrying out the LH & FSH assays required for this study.
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2.12: Histology:
EDS-injected rats were killed at the following times after
treatment: 6 and 12 h, on days 1 and 3> and at 1, 2, 3, 4, 6 and 10
weeks . Vehicle-treated control animals were killed at week 1. The
testes of 2 rats from each of the above groups were fixed by vascular
perfusion via the thoracic aorta using 5$ glutaraldehyde, 3$
formaldehyde and 0.01$ trinitrophenol buffered in 0.1M cacodylate as
described by Kerr, Mayberry and Irby(l984)- All such perfusions were
carried out by Dr. J.B. Kerr. The fixed testes were removed, trimmed
of connective tissue and fat, decapsulated and, after measurement of
their volumes by water displacement(Elias and Hyde, 1980), cut into
cubes about 2mm square and fixed for 2-3 h in the same fixative.
Following post-fixation for 2 h in 2% cacodylate-buffered osmium
tetroxide, blocks were stained en bloc with uranyl acetate, dehydrated
in graded ethanols and embedded in Epon-araldite. All blocks were cut
at 1 ^im using a Reichert 0mU3 ultramicrotome and then stained with 1$
Toluidine blue in 1$ borax. Sections were examined and photographed
using a Zeiss photomicroscope fitted with oil-immersion objectives.
All sectioning, staining and photomicroscopy was carried out by Dr.
J.B. Kerr and Mr. K. Donachie.
To assess the effects of EDS treatment upon spermatogenesis,
transverse sections of seminiferous tubules were examined to detect
the occurrence and frequency of abnormal patterns of germ cell
maturation with particular attention to the stage of the spermatogenic
cycle using the classification of Leblond and Clermont(1952b).
2.13: Statistics:
Statistical differences between treatments were assessed in the
following manner:
- 97 -
For all static incubations(Chapters 3 & 4), results were
analysed using a Students' t-test and significance values obtained
from Students' t-distributions.
Perifusions(Chapter 5) were analysed by applying Students
paired t-tests to the mean values from paired columns. For
example, where 4 columns were run in a single experiment, 2 with
Leydig cells alone and two containing both Leydig cells and
seminiferous tubules, values for each 10 minute sample were meaned
for each treatment group prior to statisical analysis. Significance
values were obtained from the Students' t-distribution.
Results obtained for tubule testosterone and protein
concentrations, serum LH, FSH and testosterone, testicular weight,
interstitial fluid and whole testis testosterone were subjected to
analysis of variance in the EDS experiments. Where changes in these
parameters were assessed at different times after the administration
of EDS(Chapter 7), the significance of differences from controls was
assessed using Dunnets' t-test and the significance of differences
between treatment times was assessed using Tukey's t-test. Results
for animals treated with MEHP, MAA or anti-LH were determined using




SEMINIFEROUS TUBULE-LEYDIG CELL CO-CULTURES
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3«1: Introduction:
The aim of these studies was to provide a system for the analysis
of communication between the seminiferous tubules and Leydig cells.
There is growing evidence pointing towards the importance of
intratesticular factors in the control of spermatogenesis, with much
of the recent data suggesting that modulation of Leydig cell
steroidogenesis by factors secreted within the testis may be an
important aspect of this control(see Ch 1). These local factors may
act in conjunction with the anterior pituitary gonadotrophins to
either modulate their actions or to alter Leydig cell responsiveness.
The seminiferous tubules and the Leydig cells comprise the two major
functional components of the testis and the dependence of
spermatogenesis upon the testosterone produced by the Leydig cells
is widely accepted(Russell & Clermont, 1977; Russell et_ al_, 1981;
Stevens and Steinberger, 1983). There are however no reliable systems
for the detection and monitoring of factors communicating between
these compartments. Using the methods described above(Chapter 2.1-4) a
system for the co-culture of Leydig cells with dissected seminiferous
tubules was assessed to determine its suitability for such studies.
3«2: Co-culture of isolated seminiferous tubules and Leydig cells:
Isolated seminiferous tubules at a concentration of 10(20 x 0-5)
cm/well were co-cultured with Percoll-purified Leydig cells, whilst
Leydig cells were cultured with dissected strips of thigh muscle
as a control. Culture was for 5 h in the presence of hCG. Neither
seminiferous tubules nor muscle caused any significant change in










Table 3-1: Effect of muscle tissue and seminiferous tubules(s/T) on
Leydig cell testosterone secretion in co-culture. Control = Leydig









Fig 3*1: Effect of seminiferous tubules isolated from adult rats
made unilaterally cryptorchid either 3(Panel A) or 5(Panel B) days
earlier on Leydig cell testosterone secretion. * p<0.05 when
compared with control(i.e. medium alone) values.



















Fig 3.2: Effect of seminiferous tubules from normal rats, dissected
by transilumination into different stages of the spermatogenic
cycle, on Leydig cell testosterone secretion in vitro in the presence
of hCG. Panel A: 1 cm seminiferous tubules/well. Panel B: 2 cm
seminiferous tubules/well. Panel C: 4 cm seminiferous tubules/well.
(Mean+/-s.d. of triplicate samples for all panels).
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3-3: Co-culture of Leydig cells with isolated seminiferous tubules
from unilaterally cryptorchid rats:
Co-culture of 4 cms(8 x 0.5 cm lengths) of seminiferous
tubules dissected from either the abdominal(cryptorchid) or scrotal
(normal) testes of adult rats, made unilaterally cryptorchid 3 or 5
days previously, with Percoll-purified Leydig cells isolated from age-
matched untreated animals revealed no change in Leydig cell
testosterone production after culture for 5 h in the presence of 0.2
or 2,000 mlU/ml hCG. However, seminiferous tubules from scrotal testes
cultured with Percoll-purified Leydig cells in the absence of added
«
hCG produced significantly(p<0.05) higher levels of testosterone than
did Leydig cells cultured in the absence of tubules for the three
day post operation group(Fig 3*1 )• Seminiferous tubules from both
scrotal and abdominal testes from rats at 5 days post operation when
incubated with Percoll-purified Leydig cells enhanced Leydig cell
testosterone production significantly(p<0.05) in the absence of added
hCG when compared with control Leydig cells(Fig 3»1)»
3«4: Co-culture of Leydig cells with seminiferous tubules dissected
according to the stage of the seminiferous epithelium:
Using the techniques for dissection of stages described above
(Chapter 2-4) 1, 2 or 4 cms of stage dissected seminiferous tubules
were co-cultured with Percoll purified Leydig cells, either without
added hCG or in the presence of 0.2 or 2,000 mlU/ml hCG. No
significant differences in Leydig cell testosterone production were
observed in the presence of tubules from any of the grouped stages
(IX-XII, XIII-I, II-VI or VII-VIII) at any dose of hCG stimulation,
either with 4 cm(Fig 3-2.A), 2 cm(Fig 3»2.B) or 1 cm(Fig 3*2.C) of




50,000 200,000 500,000 50,000 200,000 500,000
No. LEYDIG CELLS / well
Fig 3-3: Effect of varying the ratio of Leydig cells:serainiferous
tubules on basal Leydig cell testosterone secretion in the presence
of seminiferous tubules dissected according to the stage of the
spermatogenic cycle. Panel A: 1 cm seminiferous tubules/well,
Leydig cell testosterone production over 5 h. Panel B: 1 cm
seminiferous tubules/well, Leydig cell testosterone production over
24 h. Panel C: 2 cm seminiferous tubules/well, Leydig cell
testosterone production over 5 h. Panel D: 2 cm seminiferous
tubules/well, Leydig cell testosterone production over 24 h.
(Mean+/-s.d. of triplicate samples for all panels).
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cells.
To determine whether varying the time of culture or the ratio
of seminiferous tubules to Leydig cells could improve the sensitivity
of the method to any putative factors secreted by the seminiferous
tubules, 1 or 2 cm of stage-dissected tubules were co-cultured for 4
or 24 h with 50,000, 200,000 or 500,000 Percoll purified Leydig
cells/well in the absence of hCG stimulation. Despite varying the
seminiferous tubule to Leydig cell ratio from 25,000 cells/cm tubules
to 500,000 cells/cm tubules, no significant change in Leydig cell
testosterone production was evident with any of the groups of stages
after 4 h co-culture with either 1 or 2 cms(Fig 3»j5.A & B) of
seminiferous tubules per well. After 4 h the medium was changed
and the co-culture continued for a further 20 h, and levels of
testosterone produced over the whole 24 h period were calculated by
summation of the results from 0-4 and 4-24 h. However, no significant
change in Leydig cell testosterone production was induced by 1 or
2 cms of seminiferous tubules from any of the 4 stage groupings with
50-500,000 Leydig cells (Fig 3-3-C & D).
3.5: Discussion:
No effect of seminiferous tubules at any stage of the
spermatogenic cycle on testosterone production by Leydig cells was
evident during static co-cultures. Nor did muscle and Leydig cell
co-cultures reveal any effects of muscle on testosterone production
by Leydig cells during in vitro culture.
Due to the failure to demonstrate any significant reproducible
effects of seminiferous tubules on Leydig cell testosterone production
it must be concluded that either the seminiferous tubules do not
affect Leydig cell testosterone production or the system used is not
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suitable for the investigation of seminiferous tubule-Leydig cell
interactions. However, in the light of reports from other laboratories
(Parvinen _et al, 1984). It would appear more probable that under the
in vitro conditions tested the system is unable to reflect the
subtle interactions between seminiferous tubules and Leydig cells in a
consistent manner. Further modification of the culture conditions may
be required for the establishment of a robust and readily reproducible
system for the co-incubation of these tissues. Observations of a small
effect of seminiferous tubules from cryptorchid animals on Leydig cell
testosterone production(see above) could be indicative of such
communication, although no conclusions can be drawn from such
variable effects.
If it is assumed that communication between seminiferous tubules
and Leydig cells indeed exists, then the question arises as to why
these cultures have failed to demonstrate such communication.
Although tissue co-culture provides the most direct means for testing
for tissue interactions there are a number of drawbacks inherent in
the method. The primary shortcoming of any co-culture system is the
need to supply perhaps different needs for two different tissue
types, often to the disadvantage of one or both tissues. In this
system, conditions previously used for Leydig cell culture alone were
adopted for co-culture of seminiferous tubules also. This suggests
that since the requirements of these tissues are probably
dissimilar, then one or both tissues will not be functioning optimally
under these conditions. Secondly, the necessary disruption of the
seminiferous tubules that must occur during their dissection may also
affect their function in culture since the Sertoli cell tight
junctions, which normally isolate the tubular epithelium from extra-
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tubular factors, can perhaps now be bypassed via the cut ends of the
seminiferous tubules. The relatively high levels of testosterone
present in the isolated tubules(300-1,OOOpg/10 cm; see Chs 6-7) will
also have had a confounding effect on the results, since during the
culture period such testosterone as is present within the tubules is
almost certain to diffuse into the medium. The confounding effect
of this testosterone will have been more severe in conditions in which
Leydig cell testosterone production was low. For example if Leydig
cell testosterone production in the absence of hCG was 20 ng/million
cells per 4 hours, the culture concentration of testosterone would be
4 ng/well. Thus testosterone from a 10 cm length of tubule could
contribute up to 25? of the testosterone present in the culture
medium. Such effects must be taken into consideration since the
potential for falsely identifying 'Leydig cell stimulatory factors' is
obvious. However in the presence of LH or hCG such errors are reduced
dramatically since the Leydig cell contribution to the total
testosterone present is correspondingly increased.
Despite these drawbacks to the use of co-culture systems other
authors have reported positive findings. Parvinen and co-workers,
using a similar system to the one described here reported stage-
specific stimulation of Percoll-purified Leydig cell testosterone
production by seminiferous tubules at stages VII-VIII of the spermato-
genic cycle(Parvinen _et. al, 1984). However, in the same report, using
unpurified Leydig cells these authors showed inhibition of
testosterone production by tubules at all stages of the spermatogenic
cycle. It would thus appear that purification of the Leydig cells
affects their response to factor(s) produced by the seminiferous
tubules. Parvinen's group used shorter incubation times than those
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described for this study and the incubation medium also differed in
that the only supplement used was 0.1$ BSA, whilst the medium used for
the present studies also contained insulin, transferrin, fungizone,
ceruloplasmin, penicillin and streptomycin. The possibility of
interference from one of these factors cannot be dismissed. The
results discussed by Parvinen ert jal(l984) are supported by studies
with porcine Sertoli-Leydig cell co-cultures(Tabone, Benahmed,
Reventos & Saez, 1984), which demonstrated stimulation of
steroidogenesis by porcine Leydig cells when co-cultured with porcine
Sertoli cells. These authors also showed further stimulation of Leydig
cell steroidogenesis when Sertoli cells were stimulated with PSH,
suggesting a FSH-regulated mediator. However, since the Sertoli cells
used for these studies were isolated from immature pigs, and Sertoli
cell function is known to alter during development see Chapter 1, or
Sharpe, 1982 for review) the relevance of these results to the adult
remains to be shown.
In summary, although it may be possible to demonstrate effects
of seminiferous tubules upon Leydig cell steroidogenesis using a co-
culture system, such effects are not easily reproducible in
different laboratories and may be masked by the endogenous steroid
content of the seminiferous tubules as well as by other factors. In
these studies no effect of seminiferous tubules upon Leydig cells in
co-culture could be demonstrated. Therefore as a means of
circumventing these drawbacks a system of culturing Leydig cells in
the presence of medium in which seminiferous tubules had previously
been cultured was designed and tested(see Chapter 4).
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CHAPTER 4




Studies on co-culture of seminiferous tubules and Leydig cells
failed to establish whether the lack of detectable communication
between seminiferous tubules and Leydig cells observed was
physiologically relevant. It is possible to interpret the results from
these co-cultures in two ways, as discussed above(see Chapter 3)«
Therefore, since it was not possible to study seminiferous tubule-
Leydig cell communication using such a system, the decision
was made to test a different system. By using seminiferous
tubules to condition culture medium and thereafter exposing Leydig
cells to this tissue-conditioned medium a number of novel
possibilities are raised. Firstly, by extracting the steroids from
the seminiferous tubule-conditioned medium it is possible to rule out
interference by such factors and thereby the interpretation of results
is simplified. Secondly, the production of such medium and the
possibility of storing and accumulating quantities of conditioned
medium allows the concentration and further investigation of the
nature of any factor(s) identified by this procedure. With these aims
in view, the following studies were undertaken.
4.2: Effect of seminiferous tubule-conditioned medium on unpurified
Leydig cells:
Using medium conditioned with 10 cm/ml of adult rat seminiferous
tubules or with strips of muscle tissue(see Chapter 2.5.1 for
methods), co-cultured with unpurified Leydig cell preparations, no
significant effect of conditioned medium upon Leydig cell testosterone
production was evident, either basally or in the presence of a range























Fig 4.1: Effect of medium conditioned by isolated seminiferous tubules
or muscle strips on testosterone production by unpurified Leydig cells
during 5 h incubation in the presence of various doses of hCG(mean+/~
s.d. of triplicate samples).
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Table 4.1: Effect of control, muscle-conditioned and seminiferous
tubule(S/T)-conditioned media on testosterone production by Percoll
purified Leydig cells during a 5 h incubation period. Controls
represent Leydig cells alone(mean+/-s.d. of triplicate values).
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ADDED hCG (mlU/ml)
Fig 4.2: Effect of medium conditioned by isolated seminiferous tubules
on testosterone production by Percoll purified Leydig cells during 5 h
incubation either before(left) or after(right) a 24 h preincubation
period. (Mean+/-s.d. of triplicate samples in both cases).
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4-3: Effect of seminiferous tubule- or muscle-conditioned medium on
Percoll-purified Leydig cells;
When muscle-conditioned medium was used as a tissue control no
effect of such medium on basal or hCG-stimulated testosterone
secretion by Leydig cells was found(Table 4.1). In the same
experiment, increased testosterone secretion by Leydig cells co-
incubated with seminiferous tubule-conditioned medium was seen.
During a subsequent experiment with a 5 h co-incubation of Leydig
cells in seminiferous tubule-conditioned medium(lO cm/ml), a
significant(p<0.01) stimulation of Leydig cell testosterone production
was observed both basally and in the presence of 0.2 and 2,000
ml.U./ml hCG(Fig 4.2.A). Seminiferous tubule-conditioned medium also
significantly(p<0.001) enhanced testosterone production by Leydig
cells basally over 24 h(Control = 35«1+/-2.3ng testosterone/10^
cells, Seminiferous tubule-conditioned = 44.4+/-4«3ng, p<0.001, n=12,
mean+/-s.d.). During a subsequent 5 h incubation with 0, 0.2 or
2,000 ml.U./ml hCG no response of control Leydig cells to hCG was
evident(Fig 4.2.B). However, Leydig cells incubated in seminiferous
tubule-conditioned medium for the previous 24 h period retained some
responsiveness to hCG stimulation, and produced significantly(p<0.02-
p<0.001) more testosterone than did their respective controls(Fig
4.2.B). However, due to the decrease in Leydig cell responsiveness,
observed after a 24 h preincubation period, subsequent investigations


















Fig 4.3: Effect of media conditioned by varying concentrations of
isolated seminiferous tubules(5-40cm/ml) upon testosterone production
by Percoll purified Leydig cells during 5 h incubation either before
(above) or after(facing) a 24 h preincubation period(Mean+/-s.d. of
quadruplicate samples in both cases).
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Iffect of media conditioned by isolated seminiferous tubules
us stages of the spermatogenic cycle on testosterone
. by Percoll purified Leydig cells during a 5 h incubation
n+/-s.d. of quadruplicate values).
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4.4: Effect of media conditioned by varying concentrations of isolated
seminiferous tubules(5-40 cm/ml) upon testosterone production by
Percoll-purified Leydig cells:
Medium prepared as described above which had been conditioned
with differing amounts of seminiferous tubules/ml(i.e. 5 cm, 10cm,
20cm, and 40cm.) caused significant(p<0.02-p<0.001) stimulation of
both basal and hCG-stimulated testosterone production by Percoll-
purified Leydig cells over 5 h, although there was no major difference
in testosterone secretion caused by variation in the total lengths of
seminiferous tubules used to condition the medium(Fig 4.3«A).
However, following "a 24 h preincubation in the presence of conditioned
medium, and during a subsequent 5 h incubation with added hCG after
renewal of the medium, the media conditioned by 10 cm and 20 cm
tubules/ml resulted in significantly(p<0.01) greater enhancement of
testosterone production than did the 5 cm/ml group(40 cm/ml group not
tested, Fig 4.3.B). Vhilst the difference between the 10 cm/ml and
20 cm/ml media was not significant, in view of the difference in
the time required to prepare these media it was considered more
practical to adopt 10 cm/ml of seminiferous tubules as the optimum
level for the production of conditioned medium in subsequent
experiments.
4-5: Stage-dependent effects:
Conditioned medium was prepared using seminiferous tubules from
different stages of the spermatogenic cycle(Stages II-VI, VII-VIII,
IX-XII and XIII-l). Seminiferous tubule-conditioned medium from all
groups of stages significantly enhanced basal and hCG-stimulated
testosterone production by Leydig cells during a 5 h incubation




























Fig 4-5: Effect of media conditioned by isolated seminiferous tubules
from animals treated 40 h previously with an antiserum to oLH on
testosterone production by Percoll purified Leydig cells during a 5 h
incubation period(mean+/-s.d. of quadruplicate values) * p<0.05,
** p<0.01 compared with control values.
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illustrated(Fig 4.4) were achieved i.e. whilst all stages
significantly enhanced Leydig cell testosterone production, no
significant variation was seen in the ability of medium conditioned by
seminiferous tubules at different stages to enhance Leydig cell
testosterone secretion(Fig 4-4).
4.6: Effects of different in vivo treatments:
The results described above allow two possible interpretations.
They may be caused either by the release of non-specific factors
which improve the function of Leydig cells in culture, or they may
reflect the production of specific factors, with physiological
roles, which modify Leydig cell testosterone production. In an
attempt to discriminate between these two possibilities the effects of
hormone deprivation, using an antiserum to LH, and the effects of
hypophysectomy and cryptorchidism upon the ability of seminiferous
tubule-conditioned medium to modify Leydig cell testosterone
production were investigated.
4.6.1: Effects of an LH antiserum:
Using medium conditioned by tubules from normal adult rats and
from rats injected 40 h beforehand with anti-LH the effects of LH
and therefore testosterone deprivation upon the secretion or release
of seminiferous tubule factor(s) was investigated. Seminiferous
tubule-conditioned medium from both normal and anti-LH treated rats
significantly(p<0.01-p<0.001 ) increased Leydig cell testosterone
secretion above control values in the presence of maximal(2,000
ml.U./ml) hCG stimulation and also in the absence of any added
gonadotrophin stimulus(Fig 4.5). There was no difference in the degree
of stimulation of Leydig cell testosterone production induced by
medium conditioned with seminiferous tubules from control and anti-LH
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mlU/ml hCG
Fig 4.6: Effect of media conditioned by isolated seminiferous tubules
from animals made unilaterally cryptorchid(see text) on testosterone
production by Percoll purified Leydig cells during a 5 h incubation
period (mean+/-s.d. of quadruplicate values) * p<0.05, ** p <0.01
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o
Fig 4.7: Effect of media conditioned by isolated seminiferous tubules
from rats subjected to hypophysectomy, unilateral cryptorchidism or
both treatments simultaneously, on testosterone secretion by Percoll
purified Leydig cells in the absence of added hCG stimulation(Top
panel) during a 5 h incubation period(mean+/-s.d. of quadruplicate
values). The bottom panel shows the testis weights of the animals from
which the tubules were dissected. * p<0.05, *** p<0.01 , **** p<0.001
compared with control values. Other significance values refer to
differences between bracketed groups.
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treated rats. No effect of either batch of tubule-conditioned medium
was seen at a sub-maximal(0.2 ml.U./ml) dose of hCG stimulation.
4.6.2: Effects of long term cryptorchidism:
When medium conditioned with seminiferous tubules from the
abdominal testes of rats which had been made unilaterally cryptorchid
(UCD) 95 days previously was added to Leydig cells, no stimulatory
effects of such medium upon Leydig cell steroidogenesis were seen.
Medium conditioned with control(scrotal) seminiferous tubules,
screened in the same experiment, significantly (p<0.01-p<0.001)
increased basal and hCG-stimulated(2,000 ml.U./ml hCG) Leydig cell
testosterone production(Fig 4.6). No effect of medium prepared from
tubules of either the cryptorchid or control testes upon submaximally
stimulated(0.2 ml.U./ml hCG) Leydig cell testosterone production was
seen.
%
4.6.3: Effects of hypophysectomy, cryptorchidism and combined
hypophysectomy and cryptorchidism:
To assess the possible physiological significance of the
described effects, seminiferous tubule-conditioned medium was prepared
using tubules from testes in which depletion of the germ cells was
achieved by unilateral cryptorchidism, hypophysectomy, or a
combination of these procedures. Rats were hypophysectomized on day 52
after birth, made unilaterally cryptorchid 3 days later, and
eventually killed at 79 days of age. Intact male rats were made
unilaterally cryptorchid at 86 days of age and killed 42 days later.
Medium conditioned by seminiferous tubules from normal control rats or
by tubules from the scrotal testes of unilaterally cryptorchid rats
significantly stimulated basal testosterone production by Leydig
cells(p<0.01 and p<0.001, respectively; Fig 4.7). Medium conditioned
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by seminiferous tubules from the abdominal testes of unilaterally
cryptorchid rats and from the scrotal testes of unilaterally
cryptorchid hypophysectomized rats also significantly stimulated
Leydig cell testosterone production(p<0.05) but to a significantly
(p<0.01 ) lesser extent than did either medium conditioned with
seminiferous tubules from normal rats or from scrotal testes of
unilaterally cryptorchid rats(Fig 4.7)- Medium conditioned by
seminiferous tubules from the abdominal testes of unilaterally
cryptorchid hypophysectomized animals induced no increase whatsoever
in testosterone production by Leydig cells. The degree of
seminiferous tubule 'damage' induced by these various conditions, as
assessed by testicular weights for each of the treatments, closely
correlated with the degree of stimulation of Leydig cells by
seminiferous tubule-conditioned medium as described above(Fig 4.7).
However, no effect of the conditioned media from any of the groups
of animals was seen on Leydig cells which were either maximally
(2,000 ml.U./ml hCG) or sub-maximally (0.2 ml.U./ml hCG)stimulated
with hCG(data not shown).
4-7: Assessment of the reproducibility of results:
The results described above(See 4.6.2-3) in which no effect of
tubule-conditioned medium was seen under some experimental conditions
calls into question the consistency and reproducibility of the
stimulatory effects of seminiferous tubule-conditioned medium
observed. In further studies, undertaken to determine the reliability
of the methods described here, the effect of medium conditioned during
20-24 h incubation with 10cm/ml seminiferous tubules, on basal and hCG
stimulated testosterone production by Percoll-purified Leydig cells
was assessed(Table 4.2). In 13 consecutive experiments seminiferous
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TESTOSTERONE PRODUCTION (NG/10 CELLS)
EXPT No: BASAL hCG (2 IU/ml)
STIMULATION
CONTROL S/T CONTROL S/T
1 22.8+/-1 23.1+/-1 2Q2+/-21 302+/-12
2 46.7+/-5 62.0+/-7* 437+/-76 380+/-37
3 47.0+/-8 47«6+/-8 250+/-15 308+/-31*
4 20.8+/-2 26.0+/-2* 157+/-12 184+/-4*
5 46.4+/-2 61.7+/-3** 325+/-20 431+/-18***
6 52.2+/-3 58.4+/-6 366+/-14 393+/-22
7 23.6+/-4 41.7+/-5** 223+/-8 303+/-11***
8 40.6+/-7 82.6+/-15** 358+/—21 393+/-43
9 23-8+/-2 40.2+/-5** 258+/—19 211+/-3
10 22.3+/-2 63.6+/-7*** 140+/-19 196+/-12**
11 26.6+/-6 41.1+/-1** 204+/-24 306+/-31**
12 15.0+/-1 22.2+/-2*** 220+/-19 292+/-9***
13 23.9+/-2 32.5+/-4** 246+/-6 260+/-18
Table 4.2: Reproducibility of the effect of seminiferous tubule-
conditioned medium(S/T) on Leydig cell testosterone production by
Percoll purified Leydig cells during 5h incubation(Mean+/-s.d. n=4).
* Significant differences between controls and S/T exposed Leydig




Fig 4.8: Effect of dialysis on the ability of seminiferous tubule-
conditioned medium to stimulate testosterone production by Percoll
purified Leydig cells during a 5h incubation period(mean+/-s.d. of
quadruplicate values). * p<0.05 when compared with control medium.
- 127 -
tubule-conditioned medium stimulated basal testosterone production by
Leydig cells in 11/13 experiments and in 10 out of the 13 experiments
this difference was statistically significant(p<0.02-p<0.001).
Similarly, testosterone production in response to hCG was enhanced in
all but one experiment, although this reached significance in only 7
of the 13 experiments(p<0.02-p<0.001 )(Table 4.2). In this study there
was considerable variation between experiments in the amounts of
testosterone secreted basally and in response to hCG and this may
reflect differences in the percentage of Leydig cells in the
different cell preparations or differences in their responsiveness.
However, there was no consistent relationship between these variables
and the degree of stimulation of testosterone production elicited by
seminiferous tubule-conditioned medium(Table 4.2).
4-8: Concentration of seminiferous tubule-conditioned medium:
In view of this inconsistency, and also to determine whether
further studies upon the nature and physiology of the seminiferous
tubule factor(s) were feasible, attempts were made to concentrate the
active component of the conditioned medium using ammonium sulphate
precipitation.
4.8.1: Effects of dialysis:
As a preliminary to detailed experiments on ammonium sulphate
precipitation 10 mis of seminiferous tubule-conditioned and control
medium were dialysed overnight against M199H. The dialysis membrane
had a molecular cut-off of about 10,000 daltons. The results shown
(Fig 4.8) suggest that dialysis would be a suitable desalting
procedure following ammonium sulphate precipitation, and incidentally
that the active seminiferous tubule factor(s) has a molecular weight
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Fig 4.9: Effect of ammonium sulphate precipitates of M199E(control)
or seminiferous tubule-conditioned medium on testosterone production
by Percoll purified Leydig cells during a 5 h incubation period
(mean+/-s.d. of quadruplicate values). C = control medium
untreated, NST = untreated seminiferous tubule conditioned medium. 40
= 40$ ammonium sulphate precipitate of control(open bar) or
seminiferous tubule conditioned medium(solid bar). 60 = 60$ ammonium
sulphate precipitate, 80 = 80$ ammonium sulpate precipitate.



























p\ Medium 125 62.5 31.2 15.6
p\ I F. 50 25 12.5 6.25 3.1
Fig 4.10: Double dilution of 60$ ammonium sulphate precipitate of
control and seminiferous tubule conditioned(S/T) media, compared with
charcoal stripped interstitial fluid(lF) and untreated medium. The
effect of the addition of these factors on testosterone production by
Percoll purified Leydig cells during a 5 h incubation period(mean+/-
s.d. of quadruplicate values) in the absence of added liCG(top) or with
2 ml.U./ml hCG added(bottora) is shown.
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4.8.2: Precipitation of proteins with ammonium sulphate:
a) Experiment 1:
Stepwise precipitation of 20 mis of seminiferous tubule-
conditioned medium with increasing concentrations of ammonium sulphate
concentrated the factor(s) shown to increase Leydig cell testosterone
production in the 40$ ammonium sulphate precipitate(Fig 4-9).
However, all of the precipitates from both control and seminiferous
tubule-conditioned media, decreased Leydig cell responsiveness
to hCG, possibly due to inadequate desalting or to high protein
concentrations.
b) Experiment 2:
100 mis of seminiferous tubule-conditioned and control media
were stepwise precipitated with ammonium sulphate and, after
desalting by dialysis, the most active fraction was identified by a
similar procedure to that shown above(4.8.2.A). The Leydig cell
stimulatory activity in these fractions was concentrated in the 60$
ammonium sulphate precipitate. This precipitate was then used to
provide a comparison between the activity of the seminiferous tubule
factor(s) and a factor(s) recently described in testicular
interstitial fluid(Sharpe and Cooper, 1984) which also has marked
stimulatory effects on the testosterone production of Percoll purified
Leydig cells and is precipitated by 60$ ammonium sulphate. Both rat
interstitial fluid and the medium precipitates were double diluted and
aliquots from each dilution incubated with Percoll purified Leydig
cells in the presence of maximally stimulating concentrations of hCG
(2,000 ml.U/ml) or in the absence of added hCG. The results(Fig
4.10.A) showed that in the absence of hCG the seminiferous tubule








































Fig 4.11: Effect of media conditioned by isolated seminiferous tubules
from three human testes on testosterone production by Percoll purified
rat Leydig cells during a 5 h incubation period(mean+/-s.d.
quadruplicate values). * p<0.05, ** p<0.01 when compared with control
medium.
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125-31.2 /il of medium per well. The interstitial fluid also caused a
dose-related stimulation of testosterone production by Leydig cells
over the range 50-3.1 pil/well. The increased activity shown by the
concentrated seminiferous tubule medium represented an 8 fold increase
over control values(i.e. 8 times as much untreated conditioned medium
would be required to give the same effect as the treated medium).
However, in the presence of maximally-stimulating concentrations of
hCG, no effect of the concentrated seminiferous tubule-conditioned
medium was seen(Fig 4.10.B), although interstitial fluid still
markedly enhanced hCG-stimulated Leydig cell testosterone production.
4-9: Effects of medium conditioned by human seminiferous tubules:
To assess the potential for the screening of human tissue in this
system, medium was prepared from three patients who underwent sub¬
capsular orchidectomy as a treatment for prostatic cancer.
Seminiferous tubules from the three men, aged 70(Fig 4.11.A), 80(Fig
4•11•B) and 58(4.11.C) years were prepared in an identical manner to
rat seminiferous tubules. Each of the patients gave differing results
(Fig 4.11). Medium conditioned by seminiferous tubules from two of the
three patients caused a significant(p<0.05) decrease in basal Leydig
cell testosterone production when compared with control medium(Fig
4.11.A-B), whilst those from a third caused a non-significant
decrease. Medium prepared with seminiferous tubules from one patient
(Fig 4.11.C) significantly enhanced maximal hCG-stimulated Leydig cell
steroidogenesis(p<0.01) although no effect of medium conditioned with
tubules from the other two patients was observed, nor was any effect
of medium conditioned with human seminiferous tubules seen at a dose
of hCG(0.2 ml.U./ml) considered to produce sub-maximal stimulation
of Leydig cell steroidogenesis(Fig 4.11).
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4.10: Discussion:
The purpose of this study was to set up a suitable iri vitro
system to investigate cell-cell interactions between Leydig cells and
seminiferous tubules. Whilst the results presented show that a
factor(s) is released or secreted from the seminiferous tubules
which has a stimulatory effect on testosterone production by Percoll-
purified Leydig cells both in the presence and absence of
gonadotrophins, these findings were somewhat inconsistent.
Therefore, although the findings presented add further support to the
growing evidence suggesting that seminiferous tubules exert a
stimulatory influence on the Leydig cells, the inconsistency of
these findings gives cause for concern. There are several possible
explanations for this lack of consistency:
Firstly, the obvious advantage of using seminiferous tubule-
conditioned medium was that seminiferous tubules could be incubated
for up to 24 h, during which time levels of secreted factors could
accumulate prior to incubation of this conditioned medium with Leydig
cells. However, the integrity and viability of the tubules may have
varied from preparation to preparation, due to differences in the
extent of collagenase dispersion to which they had been exposed. Over-
digestion of testes causes the tubules to become fragile and friable
during the dissection and isolation procedures and this may also
mirror their viability in culture. Initial results of histological
examinations suggested some damage to tubules centered on the nuclei
of type II spermatocytes, and this was evident within JO min of
culture but remained constant, i.e. did not progress thereafter.
Damage incurred during the preparation of tubules could affect their
subsequent ability to produce and release factors able to affect the
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Leydig cells.
A further factor affecting the results may be the variability in
responsiveness of the isolated Leydig cells. Studies showing that the
isolation procedure can radically affect the ability of Leydig cells
to secrete testosterone in culture(Aldred & Cooke, 1983; Sharpe &
Cooper; 1982, Molenaar _et al, 1983) suggest that these cells are very
sensitive to damage during isolation. Additionally, in our laboratory
only about 30$ of Leydig cell preparations respond to LHRH-agonist in
the presence of maximally-stimulating concentrations of hCG, whilst
all cell preparations respond to LHRH-agonist in the absence of added
hCG(Sharpe, unpublished data). Whilst there is no explanation for
this observation, it is possible that a similar variability may
explain why over 77$ of preparations of tubule-conditioned medium
stimulated basal Leydig cell testosterone secretion significantly,
whilst hCG-stimulated testosterone secretion was enhanced
significantly by only 57$ of the preparations.
Moreover, the factor present in seminiferous tubule-conditioned
medium may not be particularly stable, contributing to the variability
of results. This supposition is supported by the likelihood that local
factors produced within the testis will be degraded rapidly because of
the nature of their function, i.e. because they must only act locally.
It has been shown that the testicular interstitial fluid factor
mentioned above loses activity readily under certain conditions, e.g.
after lyophilization(G. Risbridger & R.M. Sharpe, unpublished data),
and this is also true for the seminiferous tubule-conditioned medium
described here(data not shown).
Finally it is possible that the material tested here represents
not just a single active factor but two or more factors capable of
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acting at different hCG/LH concentrations in different ways. There
is adequate support within the literature for the presence of a
number of different intratesticular factors, for example 'testicular-
LHRH'(Sharpe, 1982 for review), a testicular interstitial fluid
factor(Sharpe & Cooper, 1984), and a number of reports of factors
present in Sertoli cell-conditioned medium or of stimulatory effects
on Leydig cells when co-cultured with seminiferous tubules(Syed, Khan
& Ritzen, 1985; Grotjans & Heindel, 1982; Verhoeven & Cailleau, 1984;
Sharpe & Rommerts, 1984; Parvinen _et_ al, 1984). However, none of
these factors are well characterised and it therefore remains unlikely
that, at the present time, such factors could be identified
individually when more than one may be present in the same test
system.
These studies failed to show any effect of seminiferous tubule-
conditioned medium upon unpurified collagenase-dispersed rat
interstitial cells. However, recent studies by Syed et al,(l985)
have shown that when spent medium from stage-dissected seminiferous
tubules was incubated with unpurified rat interstitial cells a stage-
specific inhibition of testosterone production occurred with medium
conditioned by tubules at stages VII-VIII. The discrepancy between
these studies could be due to a number of differences between the
techniques: Firstly, Syed _et_ a2 used stage dependent dissections of
seminiferous tubules to show effects on Leydig cell testosterone
production, while the results described above using unpurified
Leydig cells made use of randomly dissected tubules. Syed et al(l985)
showed that while stages VII-VIII inhibited Leydig cell testosterone
production, no effect upon unpurified interstitial cell testosterone
production was seen at other stages. Therefore, it is likely that
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using random tubules the specific effects seen at stages VII-VIII
would be 'diluted out'. Secondly, Syed et_ ^1 used 20 cm/ml of tubules
to condition the medium, twice the tissue concentration used above.
Finally, whilst the present studies used charcoal-stripped
seminiferous tubule-conditioned medium, Syed _ert al( 1985) used whole
medium without stripping with charcoal and it is possible that some
small molecular weight factors were removed by charcoal stripping of
medium.
Despite the lack of an effect of tubule-conditioned medium upon
testosterone production by unpurified interstitial cells, Percoll-
purified cells showed a significant increase in testosterone
production in the presence of tubule conditioned medium. This effect
was not seen with muscle conditioned medium, used as a control tissue.
These results are in agreement with results previously published by a
number of groups on stimulatory effects of Sertoli cell-conditioned
medium(Grotjans & Heindel, 1982; Verhoeven & Cailleau, 1984; Sharpe &
Rommerts, 1984), seminiferous tubule-conditioned medium(Syed et al,
1985), pig Sertoli-Leydig cell co-cultures(Tabone _et_ al, 1984) and rat
seminiferous tubule-Leydig cell co-cultures(Parvinen ert _al, 1984). It
is clear from these studies and those reported above that there exist
within the testis factors which can markedly affect Leydig cell
testosterone production. One such factor, a testicular LHRH-like
peptide has been identified previously(Sharpe et_ al, 1984 for review),
and shown to have direct effects upon the testis(Huhtaniemi _et_ al,
1985). Recently the presence of a factor which markedly stimulates
Leydig ceil testosterone production, either in the absence or in the
presence of maximal doses of hCG, has been reported(Sharpe & Cooper,
1984). This interstitial fluid factor has similar effects to that of
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the seminiferous tubule-conditioned medium reported above, although
its effect is markedly greater. It is becoming increasingly apparent
that the control of Leydig cell steroidogenesis relies on both
peripheral and local hormonal stimuli and that the local factors
controlling this aspect of testicular function may be numerous and
show diverse activities.
Significant stimulation of Leydig cell testosterone secretion was
seen with media conditioned by seminiferous tubules from all stages of
the spermatogenic cycle. However, although stages VII-VIII gave a
consistently higher level of stimulation than did other stages, this
did not reach significance. Therefore, although this trend may reflect
a real difference in the levels of the active factor(s) released from
seminiferous tubules at different stages of the cycle, as has been
suggested by recent findings(Parvinen _et_ aJ, 1984; Syed _et_ al, 1985),
the system described here was not sufficiently sensitive to pick up
these changes. Such a stage-related change in secretion of this
factor would support evidence from other groups that tubules at stages
VII-VIII have a greater requirement for testosterone(see Sharpe, 1985
for review) and would also provide a mechanism for ensuring that such
local differences in testosterone levels were maintained. The
morphological data presented by Bergh(l982) shows that, in the rat,
a
Leydig cells close to seminiferous tubules at stages VII-VIII are
significantly larger than those close to other stages. This clearly
suggests some stage-dependent differences in the secretion of certain
factors which can affect the Leydig cells. Whilst studies by Syed ejt
_al(l985) suggest that only stages VII-VIII exert inhibitory effects
upon unpurified cells this does not hold for the ability of tubules to
stimulate Percoll purified cells since all stages exert a stimulatory
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effect.
There was no effect of an LH antiserum given _in vivo upon the
subsequent stimulatory effects of medium conditioned by seminiferous
tubules from these animals. This contrasts with findings that
seminiferous tubule testosterone levels were reduced in these
animals and that levels of the testicular interstitial fluid
factor(Sharpe & Cooper, 1984) were elevated following injection of
LH antiserum. These latter results suggested that some effect upon
the ability of seminiferous tubules to alter testosterone production
might be expected. The reason why this effect was not seen is not
readily apparent. However, cryptorchidism and hypophysectomy both
reduced the ability of seminiferous tubule-conditioned medium to
stimulate Leydig cell testosterone production. Whilst these effects
may be due to the reduced amounts of tissue added to condition these
media, the numbers of Sertoli cells within the seminiferous tubules
should have remained constant following these treatments and
it is this aspect which is thought to be most important. Both
cryptorchidism and hypophysectomy cause significant changes in Sertoli
cell function(Jegou _et_ _al, 1983; Hansson et al, 1976; Ritzen et al,
1981), either directly, or via the disruption of hormonal supply and
of Sertoli-germ cell interactions. In animals in which increasing
degrees of testicular damage were induced by cryptorchidism and
hypophysectomy, the ability of medium conditioned by seminiferous
tubules from these testes to elicit a stimulatory response from
the Leydig cells fell as the damage became more progressive . Thus,
seminiferous tubule-conditioned medium from the most severely damaged
testes, i.e. from the cryptorchid testes of hypophysectomised rats,
had no stimulatory effect whatsoever upon Leydig cell testosterone
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production. The ability of seminiferous tubule-conditioned medium from
each of the treatment groups to enhance Leydig cell testosterone
production varied inversely with the observed degree of testicular and
tubular damage, as indicated by both testicular weight and testicular
morphology(Kerr & Sharpe, 1985a). The results presented are consistent
with the possibility that the Sertoli cell is the origin of the active
factor(s) described in these experiments.
It could be argued that the effects of seminiferous tubule-
conditioned media on Leydig cell function were aspecific, but, during
this study, no effects of muscle conditioned medium were seen,
suggesting that the effects seen are not aspecific tissue effects.
Further evidence for the specificity of these results was provided by
the results described above using tissue from cryptorchid, hypo-
physectomized and cryptorchid-hypophysectomized animals, which
showed that using damaged seminiferous tubules the stimulatory
effect could be negated.
Attempts to concentrate the factor(s) present in seminiferous
tubule-conditioned medium were only partially sucessful and did not
eliminate the variability of the results described above. This
suggests that such variability is more likely to be due to variation
in Leydig cell preparations or to the presence of more than one factor
in the conditioned medium. Further studies upon the composition of the
factor(s) in seminiferous tubule medium were hampered by the
variability of the techniques used and the time required to prepare
the large amounts of medium needed in these experiments.
The described system of incubation of Leydig cells in
seminiferous tubule-conditioned medium provided a potential model for
the ill vitro study of the interaction between seminiferous tubules
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and Leydig cells. However, due to both the lack of complete
consistancy and the fact that the use of seminiferous tubule-
conditioned medium allowed investigation only of one-way communication
between these cell types the system is not ideal. The ideal system
would be one in which the dynamic interactions between Leydig cells
and seminiferous tubules could be investigated, as this at least
approximates the physiological situation. Co-cultures of seminiferous
tubules and Leydig cells would satisfy this requirement, but this
system gave negative results, although other systems for the
assessment of such interactions have been reported(Parvinen et_ al,
1984; Tabone et_ al, 1984). Static cultures also limit the assessment
of the kinetics of hormone-cell interactions and tissue-tissue
communications. Recently a column perifusion system has been validated
for the investigation of Leydig cell desensitization by LH(Wu et_ al,
1985). Therefore as a logical extension of these studies on the
interaction between seminiferous tubules and Leydig cells in static
culture, studies using the perifusion system to investigate the
dynamic interaction between seminiferous tubules and Leydig cells were
undertaken and are described in Chapter 5«
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CHAPTER 5
CO-PERIFUSION OF SEMINIFEROUS TUBULES AND LEYDIG CELLS
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5.1: Introduction:
Static incubation systems do not provide an ideal method
for the investigation of cellular function _in vitro for a
number of reasons: Firstly, the incubation medium is in a
constant state of change due to cellular activity which produces
substrate depletion, hormonal breakdown, accumulation of waste
products and eventually exhaustion of the medium. Also with static
systems the scope for the investigation of dynamic interactions
between cell types or the dynamics of hormone action are limited by
the volume of the culture which imposes limits on the frequency of
sampling possible. Studies upon perfused testes(Chubb & Ewing,
1979a-c) have provided information on the biosynthetic pathways within
the testis, but such studies do not provide detailed information on
the interactions between individual components of the testis. The
recent development and characterization of a perifusion system for
Leydig cells, i.e. a system in which isolated cells are suspended in a
gel matrix through which culture medium is passed, provided an
opportunity to overcome these drawbacks(Wu et_ _al, 1985). With this
system, Wu and co-workers confirmed earlier observations by Davies &
Platzer(1981) and Segaloff, Puett and Ascoli(l98l) that repeated
stimulation of Leydig cells by LH or hCG resulted in desensitization
of Leydig cells when measured by the testosterone response to LH
stimulation. Wu _et al^( 1985) showed that the desensitization of Leydig
cells was not due to cellular damage or to changes in the
concentration of hCG/LH receptors. Furthermore such desensitization
was dependent upon the dose of LH administered, with low doses
(<0.01 ng/ml) producing a priming or sensitizing effect. Wu and
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Leydig cells such that a robust and reliable system was developed.
As an extension to previous studies on static incubations for
investigating interactions between seminiferous tubules and Leydig
cells(see Chapters 3 & 4) the ability of seminiferous tubules to alter
the steroidogenic capacity of Leydig cells was investigated using
this perifusion system.
These studies involved collaboration with Dr. F.C.W. Wu and
Dr. R.M. Sharpe for some parts of the preparation and running of
columns.
5-2: Validation and testing of the perifusion system;
A number of experiments were carried out to establish the
suitability of the system for studies in which seminiferous tubules
and Leydig cells were co-perifused.
5-2.1: Comparison of the use of purified and unpurified Leydig cells:
The responsiveness of Percoll purified and unpurified cells in
this system was determined. 4 columns were loaded with 1.7 million
Percoll-purified Leydig cells and 4 others with 16.6 million
unpurified cells. All columns were perifused(as described in
Chapter 2) with medium alone for 60 min prior to a 10 minute 'pulse'
of 1 ng oLH/ml being introduced. The response profiles of cells before
and after Percoll purification were essentially identical(Fig 5-1),
although the testosterone output per million cells was obviously lower
for the unpurified cell preparation. Percoll-purified cells also
showed a greater increase in testosterone production following oLH
stimulation, showing a peak response of 25 x basal levels compared to
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FRACTION No.
Fig 5- 2: Testosterone production by Percoll purified Leydig cells on
Biogel columns during 0-2h perifusion in the absence of LH stimulation
(Fractions 1-12) and then from 2-4 h perifusion(Fractions 13-24) and
from 4-6 h(Fractions 25-36) either with two 10 min pulses of LH at 2 &
hrs(open bars), or without LH stimulation(shaded bars). The total
testosterone production during the entire perifusion period(Fractions
1-36) is also shown. Values are the means+/-s.d. of duplicate
columns(open bars) or represent values from a single column
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FRACTION No.
Fig 5-3'- Effect of 200 or 400 cm of isolated seminiferous tubules
on testosterone secretion by Percoll purified Leydig cells.
Single columns were perifused for 2h in the absence of added oLH
(Fractions 1-12), and then pulsed at 2 & 4 h with 1 ng/ml oLH. Total
testosterone produced over 2h basally(Fractions 1-12) and during the
2h following the first(Fractions 13-24) and second(Fractions 25-35) LH
pulses was calculated by summation of the testosterone produced for
each of the 10 min fractions collected during these periods.
Above: Profile of testosterone production/10 min fraction for each
column. Facing: Total testosterone production over the first 2h
(Fractions 1-12), and following the first(Fractions 13-24) and second
(Fractions 25-35) LH stimuli, and for the duration of the experiment
(Fractions 1-35)- *Significant differences calculated by paired
t-tests compared with testosterone secretion by Leydig cells alone
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5.2.2: Viability of Leydig cells during perifusion:
In a single experiment Percoll-purified cells perifused with
and without the addition of oLH were compared. No difference in the
basal testosterone output from Percoll-purified cells was observed
over a 6 h period, i.e. there was no reduction in the ability of
Leydig cells to produce testosterone during column perifusions between
the first and sixth hour of perifusion(Fig 5.2). This data is in
agreement with that of Wu _et al, (1985) showing that no change in
the ability of Leydig cells to respond to an initial stimulus of LH
occurs during the first six hours of perifusion.
5-2.3: Optimization of the length of seminiferous tubules required for
co-perifusion experiments:
In 3 separate experiments the ability of differing amounts of
seminiferous tubules to alter Leydig cell testosterone production
during co-perifusion was assessed. In 2 initial experiments single
perifusion columns were loaded with either Leydig cells alone or with
Leydig cells plus 200 or 400 cm(400 or 800 x 0.5 cm segments)
seminiferous tubules. The results showed that while both 200 and
400 cm of seminiferous tubules enhanced the ability of Leydig cells to
produce testosterone, 400 cm of seminiferous tubules enhanced Leydig
cell testosterone production to a lesser degree than did 200 cm of
seminiferous tubules(Fig 5*3). In a third experiment Percoll-purified
Leydig cells were perifused alone or in the presence of 50, 100 or
200 cm seminiferous tubules. All columns were perifused for 2 h
without added oLH stimulation, and then oLH was infused at 1 ng/ml for
20 min and subsequently for a further 10 min at 4 h. The results
showed that the tubule concentration which maximized testosterone
output by Leydig cells upon co-perifusion was 200 cm/column. Addition
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1000-1 □ Leydig ce Is only
Q Leydig cells * 50cm Seminiferous tubules
JH Leydig cells ♦ 100cm Seminiferous tubules























1-12 13-24 25-36 1-36
FRACTION No.
Fig 5*4: Effect of co-perifusion with 50, 100 cm or 200 cm of
isolated seminiferous tubules on testosterone secretion by Percoll
purified Leydig cells. Columns were perifused for 2h in the absence of
LH(Fractions 1-12), and then pulsed at 2 & 4 h with 1 ng/ml oLH. Total
testosterone produced over 2h basally(Fractions 1-12) and during the
2h following the first(Fractions 15-24) and second(Fractions 25-36) LH
pulses was calculated by summation of the testosterone produced for
each of the 10 min fractions collected during these periods(See Fig
5.1 for typical profile of the response of Leydig cells to pulsing
with LH). Total testosterone produced throughout the experiment(i.e.
over 6h) was calculated by the summation of all fractions(l-36)
collected for each column. Results are shown as the Mean+/-s.d. of
testosterone produced during 2h or 6h for 2 columns. *Significant
differences compared with testosterone secretion by Leydig cells alone
(» p<0.05; ** p<0.01; *** P<0.001).
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of 50 cm/column of seminiferous tubules resulted in a significant
decrease in Leydig cell testosterone output during the initial 2 h
basal perifusion phase(p<0.01 vs controls) and also during the second
oLH stimulation(4-6 h, p<0.02) and overall(p<0.02, Fig 5*4). With
100 cm/column there was little difference in testosterone output
between control columns and those containing seminiferous tubules,
although slight but significant increases were seen during the initial
basal perifusion(0-2 h, p<0.02) and during the second oLH peak(4-6 h,
p<0.05). However no significant change in testosterone output was seen
overall when Leydig cells were co-perifused with 100 cm of
seminiferous tubules(Fig 5.4). Columns containing 200 cm of
seminiferous tubules plus Leydig cells produced significantly more
testosterone than did controls containing Leydig cells alone, both
during a basal 2 hour period(l2$ increase over controls, p<0.00l) and
during the first(l4$ increase, p<0.02) and second(24$ increase,
P<0.001) oLH 'pulses'(Fig 5-4). The overall increase in testosterone
production with 200 cm seminiferous tubules per column for the total
perifusion period was in excess of 130 ng testosterone per column
(p<0.001, Fig 5.4).
5-3: Perifusion of Leydig cells and seminiferous tubules alone or
in combination:
In 2 separate experiments, it was established that the increase
in testosterone output by Leydig cells co-perifused with
seminiferous tubules could not be attributed to leakage of
testosterone from the seminiferous tubules. In both experiments, 6
columns were perifused; 2 containing Leydig cells alone, 2 containing
both Leydig cells and seminiferous tubules and 2 containing equivalent










Fig 5-5: Testosterone secretion by Leydig cells perifused alone or co-
perifused with 200 cm seminiferous tubules. Columns were perifused for
2h in the absence of added LH and then 'pulsed' at 2 & 4h with 1ng/ml
oLH for 10 min. Testosterone secretion from seminiferous tubules
perifused alone was undetectable at a flow rate of 0.5mls/min(not
shown) and was only just detectable during LH stimulation at a flow
rate of 0.25ms/min(see Fig). .
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experiments no detectable testosterone was measured in the perifusate
from either of the 2 columns containing seminiferous tubules only in
the absence of oLH. In one experiment, following oLH stimulation,
small amounts(<200 pg in total) of testosterone were measured in the
perifusate. However this amount, when compared with the 16 ng
testosterone/million cells for the Leydig cell controls and the
25 ng testosterone/million cells for the co-perifusion columns was
able to account for only a tiny fraction of the 9 ng/million cells
difference between these treatments(Fig 5.5). The most likely
explanation for the presence of testosterone in the effluate of the
seminiferous tubule only columns is that during the dissection
procedure small numbers of Leydig cells had been carried over. By
comparison with the columns in which Leydig cells and seminiferous
tubules were co-perifused, it could be seen that the testosterone
produced by columns containing seminiferous tubules alone
represented less than 8,000 Leydig cells. It should be noted that if
cells were carried over, these experiments also prove that such
contamination would be far too small to explain the effects of
seminiferous tubules upon Leydig cell testosterone output.
However as an additional control procedure, using both teased and
collagenase-digested seminiferous tubules from rats aged 55, 55 and 70
days, hCG binding assays were carried out upon both seminiferous
tubules and Leydig cells. The results showed less than 0.5$ specific
binding of hCG to isolated seminiferous tubules(See Chapter 6
below), and this binding was never shown to be significantly
different from non-specific binding values, suggesting that few, if
any, contaminating Leydig cells were present. Leydig cells, used as a
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LC 10.0 6.4+/-1-1 139-6+/-21.7 71.8+/-2.6 217.9+7-25.'
LC+ST 10.0 9.2+/-0.1 176.6+/-10.9 92.1+/-4.3 277-9+/-15-3
p<0.001 p<0.001 p<0.001 p<0.05
Table 5•1t Effect of varying oLH stimulation on testosterone
production(ng/lO*: cells) by Leydig cells(LC) on their own or co-
perifused with seminiferous tubules(LC+ST). The mean(+/- s.d.)
response of duplicate columns are shown over the 2 h period preceding
the first LH stimulus(Fractions 1-12) and following the first
(Fractions 13-24) and second LH stimuli(Fractions 25-36), and also for
the experiment as a whole(Fractions 1-36). 'p' values shown indicate
significant differences compared with testosterone secretion by Leydig
cells alone.
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of hCG. In these experiments(Fig 5*5) testosterone production by
Leydig cells co-perifused with seminiferous tubules was significantly
higher than by Leydig cells alone both during the initial basal phase
(p<0.001 for both experiments), and following the first(p<0.01 & 0.001
respectively) and second(p<0.001 & 0.02 respectively) oLH stimuli as
well as during the whole perifusion period(p<0.001 for both
experiments).
5.4: Effect of varying oLH stimulation on the response of Leydig cells
co-perifused with seminiferous tubules:
In a series of co-perifusion experiments the effect of varying
the degree of oLH stimulation was determined. Using a range of ovine
LH concentrations from 0.01-10ng/ml duplicate columns containing both
seminiferous tubules plus Leydig cells and also duplicate control
columns containing Leydig cells only were prepared. Four levels of
oLH stimulation were assessed, 0.01, 0.1, 1.0 and 10.0 ng/ml. In all
experiments under basal conditions the presence of seminiferous
tubules enhanced Leydig cell testosterone production when compared
with Leydig cell-only control columns(Table 5.1 )•
Leydig cells alone, responded to increasing doses of oLH by
producing progressively more testosterone. Thus, in the absence of
LH stimulation, testosterone production over 2 h was about
6.9ng/lO^cells, increasing to 9.2ng/l0^cells in the presence of
0.01ng/ml oLH, 13.Ong/1O^cells for 0.1ng/ml oLH, 78.6ng/lO^cells for
1.0ng/ml oLH and reaching 139-6ng/lO^cells in the presence of
10.0ng/ml oLH. In contrast to this almost linear dose-response of
Leydig cells alone to oLH stimulation, the effect of seminiferous
tubules upon Leydig cell responsiveness followed a markedly different
pattern. During perifusion for 2 h in the absence of oLH stimulation,
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FRACTION No.
Fig 5-6: Effect of altering the flow rate on the perifusion system:
Columns were perifused in two separate experiments, at either 0.5
ml/min(Left panels) or at 0.25 ml/min(right panels). The stimulatory
effect of isolated seminiferous tubules on testosterone secretion by
Percoll purifed Leydig cells persists basally(Fractions 1-12) and
following two separate pulses of 1 ng/ml oLH(Fractions 15-24 & 25-36)
at both flow rates. Profiles(top panels) and total testosterone
production/2h(bottom panels) are from duplicate columns).
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seminiferous tubules significantly increased Leydig cell testosterone
i
production by 2.4ng/l0 cells/2h(34+/-2.5$, mean+/-sem, increase over
controls; p<0.001 in all 4 experiments when compared with controls).
Following stimulation with 0.01 ng/ml oLH this effect of the tubules
was lost, there being no significant increase in Leydig cell
testosterone production induced by seminiferous tubules when compared
with Leydig cells alone during the first LH stimulus(2-4 h), and a
slight but significant decrease during the second LH stimulus(4-6
h, p<0.00l). Thereafter, at increasing LH doses, the effect of
seminiferous tubules upon the Leydig cells, over and above that of LH,
increased at 0.1 & 1.0 ng/ml oLH(by 58 & 59 ng/10^cells/2h, 46$ & 75$,
p<0.001 & 0.001 above controls respectively) but this increment was
lower(37ng/l0^cells/2h, 26$, p<0.001 above controls) when a maximally
-stimulating dose of oLH, i.e. 10.0 ng/ml, was infused(Table 5.1)«
This pattern was repeated following the second LH stimulus and
overall throughout the perifusion period(Table 5.1). Overall only with
the 0.01 ng/ml LH dose did seminiferous tubules fail to produce a
stimulatory effect.
5-5: Effect of altering the flow rate of medium on the perifusion system;
In 2 separate experiments the effect of altering the flow-rate of
medium through the perifusion system was determined. Duplicate columns
containing seminiferous tubules plus Leydig cells or Leydig cells
alone were perifused at flow rates of 0.5 and 0.25mls/min. Whilst
altering the flow rate had little effect on the degree of enhancement
caused by seminiferous tubules of oLH stimulated testosterone
production by Leydig cells, during the initial basal period
seminiferous tubules co-perifused with Leydig cells at 0.25ml/min
showed a 75$ increase over controls while those co-perifused at
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Fig 5.7: Testosterone secretion by Leydig cells perifused alone, or
co-perifused with isolated seminiferous tubules from either the
abdominal or scrotal testes of rats made unilaterally cryptorchid six
days prior to death. Tubules from scrotal testes significantly
increased Leydig cell testosterone secretion basally over 2 h
(Fractions 1-12) and also following the first(Fractions 13-24) and
second LH pulses(Fractions 25-36) and over the whole experiment
(Fractions 1-36), when compared either with control Leydig cells
alone or with Leydig cells co-perifused with tubules from abdominal
testes. *Significant differences compared with testosterone production
by Leydig cells alone(* p<0.05; ** p<0.02; *** p<0.00l). Facing:
Profile of response to LH stimuli(Mean of two columns in each case).
Above: Total testosterone produced over the first 2 h of perifusion
(Fractions 1-12) and in the 2 h following the first(Fractions 13-24)
and second 25-36) LH stimuli, as well as the total testosterone
production over 6 h(Fractions 1-36). Mean+/-s.d. of duplicate columns.
- 160 -
0.5 ml/min showed only a 33$ increase over control values(Fig 5.6).
Again the testosterone production by Leydig cells co-perifused with
seminiferous tubules was significantly higher than control columns
containing Leydig cells only at all points throughout the perifusion
period(Table 5-2).
5'6: Effect of co-perifusion of Leydig cells with seminiferous
tubules from normal and cryptorchid testes:
Rats were made unilaterally cryptorchid six days prior to death,
and seminiferous tubules of approximately equivalent tissue mass were
prepared from the abdominal and scrotal testes. Short term
cryptorchidism provided a model for the investigation of impaired
Sertoli cell function without gross changes in the wet weight of the
abdominal and scrotal testes or seminiferous tubules from these testes
(See Sharpe _et_ _al, 1984). Duplicate columns were prepared containing
2 million Leydig cells plus or minus 200 cm of isolated tubules from
either cryptorchid(abdominal) or normal(scrotal) testes. Columns were
perifused for 6 h at a flow rate of 0.25 ml/min. During the initial
basal phase of the perifusion, Leydig cells perifused in the presence
of seminiferous tubules from abdominal testes produced significantly
less testosterone than did Leydig cells co-perifused with seminiferous
tubules from scrotal testes(p<0.001, Fig 5«7). Seminiferous tubules
in both cases produced significant increases(abdominal 33$, scrotal
77$, p<0.00l) in Leydig cell testosterone production during the
initial basal phase(Fig 5»7). During the first 'pulsing' of the
system with oLH, seminiferous tubules from the scrotal testes
significantly enhanced Leydig cell testosterone production when
compared both with columns containing Leydig cells alone(23$, p<0.02)








LC 9.4 47.4 15.1 71.9
LC+ST 11.8 88.6 20.5 120.9
p<0.001 p<0.001 p<0.001 p<0.01
LC 16.6+/-0.9 182.4+/-6.2 64.1+/-2.8 263.1+/-9-9
LC+ST 18.5+/-0.5 208.1+/-7.3 79-3+/-2.7 305.6+/-9-9
p<0.001 p<0.02 p<0.001 p<0.001
LC 10.4+/-1•5 102.7+/-1.9 39-7+/-1 .5 152.7+/-4-9
LC+ST 13.0+/-0.1 144.6+/-4.1 55•8+/-1.9 213-3+/-6.2
p<0.001 p<0.01 p<0.001 p<0.001
LC 7.2+/-0.3 92.9+/-6.7 54.4+/-4.2 154.4+/-11.2
LC+ST 10.6+/-0.6 134'9+/-1.2 71.6+/-0.9 217-1+/-2.8
p<0.001 p<0.001 p<0.02 p<0.001
LC 7.5+/-0.4 78.8+/-7.7 47.6+/-0.5 133-7+/-8.4
LC+ST 10.1+/-1.4 137.7+/-5-3 78.5+/-1•6 226.2+/-5-2
p<0.001 p<0.01 p<0.01 p<0.001
LC 5.9+/-0.5 89.7+/-6.5 49.1+/-0.5 146.1+/-9-3
LC+ST 10.5+/-1.3 110.5+/-3.6 63.6+/-5.6 184.7+/-10.0
p<0.001 p<0.02 p<0.05 p<0.001
LC 9* 5+/-3«8 99.0+/-45.1 45.0+/-16.7 153.7+/-61.8
LC+ST 12.4+/-3.2 137.4+/-40.4 61.6+/-22.0 211.3+/-60.1
p<0.001 p<0.01 p<0.01 p<0.001
- 162 -
Table 5.2: Reproducibility over 6 experiments of the stimulatory
effects of seminiferous tubules on Leydig cell testosterone secretion
(ng/10 cells) during co-perifusion. The mean(+/- s.d.) response of
duplicate columns containing Leydig cells alone or Leydig cells co-
perifused with seminiferous tubules are shown over the 2 h periods
preceding the first LH stimulus(Fractions 1-12) and following the
first(Fractions 15-24) and second(Fractions 25-36) stimuli with 1ng/ml
oLH as well as results for the whole experiment(Fractions 1-36). 'p'
values indicate significant differences compared with testosterone
secretion by Leydig cells alone, analysed by paired t-tests between
samples for individual experiments. Mean testosterone values per 2 h
period and over the whole 6 h perifusion for six experiments are shown
in the lower panel, and for this section significant differences were
calculated using paired t-tests on the mean testosterone produced
during the first 2 h(Fractions 1-12) and the 2 h following the first
(Fractions 13-24) and second(Fractions 25-36) LH pulses and also
during the whole experiment(Fractions 1-36).
with Leydig cells(p<0.05)• No significant effect of tubules from
the abdominal testes on Leydig cell testosterone production was
evident. During the second 'pulsing' of the system with oLH,
seminiferous tubules from scrotal testes significantly enhanced Leydig
cell testosterone production(26$ over controls, p<0.05; 13$ over
abdominal tubules, p<0.02 Fig 5*7). No significant effect of tubules
from abdominal testes was evident. Overall, whilst tubules from
abdominal testes enhanced Leydig cell testosterone production
significantly(lO$, p<0.05 vs controls), tubules from normal, i.e.
scrotal testes produced significantly greater enhancement of
testosterone production throughout the total perifusion period(26$,
p<0.001 vs controls, p<0.01 vs abdominal tubules, Fig 5-7).
5-7: Reproducibilty of results:
To assess the reliability and reproducibility of results
obtained in this system the results from 6 experiments in which
columns containing either Leydig cells alone or Leydig cells plus
200 cm seminiferous tubules, were perifused for up to 6 h were
compared. Of these experiments, 5 employed duplicate columns per
treatment whilst one employed only single columns. In all six
experiments Leydig cells perifused in the presence of seminiferous
tubules produced significantly greater amounts of testosterone than
did Leydig cells perifused alone(p<0.05-p<0.001, Table 5.2). During
perifusion without added oLH, i.e. basally, Leydig cells co-perifused
with seminiferous tubules produced an average of 27+/-5$(mean+/-sem,
p<0.01-p<0.001) more testosterone than did Leydig cells perifused
alone. During the 2 h following the first oLH stimulus the increment
in testosterone production during co-perifusion of tubules with
Leydig cells was 48+/-11$(p<0.02-p<0.001 ), whilst during the period
- 163 -
following the second stimulus the increment was 37+/-6$(p<0.05-
P<0.001). Overall, during the whole 6 h of perifusion the presence of
seminiferous tubules enhanced Leydig cell testosterone by
an average of 43+/-8$(p<0.01-p<0.001). This represents an average
increase of 116 ng testosterone production. Over all six experiments
it can be seen(Table 5.2) that the presence of seminiferous tubules
produces a highly significant(p<0.01-p<0.001) increase in Leydig cell
testosterone production throughout all phases of the perifusion.
5.8: Discussion:
The development of a system for the investigation of dynamic
interactions between the two major components of the testis, the
seminiferous tubules and interstitial Leydig cells provides a tool
which should enable a greater understanding of the subtle interactions
between these compartments to be formed.
The system described allows the investigation of interactions
between seminiferous tubules and unpurified or purified Leydig cells.
These studies have concentrated upon the interactions between
seminiferous tubules and Percoll-purified Leydig cells primarily
because earlier studies suggested that this would be the most
profitable approach(See Chapter 4). The results presented above have
shown that whilst seminiferous tubule-conditioned medium stimulated
testosterone production by Percoll-purified Leydig cells, no effect
of such conditioned medium was observed upon unpurified interstitial
cells(Chapter 4.2). The contrasting results obtained in other systems
using non-purified and purified Leydig cells(Sayed et_ _al, 1985,
Parvinen _et al, 1984, Ch 4) mitigated against the further study of
non-purified cells in this system. However in the light of the
results presented here it would appear likely that the perifusion
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system will prove extremely useful for further studies comparing the
dynamic effects of seminiferous tubules on purified and non-purified
Leydig cells, and also that this area of study should prove both
interesting and profitable.
The perifusion system has been previously validated for the study
of non-purified Leydig cells(Wu et_ al, 1985), and these and the
present studies have shown that Leydig cell responsiveness, and
presumably therefore their viability, remains unchanged for at least
6h during basal perifusion.
In this system Leydig cells have been shown to respond in a
dose-related manner to the presence of seminiferous tubules by
increasing their output of testosterone. Both inhibitory and
stimulatory effects have been observed, such effects being dependent
upon the ratio of seminiferous tubules to Leydig cells within the
columns. These results opened up two possible avenues for further
study using the perifusion system; to investigate either the
inhibitory or the stimulatory effects of seminiferous tubules upon
Leydig cell testosterone production. Since the testicular content of
both Leydig cells and seminiferous tubules are documented it was
possible to assess the physiological ratio between these two tissues.
On a per gram basis the adult rat testis contains approximately 19
million Leydig cells(Christensen & Peacock, 1980) and 1240 cm of
seminiferous tubules(Wing & Christensen, 1982), or about 3.0 million
Leydig cells/200 cm of tubules. The cell numbers selected for these
experiments in the light of this observation were of the order of
1.5—5-0 million cells per 200 cm of tubules. In determining the
optimum conditions for investigation of seminiferous tubule-Leydig
cell interactions it is of interest that at a ratio of 3.15 million
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cells/200 cm seminiferous tubules the maximum stimulatory effects upon
Leydig cell testosterone production were seen, whilst at a ratio of
3.15 million cells to 50 cm seminiferous tubules an inhibitory effect
of the tubules upon Leydig cell testosterone production was observed.
In the light of these observations, initial investigations into the
observed effects were centred upon the stimulatory effects of
seminiferous tubules upon Leydig cells, since these occurred with
"physiological" proportions of seminiferous tubules and Leydig cells.
Further studies into the possible inhibitory role of seminiferous
tubules could yield valuable information about possible inhibitory
factors released by seminiferous tubules which act upon Leydig cells.
That such inhibitory effects are not the result of the release of
cellular toxins is borne out by the ability of concentrations of
seminiferous tubules 4-8 times higher than those producing inhibitory
effects to enhance Leydig cell testosterone production. The
physiological significance of the stimulatory and inhibitory effects
of seminiferous tubules to is not clear. Further studies will be
required before any definite conclusions can be drawn concerning the
precise nature of such inhibitory effects.
The described stimulatory effects of seminiferous tubules
upon Leydig cell steroidogenesis have been studied under a wide
range of conditions. Significant stimulation of Leydig cell
testosterone production by seminiferous tubules has been described
in 6 separate experiments when 1.0 ng/ml oLH was used as a
stimulus, and in further experiments in which different doses of oLH
were used. The effect persisted following cryptorchidism, although
the magnitude of the stimulatory effect of the tubules on Leydig
cell testosterone production was reduced. The effect also persisted
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following alteration of the flow rate of medium through the system.
Overall, it would appear that the stimulatory effects of
seminiferous tubules upon Leydig cell testosterone production are
robust and reproducible. However, since no tissue exists which is
comparable to the seminiferous tubules in both its structure and its
complexity it was not possible to introduce a tissue control into
the system. Therefore it may be argued that the observed effects are
not tissue specific. There are two observations with which this
argument may be answered: Firstly, in experiments in which Leydig
cells were co-perifused with seminiferous tubules from the abdominal
and scrotal testes of short-term unilaterally cryptorchid rats, the
effect of the abdominal(cryptorchid) tubules upon Leydig cell steroido¬
genesis was markedly less than the effect of the scrotal(normal)
tubules. This suggests that even minor disruption of the seminiferous
tubules markedly' affects their ability to stimulate Leydig cells.
Secondly, in experiments in which the dose responsiveness of the co-
perifused tissues to oLH was assessed, the degree of stimulation of
Leydig cells by the seminiferous tubules was markedly affected by
the presence of differing oLH doses. For example, in the absence of
oLH, Leydig cell testosterone production was increased by 34$ in the
presence of seminiferous tubules, whilst in the same experiment the
infusion of 0.01 ng/ml oLH abolished this increase. In another
experiment in which the same proportionate effect of seminiferous
tubules in the absence of LH stimulation was observed, infusion of 1.0
ng/ml LH produced a further increase in the effect of seminiferous
tubules upon Leydig cell steroidogenesis. These results suggest that
the effect of seminiferous tubules upon Leydig cells is a function not
only of the ratio of seminiferous tubules to Leydig cells but is also
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modulated by the degree of gonadotroph!)! stimulation of Leydig
cells. In the light of these observations it would appear unlikely
that the observed effects are the result of non-specific tissue
interactions.
Although seminiferous tubules are known to contain relatively
high levels (300-1000 pg/10 cm, Chapters 6-7) of testosterone it has
been shown, both by perifusion of seminiferous tubules alone and by
calculating the maximum tubular contribution to testosterone in column
effluates, that the effects observed cannot be attributed to leakage
of testosterone from the tubules. Neither can the effects be explained
by the presence of Leydig cells adhering to the tubules, as in these
studies minimal amounts of testosterone were produced by seminiferous
tubules perifused alone, and no significant binding of 125-1 hCG to
isolated tubules in vitro was demonstrable.
The ability of seminiferous tubules to stimulate Leydig cell
testosterone production was shown to be dependent upon the degree
of oLH stimulation of the Leydig cells. At very low levels of LH
stimulation the ability of seminiferous tubules to stimulate Leydig
cell testosterone production was completely nullified and inhibitory
effects were seen, whilst at higher doses of LH the response of the
tubules varied in a dose-dependent manner. These results suggest that
the seminiferous tubules are sensitive to the degree of gonadotrophin
stimulation to which their companion Leydig cells are exposed and
that the tubules modify the production of factors which affect the
Leydig cells in the light of that gonadotrophin stimulation. The
means by which the Leydig cells 'inform' the seminiferous tubules of
the presence of the varying degrees of gonadotrophin stimulation they
are undergoing, and the subsequent response of the tubules are not
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known at this time. However, the presence of a complex interaction
between these compartments, involving in all likelihood more than one
factor of seminiferous tubular origin, is evidenced by the complex
modulation of seminiferous tubular stimulation of Leydig cells. It is
/
apparent that stimulation of Leydig cells by seminiferous tubule
factors can be 'switched off' or reversed, as indeed it is in the
presence of 0.01ng/ml LH, or increased and decreased in a manner
related to but not determined by the fluctuations in peripheral LH
stimulation. That is, it would appear that the seminiferous tubules
respond to LH by 'reading' a signal from the Leydig cells, and
following the receipt of such a signal(?testosterone) are able to
modulate the output of factors affecting Leydig cell testosterone
production.
It has been shown that altering the flow rate of medium through
the perifusion system has no dramatic effects on the response of
Leydig cells to co-perifusion with seminiferous tubules. Such
studies were initially undertaken as a pilot for the further
reduction of flow rate through the system and to investigate the
possibilities of scaling down the flow rate, and ultimately the
amount of tubules and Leydig cells required for the columns. One of
the major drawbacks of the present system is the extensive
preparation required to enable each experiment to be performed. For
example, each experiment requires 16-24 million Percoll-purified
Leydig cells, 800-1200 cms of dissected seminiferous tubules, and 1.5
litres of perifusion medium. Therefore for each experiment up to 24
adult rats are required. The scaling down of the system would allow
a greater range of experiments to be attempted since the preparation
time would be greatly reduced.
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In conclusion, the system described herein provides a novel and
powerful tool for the investigation of dynamic interactions between
seminiferous tubules and Leydig cells _in vitro. These studies have
shown that seminiferous tubules, added to Leydig cells in
'physiological' proportions, exert stimulatory effects on Percoll-
purified Leydig cells. These effects are modulated by LH stimulation.
Future studies using co-perifusion of seminiferous tubules and Leydig
cells could be expected to contribute greatly to our understanding of
the interactions between these cell types in. vivo, since this in
vitro system represents the closest approach to the physiological
state yet described. Future directions for study involve the co-
perifusion of seminiferous tubules with unpurified interstitial
cells , investigation of the effects of various hormones(FSH, jS-
endorphin, oestrogens, oxytocin), investigation of possible inhibitory
effects of seminiferous tubules upon Leydig cells and the scaling down




THE INTRATESTICULAR DISTRIBUTION OP TESTOSTERONE DURING DEVELOPMENT
AND DURING TESTOSTERONE WITHDRAWAL
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6.1: Introduction:
The production of spermatozoa in mammalian species is driven and
maintained by testosterone, produced by the interstitial Leydig
cells and targeted on the Sertoli cells within the seminiferous
tubules. It is known that while spermatogenesis can be qualitatively
maintained following hypophysectomy in the presence of low( 10-20$
normal) intratesticular testosterone levels(Ahmad, Haltmeyer & Eik-
Nes, 1973; Cunningham & Huckins, 1979; Buhl, Cornette, Kirton &
Kaun, 1982), much higher levels of testosterone are required (in the
upper end of the normal range) to maintain quantitatively normal
spermatogenesis(Stevens & Steinberger, 1983). In the preceding
chapters(3-5) mechanisms for the local control of testosterone
production have been shown to exist(See Ch 5), and the literature
also supports the existence of locally produced factors which
modulate Leydig cell testosterone production(see Chapter 1).
Despite extensive evidence for the dependence of spermatogenesis
upon testosterone(see Sharpe, 1983), little or nothing is known
about the precise role of testosterone in the spermatogenic process.
Studies on isolated seminiferous tubules from the adult rat
testis have demonstrated considerable changes in various aspects of
Sertoli cell function(see Chapter 1; Parvinen, 1982 or Sharpe 1983
for review). It has been shown that the testosterone content of the
seminiferous tubules is greatest at stages VII-VIII(Parvinen &
Ruokonen, 1982), which is the acutely androgen-dependent period of
the cycle(Sharpe, 1983). Following on from these reports techniques
have been developed for the assessment of testosterone distribution
throughout the testis, in the seminiferous tubules, interstitial fluid
(from which the seminiferous tubules derive their testosterone) and in
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whole testis tissue, to provide further insight into the local control
of intratesticular testosterone levels, as well as providing basic
information on the normal testosterone distribution between these
compartments. Therefore the distribution of testosterone was assessed
in animals throughout puberty and also following treatments which
impaired Leydig cell function(treatment with an antiserum to LH and
cryptorchidism). Parts of some of these experiments were performed in
collaboration with Dr. R.M. Sharpe.
6.2: Validation of techniques for the measurement of testosterone
in seminiferous tubules:
To validate the dissection procedure for isolation of
seminiferous tubules the following experiments were performed:
i) hCG binding:
As described previously(Chapter 2) hCG binding to both
seminiferous tubules and to Percoll purified Leydig cells was
determined. No significant(p>0.1) hCG binding to seminiferous
tubules was demonstrated(99+/-135 C.p.m./10 cm tubules, mean+/-s.d.
N = 4) whilst Leydig cells showed significant hCG binding(206,900+/-
15,800 c.p.m./lO^cells).
ii) Testosterone diffusion from isolated seminiferous tubules:
Tubules were dissected as described in Chapter 2 by teasing
from decapsulated testes at 4°C and incubating 20 x 0.5 cm lengths
in 2 mis medium at 21°C for periods of 0, 20, 60 and 240 mins. When
compared with the time zero tubule testosterone concentration of
437+/-72 pg/10 cm(mean+/-s.d., n = 4), after incubation at 21°C for
20 mins, values had decreased by over 50$(215+/-71 pg) and by 60 and
240 min had become virtually undetectable(19+/-33 and <5 pg/10 cm
respectively); these decreases were matched by corresponding
J
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increases in the testosterone detectable in the incubation medium.
However, the experiments described below suggest that by cooling the
medium to 4°C diffusion of testosterone from the seminiferous tubules
can be largely prevented during the first 60 mins of the dissection
procedure.
iii) Comparison of seminiferous tubule testosterone content
before and after collagenase treatment;
Tubules dissected from testes either after decapsulation or
after decapsulation and collagenase digestion at 32°C for 5 rain were
extracted and the testosterone content compared. Testosterone levels
in isolated seminiferous tubules from undigested testes were not
significantly different from those obtained from testes after
collagenase digestion in either tubules from control rats
(930+/-389 pg/10 cm, n = 8 vs 894+/-198 pg/10 cm, n = 5; teased vs
collagenase digested tubules) or those from animals treated with an
LH antiserum(262+/-70 pg/10 cm, n = 5 vs 180+/-38 pg/10 cm, n = 6;
teased vs collagenase digested tubules).
iv) Comparison of total testis testosterone with tubule
testosterone content:
Further evidence to support the supposition that during
tubule isolation diffusion of testosterone from the tubules was
minimal was provided by calculating the total testicular content of
seminiferous tubule and interstitial fluid testosterone and
comparing this value with the testosterone content of the
contralateral testis from the same animal. Results showed that the
testosterone content of seminiferous tubules + interstitial fluid
were not significantly different from contralateral testis
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DAYS
Fig 6.1: Testis weight(Top panel), interstitial fluid(lF) volume
(Bottom panel), and seminiferous tubule(S.T.) protein concentration
(Centre panel)during maturation in the rat. Values plotted are the
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Fig 6.2: Testosterone distribution within the testis during
maturation in the rat. Total testis content of testosterone(Top
panel), seminiferous tubule(S.T.) testosterone concentration(Middle
panel) and interstitial fluid(lF) testosterone concentration(Bottora
panel) are shown. Values plotted are the mean +/- s.d. of 5 animals
per group.
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testis, n = 9)«
6.3: The distribution of testis testosterone during normal
maturation in the rat:
As a basis to further investigations, and also to test the
methods developed and validated above, the following experiment was
performed. Groups of rats were killed at 25, 35, 45, 55, 70, 90
& 130 days after birth, and tubule, interstitial fluid, and whole
testis content of testosterone measured. Testis weight,
recovered interstitial fluid volume and seminiferous tubule protein
content were also recorded.
Seminiferous tubule protein content was below the assay detection
limit at 25 days of age, values being less than 25 jig/lOcm of
seminiferous tubules(Fig 6.1). As expected, testicular weight,
seminiferous tubule protein content and interstitial fluid volume all
increased steadily between 25-90 days, and thereafter tended to
plateau(Fig 6.1). Whilst testis weight and seminiferous tubule
protein increased in a more or less linear pattern, interstitial
fluid volume increased sharply between 25-35 days before assuming a
more gradual rate of increase thereafter(Fig 6.1 ). Total testis
testosterone and interstitial fluid testosterone also increased in a
linear fashion between 25-130 days(Fig 6.2). However, whilst both
seminiferous tubule testosterone and total testis testosterone
content were initially low, <50 pg/lOcm & <50 ng/testis, respectively,
at 25 days of age, interstitial fluid testosterone concentrations
were relatively high at this time (approx 140 ng/ml, Fig 6.2).
Seminiferous tubule testosterone levels also increased in a linear
fashion between days 25-70, although thereafter some fluctuation in







Fig 6.3: Seminiferous tubule testosterone, expressed per jig of
seminiferous tubule protein, during maturation in the rat. Values
plotted are the mean +/- s.d. of 5 animals per group.
- 178 -
IF TESTOSTERONE ng/ml
Fig 6.4: Relationship between seminiferous tubule testosterone
(expressed//ig protein) and the interstitial fluid testosterone
concentration in individual rats of different ages. Values are plotted


































Fig 6.5: Effect of short-term treatment with an antiserum to oLH on
the recovered interstitial volume(open symbols) and testicular
weight(closed symbols). Values plotted are the mean +/- s.d.(Numbers
are as shown for Fig. 6.6), C = control rats.
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0 2 4 8 24 40
Hours after LH antiserum
Fig 6.6: The effect of administration of LH antiserum on temporal
changes in the concentration of testosterone in testicular
interstitial fluid(lF) and seminiferous tubules in relation to the
total testicular content of testosterone(lower panel). Testosterone
values are plotted on a logarithmic scale and the ratios of
testosterone values in the tubules to that in IF are plotted in the
top panel. Each point is the mean +/- s.d. for the number of animals
shown in parentheses along the bottom axis. * p<0.05, ** p<0.01,
*** pCO.001, in comparison with the control group.
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testosterone content as a function of the protein content of the
tubules it could be seen that throughout development the amount, of
testosterone present in the tubules/microgram of protein remained
relatively constant(Fig 6.3), i.e. between 0.5 & 1.25 pg//ig protein,
between days 25-90, although values for older animals(l30 days) were
somewhat higher(approx 2 pg/jig)• To determine if the seminiferous
tubule testosterone content and interstitial fluid testosterone
concentration in individual animals were related, seminiferous tubule
testosterone/jug protein was plotted against the interstitial fluid
testosterone concentration(Fig 6.4). The line of best fit for these
values was determined by linear regression and the values found to
be positively correlated(r = 0.825, n = 29; p<0.00l).
6.4: Changes in the intratesticular distribution of testosterone
following administration of an antiserum to oLH.
6.4.1: Testis weight and interstitial fluid volume:
No significant change(p>0.05) in either testis weight or
recovered interstitial fluid volume was seen during the 40h
following administration of a single dose of an LH antiserum to
adult rats(Fig 6.5). Interstitial fluid volume decreased at 4-8h post-
injection by about 30$(Fig 6.5) but this decrease was not significant,
and by 40 h post-injection values had returned to control levels.
6.4.2: Intratesticular testosterone distribution:
Following injection of an antiserum to LH, testosterone
concentrations in interstitial fluid fell precipitously and
progessively, such that by 4h post treatment, levels were reduced
by nearly 90$ when compared with controls. By 40 h post treatment
interstitial fluid testosterone values were reduced by 99$ when
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Fig 6.7: Correlation between testosterone concentrations inside the
seminiferous tubules with those outside in testicular interstitial
fluid in control rats and rats treated with an LH antiserum. Both
sets of values are plotted on a logarithmic scale. The solid line is
the best fit calculated by regression analysis of the log values
(y = 0.55x + 1.49, r = 0.983). Open symbols are values from control
animals, closed symbols are from anti-LH treated rats, of which
round symbols are animals treated for between 16-40 h and square
symbols for animals treated for between 2-8 h.
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concentration of testosterone also fell rapidly to 25$ of control
values within the first 4 h after treatment, but thereafter fell
slowly such that by 40 h after injection with anti-LH, seminiferous
tubule testosterone content was still 11$ of control values(Fig 6.6).
Confirmation that the rate of decline of testosterone concentrations
in the two compartments was different was provided by calculating
the ratio of the testosterone concentration in seminiferous tubules to
that in interstitial fluid. This ratio was significantly(p<0.05)
increased within 4 h of injection, and by 40 h was increased more than
5-fold compared with controls(p<0.001; Fig 6.6). Measurement of the
total testicular testosterone content showed a pattern similar to that
of seminiferous tubule testosterone, with more than a 60$ reduction by
4 h compared with control values, and values reduced to 11$ of
controls by 40h. Although by 40 h after anti-LH the reduction in both
seminiferous tubule and total testis testosterone was identical, there
was a slight discrepancy at 4 h when seminiferous tubule testosterone
was reduced by 75$, whilst total testis testosterone was reduced by
only 60$.
Using these data, the relationship between the testosterone
concentration in seminiferous tubules and interstitial fluid from
individual animals was assessed by plotting the values on a log
scale(Fig 6.7). Over a wide(200 fold) range of values there was a
strong positive correlation between testosterone concentrations in
the two compartments(r = 0.983, p<0.001, n = 60). The regression
line was not, however, indicative of a 1:1 relationship between
interstitial fluid testosterone and seminiferous tubule




Serum hormone concentration :
ng/ml :
LH FSH TESTOSTERONE :
3 56+/—56 488+/-1 14 5.1+/-5.1 :
5 68+/-20 362+/-40 3.6+/-1.4 :
13 55+/—17 490+/-85 4.6+/-2.8 :
Table 6.1: Serum LH, FSH and testosterone values following
experimental induction of unilateral cryptorchidism in the rat. Values
are the mean +/- s.d. of 5 animals. No significant(p>0.05) change in
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Fig 6.8: Effect of experimental induction of unilateral cryptorchidism
on testicular weight(top) and recovered intersitial fluid volume
(bottom) from scrotal testes(closed symbols) and abdominal testes(open
symbols). Mean +/- s.d. Numbers are shown along the bottom axis of
the lower panel of Fig. 6.9. * p<0.05, ** p<0.001 significant
difference between scrotal and abdominal testes calculated by paired
t-test.
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6.5: Intratesticular testosterone distribution following
experimental induction of cryptorchidism.
Further studies were undertaken, using unilaterally
cryptorchid rats, to determine the effects of this treatment on the
intratesticular distribution of testosterone.
6.5-1: Serum hormone concentrations:
Serum concentrations of LH, FSH and testosterone
remained unchanged for up to 13 days after experimental induction of
unilateral cryptochidism(Table 6.1).
6.5.2: Testis weight, interstitial fluid volume and seminiferous
tubule protein content:
No change in the seminiferous tubule protein
concentration was seen until 13 days after induction of
cryptorchidism, when tubule protein content fell to approximately
50$ of values from the contralateral testis(Data not shown). Testis
weight, however, was significantly reduced within 3 days of induction
of experimental cryptorchidism(p<0.001, Fig 6.8), although it was
still 93$ of control values. By 5 days post operation, abdominal
testis weight had fallen to 73$ of the weight of the contralateral
scrotal testis, and by 13 days and thereafter the abdominal testis
weights were reduced to 34$ of contralateral testis values(Fig 6.8).
The interstitial fluid volume fell significantly by 3 days post-
operation, recovered between 5-13 days and was elevated at 27 & 34
days post operation(Fig 6.8).
6.5«3: Intratesticular distribution of testosterone following
experimental induction of cryptorchidism:
Seminiferous tubule, interstitial fluid and whole
testis testosterone levels in the abdominal testis were reduced by
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DAYS POST CRYPTORCHIDISM
Fig 6.9: Effect of experimental induction of unilateral cryptorchidism
on the intratesticular distribution of testosterone. Total testis
testosterone(top), seminiferous tubule(S.T.) testosterone(middle) and
interstitial fluid(lF) testosterone concentrations(bottom) are shown.
Mean +/- s.d. * p<0.05, ** p<0.01, *** p<0.001 significant differences
between scrotal(closed circles) and abdominal(open circles) testes
calculated by paired t-test. Numbers of animals are shown above the
bottom axis of the middle panel for both total testis and S.T.
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Fig 6.10: Correlation between testosterone concentrations inside the
seminiferous tubules with those outside in testicular interstitial
fluid in scrotal(closed symbols) and abdominal(open symbols) testes
from unilaterally cryptorchid rats. Both values are plotted on
logarithmic scales. The solid line is the best fit calculated by
regression analysis of the log values from the scrotal testes
(y = 1.5x + 44, r = 0.841).
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approximately 50$ within 3 days of induction of cryptorchidism when
compared with the contralateral scrotal testis(Fig 6.9). However, due
to considerable variation between animals, only the difference in
seminiferous tubule testosterone was significant at this time(p<0.05).
By 5 days post-operation, seminiferous tubule testosterone levels were
not further reduced, when compared with the contralateral scrotal
testes, although thereafter values decreased to 20-25$ of values for
the scrotal testis at 13 and 34 days post-operation,(p<0.05)•
Interstitial fluid testosterone values followed a similar pattern
as did values for the total testis testosterone(Fig 6.9). These
values were again used to determine the relationship, under these
conditions, between interstitial fluid and seminiferous tubule
testosterone levels. Using a linear regression program, the line of
best fit was described(y = 1.5x - 44) for the values from scrotal
testes, and the correlation between seminiferous tubule and
interstitial fluid testosterone levels calculated(0.841)• Values from
the abdominal testes did not fit this relationship, but were found
to fit a different linear regression(r = 0.71, y = 0.34x + 80)
suggesting that a linear relationship between these parameters was
maintained following cryptorchidism.
6.6: Discussion:
These techniques allow the distribution of a major
intratesticular hormone, testosterone, within the testis to be
assessed for the first time. However before any valid conclusions
can be drawn from the data presented above, the validity of the
techniques used must be firmly established.
In a study of the inter-compartmental distribution of
testosterone within the testis, the greatest concern is that
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inaccuracies in the measurement of this hormone may occur either due
to diffusion of the hormone from the tissue or between compartments
between the time of death and the time of isolation of the
respective tissues or fluids. The validity of the technique used for
the isolation of interstitial fluid over 16 h at 4°C has been
reported elsewhere(Chapter 2), as have the techniques for extraction
of the tissues(de Jong, Hey & Van der Molen, 1974) and for the
assaying of samples(Sharpe & Bartlett, 1985). The major concern which
must be addressed here is the possibility that testosterone diffuses
out of the seminiferous tubules during the dissection and isolation
procedures used. It is generally assumed that in vivo, testosteone
is distributed throughout the testicular tissues by passive diffusion,
and the techniques used for the isolation of seminiferous tubules were
therefore carefully validated.
Experiments with testes which had been dispersed with collagenase
at 32°C showed that diffusion from the tubules under these conditions
was minimal(see 6.2 above). However, once tubules were dissected into
0.5 cm lengths, diffusion at 21°C was rapid, with 50$ of testosterone
being lost within 20 mins. Cooling to 4°C markedly retarded this
process, and it is assumed that within the 8-15 minutes required to
dissect the tubules from an individual testis, diffusion is neglible.
This agrees with earlier findings by Parvinen and Ruokonen(1982), and
is further supported by the observation that by summing the testicular
interstitial fluid testosterone content(calculated from the volume
of interstitial fluid in the testis and the testosterone concentration
in that fluid) and the seminiferous tubule testosterone content/testis
(calculated by multiplying tubule testosterone content by total
testicular tubule length, based on 1240 cm/gm testis; Wing &
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Christensen, 1982) the values thus obtained were not significantly
different from the measured testosterone content of the
contralateral testis(see 6.2 above). This calculation was only carried
out for anti-LH treated animals, since both age and cryptochidism may
alter the total testicular length of seminiferous tubules, as may
other treatments inducing tubular damage(see Chapter 7).
As a further test of the validity of these results, hCG binding
to seminiferous tubules teased from undigested testes was assessed.
No significant binding to isolated seminiferous tubules was
demonstrated(see 6.2 above).
The results obtained for tubule testosterone contents in this
study are higher that those previously reported(Podesta & Rivarola,
1974), probably as a result of the precautions taken here to
minimise diffusion. Other studies(Ruokonen, Vihko & Niemi, 1973; de
Jong et_ a_l, 1974; Comhaire & Vermeulen, 1976) are difficult to
compare since testosterone concentrations were expressed per unit
weight or per ml of seminiferous tubular fluid. Values obtained
above for seminiferous tubule testosterone, which ranged in controls
from 80-2500pg/lOcm are also generally higher than those obtained by
Parvinen & Ruokonen(l982), whose methods were largely followed.
However, by performing stage dissections, these authors prolong the
dissection time(2-3 hrs) and also dissect the seminiferous tubules
into shorter lengths(2 mm), both of which would increase the
possibility of diffusion of testosterone from the tubules.
As a further assessment of the validity of the techniques and
also to provide basic information, the intratesticular distribution of
testosterone was determined throughout puberty, and during early adult
life. Whilst the results(Figs 6.1-3) are much as would be expected,
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with all of the parameters measured increasing throughout development
and reaching a plateau thereafter, it should he noted that, although
seminiferous tubule and testicular testosterone levels were low during
early development, interstitial fluid testosterone levels were already
approaching adult values(l50 ng/ml) by 25 days post-partum.
Furthermore, throughout development, the seminiferous tubular
testosterone/protein ratio remained more or less constant(around 0.5-
1.2 pg testosterone/^ig protein, Fig 6.3). The seminiferous tubule
testosterone concentration was shown to be positively correlated with
the concentration in interstitial fluid(Fig 6.4), which would seem to
confirm that seminiferous tubule testosterone levels are determined by
the extratubular testosterone concentration(See below).
Treatment of adult rats with an antiserum to LH(See 6.4 above)
resulted in low levels of testosterone within all testicular
compartments(Fig 6.6). However, following chemical destruction of
the Leydig cells(see Chapter 7), intratesticular levels of
testosterone are reduced to below the limit of detection of the
assay system used(<2ng/ml in interstitial fluid, <2ng/testis, <25-
50pg/10 cm seminiferous tubules). Therefore, in the animals treated
with anti-LH the possibility that testicular testosterone
concentrations are partially sustained by local factors remains.
Recent studies(Sharpe & Cooper, 1984) have identified a factor in
rat testicular interstitial fluid which markedly stimulates Leydig
cell testosterone secretion, and, in the animals treated with anti-LH
described above, levels of this interstitial fluid factor were raised
following treatment(Sharpe & Bartlett, 1985). The levels of this
factor are also elevated following EDS treatment and the induction
of cryptorchidism(Sharpe, Kerr, Fraser & Bartlett, 1985, submitted).
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That local factors may support Leydig cell testosterone production
is further supported by the evidence showing that even at 40 h
following anti-LH treatment, there were significant amounts of
testosterone present within the testis. Such observations also agree
with data obtained from hypophysectomized animals which show that at
three days following removal of the pituitary, testosterone levels
within testicular interstitial fluid are low but measurable(46 ng/ml)
suggesting that, in the absence of LH stimulation, Leydig cells
continue to produce testosterone, possibly under the influence of
local regulatory factors(Sharpe, Doogan & Cooper, 1982).
Another factor potentially affecting the distribution of
testosterone within the testis is that the seminiferous tubules
may preferentially retain testosterone. This is supported by the
observation that, following treatment with an antiserum to LH, the
ratio between seminiferous tubule and interstitial fluid testosterone
levels increased as the interstitial fluid testosterone levels
fell(Fig 6.6). Theoretically, these findings could be explained by the
presence of a high-affinity androgen-binding protein(ABP) within the
seminiferous tubules(e.g. Hansson _et_ _al, 1976b), but the reported
levels of this factor(Ritzen, Boitani, Parvinen, French & Feldman,
1982) would only account for a minute proportion of the testosterone
present in the tubules. Preliminary evidence suggests that a low-
affinity, high capacity androgen-binding factor may be present in the
seminiferous tubules(Parvinen, 1984) which may explain these
observations. That the relationship between interstitial fluid and
seminiferous tubule testosterone levels was not determined solely by
the interstitial fluid testosterone concentration was shown by
the changing relationship between these two parameters in different
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treatment groups(Figs 6.4, 6.7, 6.10). Thus the seminiferous tubule
testosterone level was not related to the interstitial fluid
testosterone concentration on a one to one basis and this was
particularly evident when values were towards the low end of the
normal range or below the normal range(Fig 6.7). This suggests
that when intratesticular testosterone levels fall, mechanisms are
activated which conserve the tubular testosterone content,
presumably to maintain testosterone levels sufficiently to permit
complete spermatogenesis to continue.
This study has also shown marked differences in the testosterone
content of testes located within the scrotum and abdomen of
cryptorchid animals(Fig 6.9), differences which were associated with
marked changes in testicular weight(Fig 6.8). As the serum LH and FSH
levels remained unchanged up to 13 days following unilateral induction
of cryptochidism(See Table 6.1), the question arises as to how the
reduced levels of testosterone output by the Leydig cells in the
abdominal testis can be explained.
It has been shown that, following experimental induction of
cryptorchidism, marked changes in Leydig cell morphology occur
(Kerr, Rich & de Kretser, 1979a,b; Rich, Kerr & de Kretser, 1979)
including increased cellular volume and hypertrophy of the smooth
endoplasmic reticulum and Golgi apparatus, two of the organelles
involved in steroidogenesis. The in vivo response of bilaterally
cryptorchid animals to exogenous LH or hCG is reduced when compared
with controls whilst _in vitro the testes are hyper-responsive to
LH(Kerr _et al, 1979a; Rich & de Kretser, 1979; see also Chapter 1).
Similarly, isolated Leydig cells from the abdominal testes of
unilaterally cryptorchid rats are hyper-responsive to LH when
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compared in vitro with control cells(Sharpe, Cooper & Doogan,
1984). Therefore the reduction in testosterone output seen in these
conditions does not seem to be explained by impairment of Leydig
cell testosterone output in response to LH stimulation. However,
following injection of hCG into bilaterally crytorchid rats, it has
been shown that the uptake of hCG in vivo into the cryptorchid
testis is reduced by up to 70$, when compared with controls, probably
as a result of decreased blood flow to the cryptorchid testis(Sharpe,
1983). Therefore, it would appear that the reduction in testosterone
levels within the abdominal testis seen in unilaterally cryptorchid
rats, is a result of reduced levels of LH reaching the Leydig cells
within that testis. This observation also suggests that whilst local
factors may play a significant role in the regulation and
maintenance of testicular testosterone concentrations, the presence
of near normal LH stimulation is essential if such mechanisms are to
be completely effective, since in the absence of such stimulation
the testis cannot compensate solely by increasing the levels of
'local regulators'. In the light of this observation, it should be
noted that the factor(s) present in testicular interstitial fluid
which stimulates Leydig cell testosterone secretion is far more
effective in the presence of hCG than in its absence(Sharpe & Cooper,
1984), suggesting that it is a synergistic agent which complements LH
action rather than replacing it.
In conclusion, methods for analysis of the intratesticular
distribution of testosterone have been established, validated and
applied to normal developing rats and those in which testosterone
levels are lowered. The results suggest that during periods of low
testosterone supply, seminiferous tubule testosterone levels are
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maintained either by the sequestering of testosterone within the
seminiferous tubules or by the action of local factors which
stimulate Leydig cell testosterone production, or by a combination
of these factors. These methods will provide a useful tool for the
future assessment of the role of testosterone in the control of
spermatogenesis(see Chapter 7), and of the relative roles of LH and




THE USE OF SPECIFIC TOXINS IN THE ELUCIDATION OF TESTICULAR FUNCTION
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7.1: Introduction:
Further to the studies described above(Chapter 6),
investigations into the use of specific cellular toxins were carried
out. A number of chemicals thought to have specific testicular cell
targets have now been identified, such as: methoxyacetic acid(MAA)
which is thought to target specifically upon the primary
spermatocytes(Foster, Creasy, Foster, Thomas, Cook & Gangolli, 1983;
Foster, Creasy, Foster & Gray, 1984), some phthalic acid esters,
which are thought to specifically impair Sertoli cell function
(Foster, Thomas, Cook; & Gangolli, 1980; Foster, Foster, Cook, Thomas
& Gangolli, 1982; Creasy, Foster & Foster, 1983), and an alkane
sulphonic ester, ethane dimethane sulphonate(EDS) which is thought
to impair Leydig cell function(Morris, 1985; Bu'Lock & Jones, 1976;
Bu'Lock & Jackson, 1971).
Methoxyacetic acid(MAA) has been shown to be the active agent
reponsible for the toxic effects of the ethylene glycol monoethyl and
monomethyl esters in the rat(Foster et_ _al, 1984), and these toxins
appear to initially affect primary spermatocytes undergoing post-
zygotene meiotic maturation and division(Foster _et_ al, 1984). This
compound could therefore provide a useful model for the investigation
of the effects of disruption of Sertoli cell interactions with a
specific germ cell population.
A number of phthalate esters have been shown to have deleterious
effects on testicular morphology(Creasy, Foster & Foster, 1983). Of
these Di-n-pentyl phthalate has been established as the most effective
agent, with respect to the toxic actions described(Creasy et al,
1983). The phthalates have been shown to increase urinary excretion
of zinc and to reduce the testicular content of this metal(Foster,
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Thomas, Cook Sl Gangolli, 1980). The morphological effects of these
compounds have also been described. Thus, within 3 h of a single oral
dose of di-n-pentyl phthalate the early and late spermatocytes are
displaced towards the lumen of the seminiferous tubules and there is
extensive vacuolation of the Sertoli cell cytoplasm and, by 6 h after
treatment, both this displacement of early and late spermatocytes
and the degree of Sertoli cell vacuolation was more marked(Creasy
jrt aJL, 1983)* As treatment progressed there was a gradual depletion of
germinal cells from all tubules leaving a Sertoli cell matrix with a
few necrotic spermatocytes and occasional normal spermatogonia(Creasy
_et _al, 1983). In the light of these studies, and of other studies
suggesting that the active metabolites are the de-esterified
phthalates, a pilot study using mono-2-ethylhexyl phthalate(MEHP) to
disrupt tubular function was undertaken, and the effects of this
compound upon the intratesticular distribution of testosterone,
testicular weight and serum testosterone and gonadotrophins were
determined.
The antifertility effects in rodent species of a number of alkane
sulphonic esters are well documented(Jackson, Fox & Craig, 1961,
Cooper & Jackson, 1970). Of the substances investigated, one in
particular, ethane dimethane sulphonate(EDS), has been shown to
specifically impair the endocrine function of the Leydig cells
(Jackson, 1973). Other studies(Jackson & Jackson, 1984) have suggested
that treatment of fertile rats with EDS results in spermatogenic
disruption and temporary loss of fertility due to Leydig cell
dysfunction.
In adult rats, EDS has been shown to suppress testicular
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synthesis of testosterone and its precursors _in vitro(Bu'Lock &
Jackson, 1971), and it also markedly decreases the synthesis of cyclic
AMP in response to hCG stimulation(Bu'Lock & Jones, 1976). Studies
in vivo have shown a marked reduction of serum testosterone levels
within 24 h of EDS treatment(Morris & McCluckie, 1979), and parallel
increases in plasma gonadotrophin levels(Jackson & Morris, 1977;
Morris & Jackson, 1978), suggesting an alteration of the feedback
signals from the testis to the pituitary. All of these effects occur
within 24 hours of a single EDS treatment. However, levels of
circulating reproductive hormones return to within the normal range
over a similar time period to the return of fertility, i.e. 6-9 weeks
after treatment with EDS(Cooper & Jackson, 1961; Bu'Lock & Jackson,
1975; Jackson & Morris, 1977; Morris & McCluckie, 1979). As suggested
by these authors, impairment of parameters of Leydig cell function
implies that EDS acts, either directly or indirectly, by impairment of
Leydig cell function.
Despite these numerous studies providing evidence for an action
of EDS on spermatogenesis via a direct effect on the Leydig cells
there is no convincing information on the effects of EDS on the
morphological and functional status of the intratesticular
environment.
In these studies, two testicular toxins, methoxyacetic acid and
MEHP were used in an attempt to disrupt testicular function over a
short time period(2 days). Also, further to studies by Kerr,
Donachie and Rommerts(l985b) which have shown that EDS specifically
destroys Leydig cells in the adult rat, an in depth study of the
effects of such destruction of Leydig cells on the intratesticular
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Fig 7.1: Effect of a single dose of MEHP(n = 9) or MAA(n = 3) on
FSH(left), LH(centre) and testosterone(right) levels in plasma
recovered from adult male rats 2 days after treatment. * p'CO.OS*























Fig 7.2: Effect of a single dose of MEHP(n = 9) or MAA(n = 3) on the
recovered interstitial fluid volume(left) and testis weight(right) of
animals two days after treatment. * p<0.05, ** p<0.01 when compared
with control values(n = 8), Means +/- s.d.(Student's t-test).
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tubule and interstitial tissue morphology and function was performed.
These studies were performed in collaboration with Dr. J.B. Kerr and
Dr. R.M. Sharpe.
7.2: Effects of Methoxy acetic acid(MAA) and mono-2-ethylhexyl
phthalate on testicular function:
The effect of a single dose of MAA and MEHP given by oral
gavage on the testicular function of adult male rats was assessed.
Two days after treatment 8 controls, 9 MEHP-treated and 3 MAA-treated
rats were killed and plasma LH, FSH and testosterone levels measured
as well as the levels of testosterone in interstitial fluid,
seminiferous tubules and whole testes. Testicular weight and
interstitial fluid volume were also recorded.
a) Plasma LH, ESH and testosterone:
Two days following a single dose of either MAA or MEHP,
plasma testosterone and LH levels were decreased, although, in neither
case was the effect significant(Fig 7.1). Plasma FSH was
significantly decreased in both MAA-treated animals(p<0.05) and in
those treated with MEHP(p<0.01 ) within two days(Fig 7.1).
b) Testis weight and interstitial fluid volume:
Treatment with MA produced no changes in either
testis weight or the recovered interstitial fluid volume(Fig 7.2).
Treatment with MEHP, however, produced a slight but significant
increase in both testicular wieght(l1$, p<0.05) and the recovered
interstitial fluid volume(44$, p<0.0l) when compared with controls.
c) Testicular distribution of testosterone;
Treatment with MA caused a 26$ reduction in seminiferous
tubule testosterone content, a 34$ reduction in interstitial fluid






Fig 7.5: Effect of a single dose of MEHP(n = 9) or MAA(n = 3) on total
testicular content of testosterone(left), seminiferous tubule(TUBULES)
testosterone content(centre) or interstitial fluid(lF) testosterone
concentration(right) two days after treatment. ** p<0.01 when
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HOURS DAYS
Fig 7.4: Temporal changes in(top) the serum levels of LH and FSH and
(middle)the serum levels of testosterone in relation to(bottom)
testicular weight and seminiferous tubule protein content following a
single injection of EDS into adult rats. * p<0.025, ** p<0.01,
*** p<0.001, in comparison with control values. Mean+/-s.e.(n as
described for Fig 7.5).
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testicular content of testosterone; however none of these effects were
significantly different from control values. Treatment with MEHP
produced similar reductions in both seminiferous tubule testosterone
content(reduced by 30$) and interstitial fluid testosterone
concentration(reduced by 42$) but produced a greater decrease in total
testicular testosterone content when compared with controls(reduced by
22$). However, only the decrease in interstitial fluid testosterone
was statistically significant(p<0.01) when compared with controls(Fig
7.3).
7«3: Effects of EDS on testicular morphology and function;
a) Serum hormones;
Serum testosterone fell rapidly and significantly(p<0.005)
within 6h of treatment to less than 15$ of control values(Fig 7.4). At
12 and 24h no further decrease was observed, but at three days after
EDS administration there was a further reduction in serum testosterone
levels which fell to below the limit of detection of the assay
(<0.05ng/ml), and remained undetectable until two weeks post EDS, when
a slight recovery was seen(mean values approx 0.3ng/ml). By 3 weeks
and thereafter up to 10 weeks, serum testosterone levels returned to
- within the normal range( 1 .0-15ng/ml) although the mean levels were
still significantly(p<0.005) reduced compared with controls.
There were no significant(p>0.05) changes in serum LH and FSH up
to 24h following EDS treatment, but between 24 h and 3 days the
concentrations of both hormones increased significantly(p<0.005),
reaching 650 and 250$ of their respective control values(Fig 7«4).
Thereafter, serum LH levels remained elevated to a similar degree
(570-650$ above controls)up to 2 weeks after EDS treatment, fell to
330$ of control values at 3 weeks, and returned to control levels by 4
- 207 -
weeks and remained so at 6 and 10 weeks post EDS. In contrast, serum
PSH levels were increased significantly(p<0.005) for a longer period,
up to 4 weeks, following EDS treatment, and did not return to control
levels until between 6 and 10 weeks(Fig 7-4).
b) Testis weight and seminiferous tubule protein:
While testis weight is accepted to provide a general index
of testicular damage, seminiferous tubule protein content was also
measured to provide a further index of tubule integrity.
Whilst the protein content of isolated seminiferous tubules
changed in a similar manner to the testicular weight after EDS
treatment there were differences in the time scale of these changes.
Thus, at 7 days after EDS treatment, testicular weight was
significantly decreased(p<0.005) whilst there was no significant
change in seminiferous tubule protein content(Fig 7-4).
By 2 weeks post-EDS, testis weight had reached its lowest values,
being only 50% of control values, whilst seminiferous tubule protein
content showed its first significant decrease at this time and did not
reach its lowest value until three weeks post EDS, when it represented
57% of control values, and at which time testicular weight had begun
to recover. Between 3 and 10 weeks there was a significant recovery of
both testicular weight and seminiferous tubule protein content, such
that by 6 weeks testicular weight had fully recovered whilst at 10
weeks after EDS treatment seminiferous tubule protein was
significantly(p<0.025) elevated above control values.
c) Interstitial fluid volume:
Within 6 h of EDS treatment the recovered interstitial
fluid volume fell signifcantly(p<0.005) to 50% of control values,
and by 12 h had reached less than 12.5$ of control values(9 vs 73
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HOURS DAYS
Fig 7.5: Temporal changes in the recovered volume of interstitial
fluid from the testes of animals following a single injection of EDS.
* p<0.005 in comparison with control values. Numbers placed above the
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Fig 7.6: Temporal changes in the concentration of testosterone
in(top) isolated seminiferous tubules and the whole testis and
in(bottom) testicular intersitial fluid following a single injection
of EDS into adult rats. In both panels, square symbols indicate values
below the limit of detection(see text). * p<0.025, ** p<0.01,
*** p<0.005, in comparison with control values(Kean+/-s.e., Numbers
are shown in brackets).
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pil/testis, Fig 7-5). Thereafter, however, the recovered interstitial
fluid volume returned to near normal values, i.e. 45$ above controls at
24 h(p<0.005 vs 12 h values), and 71$ of controls at 5 days(p<0.005 vs
24 h values) after EDS treatment, although neither of these values
were significantly different from control values. By 7 days post EDS
treatment the recovered interstitial fluid volume was again
significantly lower than control values(p<0.005, Fig 7.5). Between
3-14 days post EDS treatment there was no significant change in
interstitial fluid volume compared with controls, although between 2-3
weeks after EDS treatment recovered interstitial fluid volume more
than doubled(p<0.005 vs controls & 2 week values). By 4 weeks after
EDS treatment the interstitial fluid volume was 212$ of control
values(p<0.005, Fig 7-5). Thereafter, by 6 weeks after treatment
with EDS the recovered interstitial fluid volume had fallen
significantly(p<0.005 vs 4 weeks) to reach control values and
remained at this level until 10 weeks post EDS treatment(approx 90 jil/
testis, Fig 7.5).
d) Intratesticular distribution of testosterone;
The total testicular content of testosterone per gram of tissue
was unaltered at 6h after EDS treatment despite a significant(p<0.05-
0.005)fall in serum, interstitial fluid and seminiferous tubule
levels of testosterone(Fig 7.6). Between 6 and 12h post EDS there was
a significant(p<0.025) fall in testicular testosterone, and between
12h and 3 days after EDS the values fell progressively, to reach
levels at or below the limit of detection by 3 days(<2.Ong/gm).
Between 3 and 7 days post EDS treatment, testicular testosterone was
barely detectable, but by 2 weeks there was the return of small but
measurable amounts of testosterone in the testis, and thereafter the
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content rose rapidly to reach about 250ng/gm. Between 3-4 weeks there
was a transitory decrease in testosterone content per gram of tissue
but at six weeks post EDS, the testosterone content of the testis was
significantly(p<0.025) increased compared with control values, before
it fell again slightly by 10 weeks (p<0.005 vs 6 week values).
Interstitial fluid levels of testosterone fell significantly
by 6h post EDS, but, unlike serum testosterone levels which fell by
>85$ within 6h, interstitial fluid testosterone fell by only 67$.
Between 6 and 12h after treatment there was no further fall in the
interstitial fluid testosterone concentration, but between 12 and 24h,
levels fell by 50$(Fig 7-6). Within 3 days after injection of EDS,
interstitial fluid levels of testosterone were undetectable(<2ng/ml)
and remained so until 2 weeks when concentrations of around 50 ng/ml
were measured. By 3 weeks post EDS treatment interstitial fluid levels
of testosterone were increased to values comparable to those in
controls, but thereafter fell again to about 50$ of the control levels
and then recovered slightly during weeks 6 and 10.
Because of the observed change in seminiferous tubule protein
content, seminiferous tubule testosterone measurements have been
expressed as pg of testosterone per jig of tubular protein(Fig 7.6).
Seminiferous tubule testosterone levels fell rapidly over the first 6h
following EDS treatment, but then remained stable between 6 and 24h
post EDS. Beyond 24h seminiferous tubule testosterone levels fell to
become undetectable by 3 days post EDS treatment(<21-50pg/l0cm,
<0.05-0.1 pg/jig protein) but by 2 weeks levels were again detectable
(0.125pg/pg protein). Three weeks after EDS treatment seminiferous
tubule testosterone concentrations had increased to nearly twice the
control values(l.2pg/^ig protein) but by 4 weeks were once again within
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Fig 7-7: Top left: Vehicle treated rat, showing typical morphology of
the interstitial tissue, which contains Leydig cells(L),
macrophages(M), endothelial nuclei(arrows) and the interstitial
lymphatic space(LS)(Mag x 930).
Top right: One day after EDS treatment, illustrating fragmented
interstitial cells, pyknotic bodies(arrows), macrophages(M)
containing large cytoplasmic inclusions and interstitial fibrillar
material(Mag x 930).
Bottom left: Seven days after EDS treatment, when Leydig cells
have disappeared, leaving macrophages(M) and endothelial
or fibroblast nuclei(arrows)(Mag x 930).
Bottom right: Two weeks after EDS treatment, illustrating
Leydig cells with cytoplasmic lipid droplets(L), macrophages(M) and
spindle-shaped interstitial cells(arrows)(Mag x 930).
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the control range and remained so at 6-10 weeks,
e) Testicular histology:
i) Leydig cells and interstitium:
Leydig cells in vehicle-treated animals showed normal adult
histology, with polygonal or irregular nuclei containing a small
nucleolus. The cytoplasm was granular in appearance reflecting the
abundant numbers of mitochondria(Fig 7.7). Macrophages were also
present within the interstitial tissue, characterized by their pale-
staining nuclei and cytoplasm containing small granules, representing
their lysosomal components.
By 24h after EDS treatment many of the Leydig cells showed signs
of disintegration and fragmentation, and numerous dense pyknotic
bodies were present both within the interstitial space and within the
cytoplasm of interstitial macrophages(Fig 7.7). Leydig cells which
had not yet broken down completely showed evidence of morphological
alterations involving vesiculation of the cytoplasm. Other Leydig
cells or their fragmented parts appeared to be enclosed by macrophage
cytoplasm, suggesting that they were being phagocytozed by the
macrophages. The interstitial space also contained random depositions
of fibrillar material, a feature not seen in control animals.
At 3 and 7 days following EDS injection the interstitial space
contained no histologically identifiable Leydig cells or pyknotic
structures, nor were there any cells present which were recognisable
as either damaged or atrophied Leydig cells(Fig 7.7). Interstitial
macrophages were still evident, although there were no longer any
basophilic inclusions within their cytoplasm.
By 2 and 3 weeks after EDS administration the interstitium
contained very small numbers of Leydig cells in perivascular or
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Fig 7.8: Top left: Three weeks after EDS treatment, showing peri¬
vascular and peritubular Leydig cells(L), mononucleated spherical
cells(asterisk) and numerous elongated interstitial cells(arrows)
(Mag x 930).
Top right: Four weeks after EDS treatment, illustrating
abundant foetal-like Leydig cells with many pale-staining cytoplasmic
lipid inclusions(Mag x 930).
Bottom left: Six weeks after EDS treatment, showing numerous
Leydig cells. Macrophages are shown(M), together with peritubular
Leydig cells(arrowheads) and fusiform interstitial cells(arrows)
(Mag x 930).
Bottom right: Ten weeks after EDS treatment, illustrating normal
adult-type morphology of the interstitial tissue(Mag x 930).
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peritubular locations(Figs 7.7-7-8). In contrast to the typically-
irregular shape of Leydig cells in the control testes, the Leydig
cells at 2 and 3 weeks post-EDS exhibited smoothly contoured shapes
with few cytoplasmic granules. The interstitium also contained
numerous elongated or spindle-shaped cells although their identity
could not be established by light microscopy(Fig 7.8).
A remarkable feature of the interstitial tissue 4 weeks post-EDS
was the abdundance of a new population of Leydig cells(Fig 7.8). In
some sections the Leydig cells often filled the interstitial space in
large clusters, yet in contrast, other areas of interstitial tissue
contained no Leydig cells. By light microscopy the Leydig cells were
very similar to foetal rat Leydig cells(see Chapter 1), exhibiting
spherical nuclei with little or no heterochromatin and numerous
cytoplasmic lipid inclusions.
At 6 weeks after EDS it was occasionally possible to identify
'foetal-type' Leydig cells although the majority showed morphological
features intermediate between foetal-like and the classical adult-type
Leydig cell. Thus, the nucleus was often spherical and lacked
significant deposits of heterochromatin(similar to foetal Leyidg
cells), whilst the cyptoplasm more closely resembled the adult
structure, lipid inclusions being rarely observed(Fig 7.8).
Peritubular interstitial cells associated with the seminiferous
tubules also included elongated Leydig cells, possibly enclosed
within the thin cytoplasmic extensions of endothelial cells.
Macrophages, mononucleated cells and fusiform-shaped interstitial
cells resembling endothelial tissue were commonly observed within the
interstitial area.
At 10 weeks after EDS treatment the interstitial space and its
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Fig 7.9: Top left: Vehicle treated rat, illustrating normal
seminiferous epithelium at stage VIII. Note Sertoli cell nuclei(S),
primary spermatocytes(P) and round(R) and elongated spermatids
(Mag x 930).
Top right: Three days after EDS treatment, showing two basally
situated degenerating bodies(arrows)(Mag x 930).
Bottom left: Seven days after EDS treatment, illustrating
increased frequency of degenerating cells(arrows) within stage VII and
VIII seminiferous tubules(Mag x 930).
Bottom right: Seven days after EDS treatment, showing a stage X
seminiferous tubule with retention of sperm heads and flagella
(arrows), and a degenerating spermatid(S)(Mag x 930).
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population of interstitial cells were similar in appearance to the
normal adult rat(Fig 7.8). The Leydig cells were predominantly adult
in appearance, with features characteristic of the adult population of
Leydig cells as described above.
ii) Seminiferous epithelium;
Up to two days after EDS treatment, light microscope examination
of the seminiferous epithelium showed no detectable morphological
changes from controls(Fig 7-9). The first alteration in the normal
composition of the seminiferous epithelium was seen at 3 days after
treatment, when a few seminiferous tubules at stages VII and VIII of
the spermatogenic cycle were found to contain degenerating primary
spermatocytes(Fig 7-9), and occasional focal aggregations of vacuoles
within the basal area of the Sertoli cell cytoplasm. However, these
structural alterations were not evident in the majority of tubules at
these stages.
At 7 days after EDS, some stage VII seminiferous tubules showed
degenerating primary spermatocytes(Fig 7.9), together with basally
situated vacuoles in the region of the Sertoli cell tight junctions.
Occasionally the whole Sertoli cell cytoplasmic body was altered,
containing irregular vacuoles which were empty or 'watery' in
appearance. The majority of stage VII tubules showed qualitatively
normal spermatogenesis with no indication of cellular damage. In
stages VIII-IX basal Sertoli cell vacuoles and degenerating germ cells
were apparent, together with a number of retained spermatid heads and
tails often deeply embedded within the body of the Sertoli cell. There
was also evidence of abnormal patterns of spermiation during stage
VIII of the cycle(Fig 7.9). Within stages X-XI occasional undigested
remnants of residual bodies were observed within the basal Sertoli
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Fig 7.10: Top left: Two weeks after EDS treatment, illustrating
impairment of spermatogenesis at stage II. Note large lipid
inclusions(L), extracellular spaces(asterisks) and few primary
spermatocytes(arrow)(Mag x 930).
Top right: Three weeks after EDS treatment, showing
absence of mature spermatids in a stage VII tubule(Mag x 930).
Bottom left: Four weeks after EDS treatment, showing
substantial recovery of spermatogenesis at stage VIII-IX. Note
pyknotic body(arrow), abnormal spermatid nucleus(arrowhead) and
aberrant residual body(asterisk)(Mag x 930).
Bottom right: Four weeks after EDS treatment, illustrating




cell cytoplasm. Despite the range of the changes seen at this time,
the degenerative changes were not extensive as the majority of tubules
were qualitatively normal in appearance.
Two weeks post-EDS, histological alterations to the seminiferous
epithelium were both more common and involved a wider range of cell
types. Disruption of spermatogenesis occurred in stages VII-II of the
spermatogenic cycle, although stages III-VI exhibited no qualitatively
detectable changes by light microscopy. Tubules at stages VII-VIII
showed similar cellular alterations to those described at 7 days.
Mature elongated spermatids were either absent or, if present, showed
aberrant morphology and orientation in the adluminal regions of the
epithelium. During stages IX-XIV a variety of histological changes
were seen which included the formation of basally-located vacuoles,
wide extracellular spaces, increased lipid inclusions, degenerating
primary spermatocytes and loss or degeneration of elongating
spermatids. The most severely disrupted tubules, at stages I-II, showed
a very substantial or total depletion of elongating spermatids
(Fig 7.10), and an apparent reduction in primary spermatocytes
together with epithelial vacuoles, extracellular spaces and
accumulation of large lipid inclusions.
By the third week following EDS treatment, depletion of the
mature generation of elongating spermatids, with increased numbers of
basal Sertoli cell lipid droplets and occasional degenerating primary
spermatocytes could be seen at stages III-VIII of the spermatogenic
cycle. At times, seminiferous tubules at stage VI-VII of the
spermatogenic cycle appeared normal except for the absence of the
mature generation of spermatids(Fig 7.10). Abnormal retention of sperm
heads and residual cytoplasm were often seen at stages IX-XI, together
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Fig 7-11: Top left: Six weeks after EDS treatment, illustrating
substantial restoration of spermatogenesis at stage III. A
degenerating germ cell is shown(arrow)(Mag x 930).
Top right: Ten weeks after EDS treatment, showing a severely-
disrupted seminiferous tubule. Note pleomorphic Sertoli cell
nuclei(s), vacuoles(V), extensions of Sertoli cell cytoplasm(arrows)
and spermatogonia(SG)(Mag x 930).
Bottom: Ten weeks after EDS treatment, showing qualitatively
normal spermatogenesis at stage VIII(Mag x 1300).
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with basal degenerating germ cells and vacuoles. Stages XII-II
appeared qualitatively normal by light microscopy.
By 4 weeks after EDS injection most stages of the spermatogenic
cycle showed some degree of damage similar to the pattern of
disruption seen during weeks 2-3. However restoration of qualitatively
normal seminiferous epithelial architecture was occasionally observed
at stages VII-VIIl(Fig 7.10) in which the epithelium showed
considerable depth due to the appearance of several germ cell
generations. The few structural abnormalities noted were dense
pyknotic bodies, occasional extraction of spermatid nuclear chromatin
and unusual configurations of spermatid residual cytoplasm. Otherwise
many tubules at these stages appeared normal. In a very small number
of tubules, severe germ cell damage was noted(Fig 7.10), with
substantial loss of germ cells. These collapsed seminiferous tubules
also contained abnormal pleomorphic profiles of Sertoli cell nuclei
and disorganization of the Sertoli cell cytoplasm.
Six weeks after EDS injection, spermatogenesis began to show
signs of recovery, the vacuoles and lipids associated previously with
the Sertoli cell cytoplasm having largely disappeared by this time.
Stages I-II appeared normal except for a reduction in the normally
plentiful numbers of elongated spermatids, whilst stages III-IV(Fig
7.11) and VII-IX contained reduced numbers of elongating spermatids,
and stage IX also lacked normal numbers of residual bodies. Stages
X-XI contained fragments of residual bodies not normally seen at these
stages. Stages XII-XIV showed occasional abnormalities of flagella and
cytoplasmic tails of elongating spermatids. Stages IV-V were still
severely damaged, totally lacking in spermatids, with only occasional
primary spermatocytes and spermatogonia present.
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By 10 weeks the majority of seminiferous tubules were fully
expanded, with a normal seminiferous epithelium(Fig 7.11). However,
approximately 5$ of tubules remained shrunken in diameter due to
collapse of their epithelium, with irregularly shaped Sertoli cell
nuclei and interdigitating areas of Sertoli cell cytoplasm. These
tubules often contained only B-type spermatogonia or preleptotene
spermatocytes and exhibited a small lumen and peritubular
fibrosis(Fig 7.11).
7.4: Discussion:
This study has shown the great potential of testicular cell-
specific toxins in the elucidation of cell-cell interactions in the
testis. Using a single injection of ethane dimethane-sulphonate(EDS),
which has been shown to target exclusively on the Leydig cell and to
denude the testis of these cells(Kerr _et_ aJ, 1985b), it has been
possible to study the effects of destruction and regeneration of
Leydig cells on the intratesticular distribution of testosterone in
relation to changes in testicular morphology. Furthermore the use of
short-term screening procedures has identified two other compounds
which may repay further study, i.e. methoxyacetic acid and mono-2-
ethyl-hexyl phthalate. Although the effects of these latter compounds
were not as marked as those of EDS, further study of these compounds
could produce greater understanding of the role of germ cell-Sertoli
cell interactions in the control of testicular function.
The effects of both MEHP and MAA on testicular function were
limited at 2 days post treatment and, in the case of MAA, analysis
of results was hampered by small numbers. Both treatments reduced
plasma concentrations of testosterone, LH and FSH, although only in
the case of FSH was this effect significant(p<0.05-p<0.001, see Fig
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7.1). If the fall in plasma testosterone is a result of local
impairment of testicular function then it would be expected that
plasma LH & FSH would be raised as a result of reduced steroid(and
possibly inhibin) feedback from the damaged testis. However, since the
results are of a preliminary nature care should be taken before any
hard and fast conclusions are drawn. MAA treatment had no effect on
the interstitial fluid volume recovered nor on the testis weight of
animals within 2 days of treatment. MEHP however significantly
increased both IF volume and testis weight, and the latter effect may
be a result of the increased fluid content of the testis.
Testosterone concentrations in interstitial fluid, seminiferous
tubules and in whole testis tissue were also reduced by both MEHP
treatment and MAA treatment. However, only with MEHP treatment was
the interstitial fluid testosterone content significantly reduced.
These results, being of a preliminary nature, are only open to
limited interpretation. It is of interest that whilst testicular and
plasma testosterone levels are reduced, there is no concomitant
increase in plasma EH. Furthermore, despite the presumed presence of
tubular damage, as shown previously(Creasy _et al, 1983; Foster et
al, 1983), plasma FSH levels were also significantly reduced. The
effect of MEHP on testis weight and IF volume also suggest further
studies would be of value to establish whether these effects persist.
Following treatment with EDS the Leydig cell population was
completely destroyed, such that within three days of administration of
the toxin no morphologically recognizable Leydig cells were present in
any of the testicular sections analysed. This absence of Leydig cells
was maintained from 3-7 days post treatment, but thereafter, a new
Leydig cell population began to differentiate. These Leydig cells
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showed marked differences from normal adult type Leydig cells and
closely resembled foetal Leydig cells(see Chapter 1). Only after 28
days did the numbers of Leydig cells increase dramatically, and
between 6-10 weeks post treatment these cells were replaced by or
transformed into adult-type Leydig cells. However, it is of interest
to note that when testosterone levels and Leydig cell numbers within
the testis recovered beyond 7 days post-EDS there were striking
disparities between the intratesticular testosterone concentration and
the numbers of Leydig cells present. When at 2 weeks after EDS
administration, the first foetal-like Leydig cells were evident, this
correlated with the first detectable levels of testosterone in serum,
interstitial fluid, seminiferous tubules and whole testis. However, by
5 weeks interstitial fluid and seminiferous tubule testosterone
concentrations had returned to normal, while serum testosterone and
whole testis testosterone were only about 50$ of control levels(see
Figs 7«4 & 7.6). Paradoxically, there were still very few
morphologically recognizable Leydig cells within the testis at this
time, and whilst detailed morphometric analyses are not yet available,
it is highly unlikely that the differences between intratesticular and
serum testosterone levels observed between weeks 2-5 could be
explained by any increase in Leydig cell numbers seen during this
period.
To account for such a dramatic rise in testosterone levels
another explanation is required, and there are several possibilities.
For example, the high serum levels of LH(approx 500ng/ml) may be
responsible for the high testosterone levels, or the small number of
Leydig cells present may be hyper-responsive to LH. However, neither
of these possibilities would account for the difference in
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testosterone levels between 2 and 3 weeks post-EDS(see Fig 7.6). A
third possible explanation for the increase in testosterone output at
3 weeks could be the production of local testicular factors which
acted to stimulate Leydig cell testosterone production. There are
several possible candidates for such a role including testicular
'LHRH'(Sharpe, 1983 for review), a non-LHRH like polypeptide
present in rat testicular interstitial fluid(Sharpe & Cooper, 1984)
and other less well defined factors(Parvinen _et_ jil, 1984; Sharpe &
Rommerts, 1984). The potential importance of local regulators of the
Leydig cells has been reviewed elsewhere(Sharpe, 1986). Finally, it is
possible that the interstitial cell precursors of the foetal-like
Leydig cells which repopulate the testis following EDS treatment
acquire the ability to produce testosterone before they become
morphologically recognizable as Leydig cells, such as occurs in the
human testis in which Leydig cell fibroblastic precursors have been
shown to respond to hCG stimulation by production of testosterone
(Chemes e_t _al, 1985). If this is the case there may be large changes
between 2-3 weeks post EDS in the numbers of such Leydig cell stem
cells which could then account for the rapid increase in testosterone
production at this time. Future studies should help to resolve which
of these possibilities is correct.
At 6 hours after EDS administration, serum, interstitial fluid
and seminiferous tubule testosterone concentrations fell dramatically
but the total testicular concentration of testosterone remained
unaltered. Within the testis it is accepted that testosterone is
synthesized exclusively by the Leydig cells, and is then secreted into
interstitial fluid from whence it is transported or diffuses to the
seminiferous tubules and serum. It therefore seems likely that during
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the times when the change in testicular content of testosterone was
not reflected by a similar change in testosterone levels in
interstitial fluid and seminiferous tubules, that the Leydig cells
failed to release testosterone. At 6h post EDS, when this phenomenon
was first apparent, it is probable that the retention was due to
damage to the Leydig cells, as ultrastructurally at this time there is
extensive distension and vacuolization of both the smooth endoplasmic
reticulum and the Golgi apparatus(Kerr, Bartlett & Donachie, 1985a),
organelles which are known to be principally responsible for Leydig
cell testosterone secretion(Ewing _ert _al, 1985).
Interstitial fluid bathes the interstitium and the seminiferous
tubules and thus provides a medium of communication between these
two compartments. Changes in the testicular interstitial fluid
volume therefore can play a major role in the modulation of the
concentration of testicular factors. It is with testosterone that
this change can be most readily observed. For example, if a constant
rate of testosterone production by the Leydig cells is assumed, any
decrease in interstitial fluid volume will result in an increase in
the concentration of testosterone surrounding the tubules. Similarly,
if both the rate of production of interstitial fluid and testosterone
fall, then the fall in testosterone concentrations will be less marked
than if the interstitial fluid content of the testis remained constant.
Modulation of the testicular interstitial fluid volume could therefore
provide an additional means of maintaining intratesticular
concentrations of testosterone as, for example, has been shown for
LHRH(Sharpe, 1984). The rate of turnover of interstitial fluid also
affects the transport of serum hormones into the testis, and therefore
the flow of LH & FSH into the testis is also affected by any change in
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the turnover of interstitial fluid. It could therefore be postulated
that, in the event of Leydig cell dysfunction, mechanisms controlling
testicular interstitial fluid volume would be activated, to conserve
testosterone concentrations within the testis. However, since
testicular damage also produces changes in capillary
permeability(Setchell, 1980), it is not possible in this instance to
draw any conclusions from the data presented above relating to
interstitial fluid volumes recovered from EDS treated rats, since both
mechanisms may be active at the same time. Nevertheless, the fact
that interstitial fluid volumes change rapidly following EDS
treatment suggests that mechanisms for the control of interstitial
fluid turnover may be activated following testicular damage.
Following EDS-induced destruction of the total Leydig cell
population testosterone concentrations in serum and within the whole
testis were reduced such that at 3 days post-EDS, serum values were
less than 50pg/ml, and interstitial fluid levels were less than
2ng/ml. The levels of testosterone found within the testis following
EDS treatment were much lower than those reported after 2 days of LH
deprivation(See Chapter 6), and also much lower than those seen at 3-4
days after hypophysectomy(Sharpe et al, 1982), when serum testosterone
levels fell to 400pg/ml and interstitial fluid testosterone to
46ng/ml. This suggests that even during total gonadotrophin
deprivation following hypophysectomy or after treatment with an LH
antiserum the Leydig cells retain the ability to secrete small amounts
of testosterone, possibly in response to local stimulatory factors.
Since this is the case, and because in EDS-treated animals the
pituitary remains functionally intact it is possible, perhaps for the
first time, to assess the acute effects of selective and total with-
- 228 -
drawal of testosterone on the seminiferous epithelium.
Three days' after EDS treatment, testosterone levels were
undetectable in both serum and within the testis, and therefore at
this time the first signs of testosterone withdrawal should have
become apparent. However, only tubules at stages VII-VIII showed any
signs of degeneration and this was slight. Even after at least 5 days
of testosterone deprivation(i.e. 3-7 days post-EDS), degenerative
changes in the seminiferous epithelium were not as extensive as might
have been expected and were limited to stages VII-XI. It appears
therefore that the seminiferous epithelium is relatively resistant to
short-term testosterone withdrawal. Stages VII-VIII appeared to be the
most sensitive to testosterone withdrawal and it is these stages which
are considered to be classically androgen dependent(Russell et_ al,
1981). However, the majority of stages of the seminiferous epithelium
appeared qualitatively unaffected by the removal of testosterone for 5
days. The progressive pattern and stage specificity of germ cell
degeneration in the testis at seven days after hypophysectomy or after
blockade of androgen action on the tubules have been described
previously(Russell & Clermont, 1977; Russell _ejt _al, 1981). Although
no hormonal data was presented in the latter studies, evidence gained
from experiments on hypophysectomised rats(Sharpe, Cooper & Doogan,
1981) suggests that major but incomplete depletion of testicular
testosterone would have occurred in response to hypophysectomy.
Three days after EDS injection testosterone was undetectable
within the testis, and at this time the first degenerative changes in
primary spermatocytes at stages VII-VIII were seen, suggesting that
these cells are the most sensitive to testosterone removal. Seven days
after EDS treatment, damage to the seminiferous epithelium appeared to
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be more limited than that described by Russell and his colleagues. The
presence of numbers of degenerating primary spermatocytes at stage
VIII and also of retained sperm heads within the basal areas of the
Steroli cell at stage IX were both reported by Russell and Clermont
(1977), although the continued presence of such retained sperm heads
at stage X was not described by these authors. Furthermore, Russell &
Clermont(1977) reported reduced numbers of step 7 and step 19
spermatids at stages VII-VIII, and although these effects were not
readily apparent within seven days of EDS treatment, quantitative
analysis of the effects of EDS upon the seminiferous epithelium may
be necessary to resolve this point. The discrepancy between the latter
results and those of Russell and Clermont(1977) may be explained by
the fact that the damage seen at 7 days post EDS may only represent
the fifth day after testosterone withdrawal as testosterone levels
within the first 24 h of EDS treatment were still relatively high.
Alternatively, the high levels of FSH present in EDS-treated rats,
which are not present in hypophysectomized rats, may have exerted a
protective effect on the seminiferous epithelium. The vacuoles seen
within the basal areas of the Sertoli cell by 3 days after EDS, and
also thereafter(see above), have been described previously in acutely
cryptorchid rats (Kerr et_ _al, 1979b). Their presence at stages VII-VIII
in the EDS treated testes suggests that these vacoules, thought to
represent disruption of the Sertoli cell tight junctions(Kerr ert al,
1979), are induced by testosterone deprivation rather than exposure of
the testis to high(i.e. abdominal) temperature. However, it remains to
be shown whether this represents a primary effect of testosterone
deprivation, or is simply a consequence of the disruption of Sertoli
cell-germ cell interactions.
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From 2-4 weeks after EDS the damage to the seminiferous
epithelium became progessively more extensive despite the fact that
testosterone levels within the testis had returned to near normal by
three weeks. At the latter time, stages XII-II of the spermatogenic
cycle appeared normal and by 4 weeks stages VII-VIII had also shown
substantial improvement in the numbers and maturity of the germ cells
present. However a general recovery accompanied by the loss of the
basal vacuoles and basally degenerating primary spermatocytes was not
seen until 6 weeks after EDS. The most likely explanation for this
observation is that damage sustained earlier in the cycle of the
seminiferous epithelium has a 'flow-on' effect downstream, in which
with the passage of time, subsequent and later stages of the cycle are
seen to be affected. For example, the normal stage XII-II tubules seen
three weeks after treatment would be represented by stage VII-VIII
tubules by four weeks, and it is of note therefore that this
corresponds to the recovery seen at these times.
By 10 weeks after EDS treatment 4 complete cycles of the
seminiferous epithelium would have occurred since the return of normal
intratesticular testosterone levels 7 weeks earlier. By this time the
large majority of tubules had fully recovered and appeared to show
complete and normal spermatogenesis. However, a small proportion of
tubules(probably less than 5%) failed to recover spermatogenic
activity. These may represent the most severely damaged tubules which
will either eventually recover, or which may remain atrophied
indefinitely. Such focal impairment of spermatogenesis is commonly
seen following the recovery of spermatogenesis from disruption(Labrie
_et_ _al, 1980; Vickery ert al_, 1983), but its aetiology remains unknown.
Since no degeneration of the seminiferous epithelium occurred
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until at least 3 days after EDS injection it is assumed that EDS has
no direct effect on the seminiferous epithelium. This is supported by
a recent study (Morris, 1985) which showed that multiple injections of
EDS in the rat failed to induce chronic spermatogenic damage and
failed to prevent restoration of spermatogenesis.
\
Serum levels of FSH and LH were both significantly increased 3
days after EDS treament, but whilst serum FSH remained elevated until
6 weeks following EDS, serum LH had returned to normal levels by 4
weeks, and even by 3 weeks was already significantly lower than the
maximum levels reached. Serum testosterone, although never fully
returning to control levels had stabilized within the normal range by
3 weeks post EDS. This data supports the current theory of
differential control of LH and FSH secretion, with LH being regulated
by testosterone negative feedback, whilst FSH is under the dual
control of steroids and testicular inhibin(see Baker _et_ _al, 1983
for review). Due to the marked changes seen in FSH during this study,
further investigations are necessary to determine the levels of
testicular inhibin following EDS treatment and to relate these levels
to the other intratesticular changes described.
These studies have shown the potential of specific toxins for
the investigation of testicular function and have identified two such
chemicals, methoxyacetic acid and mono-2-ethyl hexyl phthalate, for
further investigation. Ethane di-methane sulphonate has been shown
to specifically target on the Leydig cells and should provide a
powerful tool for the future investigation of seminiferous tubule-
Leydig cell communication. It is apparent that the testis has the
ability to replenish the population of Leydig cells if the resident
generation is compromised or removed by toxicological means. The
- 232 -
seminiferous epithelium also appears relatively resistant to damage in
the absence of testosterone within the testis either, as a result of
hormonal support from raised gonadotrophin levels or because






The aim of the studies described in this thesis was to investigate
communication between seminiferous tubules and Leydig cells within the
testis. Since it is established that qualitative and quantitative
maintenance of spermatogenesis requires high levels of testosterone
and that the testosterone content of the seminiferous tubules
tubules may alter in a cyclical fashion(Parvinen, 1982), as does the
size of peritubular Leydig cells(Bergh, 1982), it is likely that a
significant degree of communication between these tissues occurs in
vivo. However, methods for the investigation of such interactions
in vitro were not available at the time that the present studies
were commenced.
Recently a number of static systems for the investigation of
such interactions have been developed(See Chapters 3-4; Parvinen _et
al, 1984; Syed _et_ al, 1985). However, the results obtained with these
systems vary between laboratories(see Chapters 3-4) and according
to the Leydig cell preparations used. It has been shown that co-
culture with seminiferous tubules inhibits testosterone production by
unpurified Leydig cells but stimulates testosterone production by
purified Leydig cell preparations (Parvinen _et_ _al_, 1984). Furthermore
such systems are subject to a number of complicating factors, thus it
is recognized that in static incubation systems, either for co-culture
of tissues or for incubation of cells in 'conditioned' medium, the
composition of the culture medium is in a constant state of flux, due
to medium exhaustion, the build up of cellular metabolites and
also of possibly toxic factors. Despite these drawbacks such systems
have provided convincing evidence that a factor or factors exist
which are produced within the seminiferous tubules and are targeted
on the Leydig cells. Co-culture of porcine Sertoli and Leydig cells
produced marked changes in Leydig cell morphology and testosterone
production when compared with cultures of Leydig cells alone(Tabone _ert
al, 1984). In the rat, seminiferous tubules have been shown to
modulate testosterone production by Leydig cells in a stage-
dependent manner(Parvinen et al, 1984), although, in the present
studies no such effects were evident(Chapters 3-4).
It has been shown that Sertoli cell-conditioned medium stimulates
Leydig cell testosterone secretion in the rat(Grotjan & Heindel,
1982), and recent studies have shown that the apparent levels of a
comparable Sertoli cell factor are increased by both FSH- and
dibutyryl cAMP-stimulation of the Sertoli cell cultures(Verhoeven &
Cailleau, 1985). However, Syed _et_ al_( 1985) have shown that
seminiferous tubule-conditioned medium produces inhibitory effects on
testosterone production by unpurified Leydig cells. Such results agree
with those of Parvinen _et_ al( 1984) obtained with a co-culture system
using unpurified Leydig cells. The system described in the present
study demonstrated stimulatory effects of seminiferous tubule-
conditioned medium on testosterone production by Percoll-purified
Leydig cells(Chapter 4). However, such effects were highly variable
and initial results of studies in which the active factor(s) were
concentrated by ammonium sulphate precipitation were inconclusive.
Nevertheless, it is apparent from these studies and those in the
literature, that more than one factor is produced by the seminiferous
tubules which can affect Leydig cell testosterone production. Such
factors, presumed to be of Sertoli cell origin, include; 'testicular
LHRH'(Sharpe, 1982 for review), an interstitial fluid factor or
factors(Sharpe & Cooper, 1984) and possibly factors present in
seminiferous tubule-conditioned media(see above and Chapter 4). It
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remains to be firmly established whether the activities of any of
these factors are of physiological importance, and whether any of them
represent identical factors.
In the light of the variability of the results produced by static
culture systems and also their drawbacks a system for the study of
dynamic interactions between seminiferous tubules and Leydig cells was
investigated. Previous studies on the perfused testis have proved of
some value in the elucidation of testosterone biosynthetic pathways in
an in vitro system(Chubb & Ewing, 1979a-c). However, such a system
has severe limitations when used for the study of interactions between
the seminiferous tubules and Leydig cells, because it is not possible
to study the individual components of the testis in such a system.
A perifusion system based on a system previously validated for the
perifusion of unpurified Leydig cells(Wu _et_ _al, 1985) was adapted and
validated for co-perifusion of Leydig cells with seminiferous tubules.
Such a system enables the investigation of direct communication
between these tissues in a dynamic state. Using this system it has
been possible to demonstrate that at a ratio of Leydig cells to
seminiferous tubules similar to that seen in vivo(i.e. approx. 3
million Leydig cells/200 cm seminiferous tubules) Leydig cell
testosterone production was significantly increased by the presence of
seminiferous tubules, and that, at 'non-physiological' ratios(i.e. 3
million Leydig cells/50 cm seminiferous tubules) Leydig cell
testosterone production was decreased(See Chapter 5). Whilst the
latter finding is still of a preliminary nature, it may help to
explain the inhibitory effects on unpurified Leydig cells of
seminiferous tubules and seminiferous tubule-conditioned medium
reported in other studies(Syed _et_ al, 1985; Parvinen _et_ a^, 1984). The
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latter findings may be explained by postulating that either the ratio
of Leydig cells to seminiferous tubules was unphysiological, or that
other cell types, particularly germ cells and macrophages, present in
the un-purified cell preparations interact with the Leydig cells to
further affect their testosterone output. Presumably any effects of
germ cells on the Leydig cells would be aspecific, as it is difficult
to conceive how germ cells could directly communicate with the Leydig
cells in a physiological situation.
Whilst it has yet to be proven that macrophages have a paracrine
role within the testis, recent studies suggest that this may be the
case. In macrophages FSH has been shown to increase amino acid and
uridine incorporation into acid precipitable material _in vivo and
in vitro(Yee & Hutson, 1985a,b) and these cells have been shown
to possess specific FSH receptors(Yee & Hutson, 1985a). Furthermore,
macrophage-conditioned culture medium has been shown to affect Leydig
cell testosterone production and the levels of stimulatory factors in
macrophage-conditioned medium were increased in a dose-related fashion
by FSH(Yee & Hutson, 1985c). Macrophages make up approximately 10-15$
of the cells in the Percoll-purified Leydig cell preparations used in
the present studies, and in vivo the ratio of Leydig cells to
macrophages is about 4:l(Bergh, 1985). Macrophages have been shown
to be closely associated with Leydig cells(Miller _et_ _al, 1985; see
also Chapter 1), and whilst the possibility that macrophages play a
role in the paracrine regulation of Leydig cells has not previously
been widely considered, evidence is growing that such a role may
exist. In this light, the ability of EDS to specifically destroy
Leydig cells in vivo(Chapter 7), may enable the preparation of
macrophage-enriched, Leydig cell-free preparations which should permit
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further studies in this area to be carried out.
Some degree of 2-way communication between Leydig cells and
seminiferous tubules _in vitro may be demonstrable using the
perifusion system, since the effect of seminiferous tubules on
testosterone production by Leydig cells has been shown to vary
according to the LH dose to which these cells are exposed(Chapter 5).
However, the possible involvement of macrophages in this context has
not yet been considered and the use of macrophage-enriched
preparations may be of value in this situation.
The validation of a perifusion system for the investigation of
dynamic interactions between seminiferous tubules and Leydig cells, in
the absence of such problems as build up of toxic wastes and end-
products, should provide a powerful tool for further studies. Results
suggest that such a system will enable investigations to proceed along
two initial avenues: Firstly, to use the system as an in vitro
bioassay for the identification of possible paracrine factors, such as
the endorphins, and their effects on perifused Leydig cells or on
columns containing both Leydig cells and seminiferous tubules.
Secondly, to characterize the effects of such factors and to elucidate
the hormonal control of interactions between seminiferous tubules
and Leydig cells. For example, the effects of either 'pulsing' the
system with FSH or yS-endorphin or the addition of these hormones to
the perifusion system for longer periods(l-6 h) could be used to
study their effects. Further purification of the factor(s) present in
seminiferous tubule-conditioned medium or interstitial fluid, and
subsequent perifusion of Leydig cells with either the isolated or
partially-purified factors may also provide further information about
the actions of these factors. The effects of toxins targeted on
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specific cell types either _in vitro, using for example
MEHP(Chapter 7) to impair Sertoli-germ cell interactions, or in
vivo, using EDS to produce testosterone-deprived tubules may also
be used to investigate the importance of both cellular interactions
and cellular function. Finally, the use of various _in vivo
treatments in rats, or the use of human interstitial cells or
tubules may also provide information about the paracrine regulation
of the testis. At present, the perifusion system developed herein
provides possibly the best opportunity for the study of
intratesticular paracrine regulators of Leydig cell function, and
its further application should yield much interesting and novel
information about this regulation.
Methods for the quantification of testosterone concentrations
within different compartments have also been established and validated
(Chapter 6). Testicular testosterone levels were reduced either by
removing peripheral LH using a potent antiserum or by inducing
experimental cryptorchidism(Chapter 6). In early cryptorchidism,
reduced testosterone levels in vivo are observed, whilst in
vitro Leydig cells are hyper-responsive to LH(Sharpe, Doogan &
Cooper, 1981). This apparent paradox may be a result of a sharp
reduction in testicular blood flow during cryptorchidism, which could
result in a reduction in the levels of LH reaching the Leydig cells in
the cryptorchid testis, since serum LH levels do not alter during
short term cryptorchidism(Chapter 6). Whilst this hypothesis is
attractive, it is not proven. In both cryptorchidism and following
anti-LH treatment, there is evidence that levels of a testicular
factor(s) which stimulates Leydig cell testosterone production are
increased(Sharpe _ert _al, 1985). Despite this change, intratesticular
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testosterone levels are markedly reduced shortly after withdrawal of
LH stimulation. Also, during the co-perifusion of seminiferous tubules
with Leydig cells or the culture of Leydig cells with interstitial
fluid the most marked stimulation of Leydig cell testosterone
production was seen in the presence of LH or hCG stimulation(Sharpe &
Cooper, 1984; Chapter 5). This data may be explained by suggesting
that the role of such local factors is to interact with and supplement
peripheral LH stimulation rather than to replace it. If this is true
then it would appear that the function of paracrine regulators in
vivo is to respond in situations in which LH stimulation is
insufficient to maintain intratesticular testosterone levels, thus
providing a mechanism for the control of testosterone levels within
the testis. However, this interpretation is largely speculative at
present.
A further mechanism for the maintenance of spermatogenesis could
be by the retention of testosterone within the seminiferous
tubules. Following treatment with an antiserum to LH the ratio of
testosterone in the seminiferous tubules to that in the surrounding
interstitial fluid rose significantly(Fig 6.6). Furthermore the
regression line representing the relationship between seminiferous
tubule and interstitial fluid testosterone for both cryptorchid
animals and those treated with anti-LH was not representative of a
1:1 relationship, again suggesting that testosterone may be
preferentially retained within the tubules. However, following
EDS treatment, which destroys Leydig cells and abolishes testicular
testosterone(Chapter 7), the same relationship was not evident and
the testosterone concentration in both seminiferous tubules and inter¬
stitial fluid declined at the same rate. Therefore, it would appear
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likely that for testosterone to be preferentially held within the
seminiferous tubules at times when testicular testosterone content
is low, the presence of functionally competent Leydig cells
is required. If this is true it would imply that rather than the
seminiferous tubules being able to store testosterone or to actively
concentrate testosterone, the Leydig cells preferentially direct
testosterone into the seminiferous tubules during testosterone
deprivation. Whilst it is unlikely that Leydig cells secrete
testosterone uni-directionally, the presence of a peritubular
population of Leydig cells may result in the formation of a locally
high testosterone concentration proximal to the seminiferous
tubules. Furthermore, such cells, being positioned directly adjacent
to the seminiferous tubules might also be exposed to higher
concentrations of paracrine factors derived from the seminiferous
tubules. Since peritubular Leydig cells adjacent to stages VII-VIII
of the spermatogenic cycle have been shown to be larger than
those situated perivascularly(Bergh, 1982) such a relationship
may exist in vivo. However, whilst such an arrangement is
attractive to postulate, its existence is speculative and will
prove difficult to test in practice.
The availability of techniques for the investigation of
the distribution of testosterone will also allow studies on the
control of testosterone utilization within the testis to be carried
out. For example, it has been suggested that FSH increases
seminiferous tubule testosterone uptake _in vivo(Seilicovich &
Rosner, 1972), and treatment of animals with FSH may provide further
information on this putative action of FSH. These techniques may also
be used in conjunction with the in. vitro perifusion system
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described above, to assess the in vivo effects of any putative
paracrine regulatory factors on interactions between seminiferous
tubule and Leydig cells as reflected by both the intratesticular
distribution of testosterone and the levels of an interstitial fluid
factor(s) which acts on the Leydig cells(Sharpe & Cooper, 1984).
These studies have also shown that chemical toxins should prove
extremely useful tools for the investigation of testicular function
(Chapter 7). The use of a specific Leydig cell toxin, ethane-dimethane
sulphonate(EDS), has provided a novel and powerful tool for the
investigation of testicular function. Previously, studies on the in
vivo role of testosterone have been hampered by the ability of
Leydig cells, in the absence of any pituitary stimulation, to produce
appreciable although markedly reduced quantities of testosterone(see
above and Sharpe, Cooper & Doogan, 1981). However, by specifically
removing the Leydig cell population from the testis it has been
possible to study the effects of complete testosterone withdrawal on
the spermatogenic process without removing stimulation of the testis
by peripheral hormones. By monitoring the morphological changes
in both the interstitium and the seminiferous tubules following EDS
treatment, it has been possible to state with reasonable certainty,
that this chemical does not, in the rat, affect the seminiferous
tubules directly, but that its effects are centred on the Leydig
cells. It can therefore be assumed that the effects on the
seminiferous tubules described in this study(see Chapter 7) are due
wholly to the removal of the Leydig cell population, and probably to
the resultant decrease in testicular testosterone concentration.
Therefore it is of interest to note that, following removal of
testicular testosterone, damage to the seminiferous epithelium was
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less extensive than expected and was initially restricted to stages
VII-VIII of the spermatogenic cycle. By seven days post EDS, which
represents 5 days post testosterone withdrawal, the incidence of
damage increased to cover stages VII-XII. It would appear that
stages VII-VIII are the most sensitive to testosterone(Chapter 7;
Russell _et _al, 1981), but the fact that most stages of the
spermatogenic cycle were unaffected by removal of testosterone
strongly suggests that many of the stages of the cycle are not
dependent on testosterone. However, it should be noted that these
conclusions are based on qualitative rather than quantitative
observations and studies on the quantitative effects of testosterone
withdrawal are needed to provide a clearer picture.
From these studies it has been possible to identify the primary
spermatocytes at stages VII-VIII as the cells most sensitive to
testosterone withdrawal. The germ cell damage seen following EDS-
induced Leydig cell destruction was less extensive than that observed
following hypophysectomy(Russell & Clermont, 1977; Russell et al,
1981) possibly due to increased FSH levels exerting a protective
effect on the spermatogenic process.
However, before such studies are attempted the specificity of such
toxins must be clearly established, involving detailed and time-
consuming evaluation of testicular morphology. In this study a
specific Leydig cell toxin(EDS) has been described with preliminary
findings relating to two further toxins which act, respectively, on
Sertoli cells and on a specific generation of germ cells. Whilst
studies on EDS have been limited to the _in vivo situation the
potential of this compound and others for the study of the effects of
"damaged" seminiferous tubules on Leydig cells jln vitro using the
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perifusion system is considerable: e.g. it should be possible to
compare the effects of normal untreated seminiferous tubules with
tubules lacking a specific germ cell generation and tubules deprived
in vivo of normal testosterone supplies, and to use these to study
interactions between seminiferous tubules and Leydig cells.
EDS treated animals have also shown the ability to replenish the
testicular Leydig cell population. In the human, the Leydig cell
precursors appear able to produce testosterone prior to acquiring the
morphological characteristics of Leydig cells(see Chapter 1). As
may be suggested by the evidence shown above(Chapter 7), this also
occurs in the rat, and assuming that the normal Leydig cell population
of the testis is continually turning over, the presence of such
precursor cells in the normal testis may further complicate the study
of the paracrine regulation of the testis by providing a hitherto
unrecognised or unconsidered population of steroidogenic cells.
The use of specific toxins will prove of great value in the
unravelling of cell-cell relationships within the testis, and
especially within the seminiferous tubule. This could have possible
long-term benefits related to our understanding of the causes of
idiopathic infertility in men, especially those cases(the majority)
clearly involving abberations of spermatogenic development.
Furthermore, such studies will serve to highlight potentially damaging
chemicals in the environment, from which category, two of the
compounds used in these studies were drawn. Mono-ethyl hexyl phthalate
(mehp) is derived from one of a class of plasticizers used throughout
the plastics industry to which normal males are continually
exposed(through the use of plastic containers for food and drink and
also the use of plastics for storing blood for transfusions), whilst
methoxy acetic acid(MAA) is a metabolic derivative of a compound
found in most paints. Both of these compounds are potentially valuable
tools for the study of seminiferous tubule cell-cell interactions,
since MEHP appears to act specifically on the Sertoli cell to cause
exfoliation of germ cells, whilst MAA appears to act selectively on
primary spermatocytes undergoing post-zygotene meiotic maturation and
division(see Chapter 7). Studies similar to those carried out on EDS
and possibly involving perifusion of treated seminiferous tubules
should provide useful information relating to the importance of
cellular interactions within the tubules for the maintenance of
testicular function and spermatogenesis.
In conclusion, these studies have established novel and powerful
techniques for the investigation of the paracrine regulation of
testicular function. The perifusion system described represents a
significant improvement upon the _in vitro systems previously
available for the investigation of seminiferous tubule-Leydig cell
interactions. Results obtained with this system suggest that
communication between these cell types may act in both directions,
as might be expected for a physiological feedback regulation
systein(Chapter 5). Techniques for the determination of
intratesticular distribution of testosterone, when combined with
histological and toxicological techniques, have provided insights
into the role of testosterone in the regulation of spermatogenesis
and have also identified chemicals which may further advance our
understanding of the role of intratubular cell associations in the
maintenance of testicular function. It is apparent from these and
other studies that seminiferous tubule-Leydig cell interaction, far
from being a 'simple' dynamic system involving only Leydig and Sertoli
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cells, also involves germ cells, and possibly macrophages and Leydig
cell precursors(Chapter 7), and it seems certain that many paracrine
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